- Staat
- -
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 30.09.2023
- Impfdatum
- 17.10.2022
- Beginn
- 05.09.2023
- Tage bis Beginn
- 323,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Abdominal pain
Abdominal pain lower
Abdominal tenderness
Acute respiratory failure
Asthenia
Back pain
Bacteraemia
Bacterial test positive
Bladder catheterisation
Blood culture positive
Blood glucose decreased
Blood immunoglobulin A
COVID-19
Chronic obstructive pulmonary disease
Computerised tomogram abdomen normal
Computerised tomogram thorax normal
Condition aggravated
Confusional state
Symptomtext
Patient is a 69 y.o. female hx of COPD, lung cancer s/p L sided pneumonectomy who presented from home on 9/5/2023 with weakness found to be hypoxic with COVID 19. Hospital course complicated by progressive focal weakness, diplopia, with concerns for possible neuromuscular etiology; neurology evaluated. Will transfer to Riverside for further neurological evaluation. Also currently undergoing septic work up. Assessment and Plan Acute on chronic respiratory failure with hypoxia COPD Exacerbation COVID 19 - Presented with: Dyspnea, hypoxia and weakness - Symptom onset: 9/2/23 - Positive COVID-19: hospital 9/5/23 - CTPE on admission negative for PE - Oxygen status: Baseline PRN oxygen, presented on face mask weaned to 2-3L NC - Decadron: Yes. Expected end date 9/14/23 - Remdesivir: Yes. Expected end date 9/9/23- completed prior to transfer - DVT prophylaxis:Lovenox - Serial COVID labs ordered: No - Case Management/Social Services consulted: Yes - Continue home inhaler regimen with scheduled albuterol QID Progressive weakness Diplopia - possible underlying neuromuscular disorder or possible exacerbation of chronic complaints with covid and possible UTI - though some concerning exam findings -pt with baseline right foot drop, chronic history of dysphonia (follows with ENT) and some chronic left upper ext numbness - in context of above; pt has stated she has new weakness in left leg since discharge from hospitalization around mid 8/2023 (pt was there with small bowel obstruction; s/p surgical intervention) - pt normally does not use walking device though started using a walker several days prior to admission - over course of hospitalization at hospital this admission; pt with notable increased left lower extremity weakness and increased left upper ext weakness compared to right; also with new complaints of diplopia; mild ptosis b/l and weakness neck flexion; NIF around -20 to -25 - also intermittent complaints low back pain with left radicular symptoms with pain and paresthesias left lower ext - MRI brain unremarkable; MRI cervical, thoracic and lumbar spine was overall unremarkable; shows herniated disc L4-L5 with narrowing lateral recesses on left; no central stenosis - this is similar to MRI in 6/2023 - neurology evaluated on 9/9 - concerns given progressive weakness; diplopia; b/l ptosis and neck flexion weakness - considering myasthenia gravis, vs LEMS or AIDP vs other - NIF's mildly low around - 20 to -25; unable to obtain vital capacities at hospital given covid status per respiratory - consideration given for IVIG though with some risk given hypercoagulable state with covid and cancer; no active clot though; unclear if underlying bacterial infection at this time - per neurology; will hold on IVIG for now; preferred PLEX if needed though given pt's stability ideally planning for EMG evaluation; myasthenia gravis panel pending and IgA level pending; will need neurology consult. Updated on call neurologist about admission. Bacteremia - unclear if contamination or true infection - blood cultures from 9/7 showing coag neg staph - only one blood culture was drawn (not sure why two were not collected) - repeated blood cx's 9/8 and started on vancomycin after repeat cultures were drawn - pt afebrile though weak with hypoglycemia requiring dextrose gtt and mild hypothermia overnight; transient hypotension that resolved - cont vancomycin; IVF's, f/u repeat blood cx's - pt also started on empiric zosyn with concerns for developing sepsis overnight - noted TTE on 7/25/23 showed small linear mobile mass in RA of uncertain etiology; no valvular involvement; appears pt was to have cardiac MRI to further evaluate and did not have done yet; if repeat cx's positive then will plan for TTE and ID consult. Hypoglycemia - probably due to poor oral intake with underlying covid; evaluating for bacterial infection as well with above --with still some low/normal glucose levels despite dextrose in IVF's - infectious work up as above; - consider am cortisol level though current steroids may interfere with interpretation. - cont D5W infusion - monitor Urinary retention - noted overnight from 9/8 - 9/9 - possible UTI contributing to above - UA only with rare bacteria though unfortunately urine studies were not able to be collected prior to antibiotics - consider at least 5 days empiric treatment for possible UTI that could be masked in context of above as this could also contribute to some of her symptoms - cont foley catheter for now and voiding trial later Metabolic encephalopathy - pt with mild confusion; overall appropriate in conversation on exam; pt's husband noted some increased confusion at bedside - suspect due to covid 19; possible bacterial infection as well - currently ruling out; also hypoglycemia and oxycodone ; also working up for neuromuscular disease - MRI brain negative for acute process - no known hx of myasthenia gravis or other neurodegenerative disease; follows with neurologist for orthostatic hypotension; no dysphagia - cont dextrose in IVF's, reduce oxycodone; cont as above; urine cx pending though collected after antibiotics. - monitor closely Abdominal pain Nausea - suspected nausea and intermittent vomiting due to COVID 19; pt with poor oral intake - also urinary retention overnight - abd pain mostly RLQ - abd soft, on exam; tender to palpation - KUB on 9/7 with non specific haziness of abdomen - uncertain significance - given recent surgery for small bowel obstruction, CT abd/pelvis was done and unremarkable - monitor; cont zosyn for empiric coverage for UTI in context of acute illness above.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 13.07.2023
- Impfdatum
- 22.10.2022
- Beginn
- 19.01.2023
- Tage bis Beginn
- 89,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Pulmonary embolism
Symptomtext
ACUTE PULMONARY EMBOLISM
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 13.07.2023
- Impfdatum
- 24.10.2022
- Beginn
- 11.03.2023
- Tage bis Beginn
- 138,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Symptomtext
ACUTE RESPIRATORY FAILURE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 11.07.2023
- Impfdatum
- 02.11.2022
- Beginn
- 15.03.2023
- Tage bis Beginn
- 133,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute myocardial infarction
Symptomtext
ACUTE NON ST ELEVATION MI
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 93,0
- Geschlecht
- F
- Eingang
- 26.06.2023
- Impfdatum
- 09.11.2022
- Beginn
- 14.11.2022
- Tage bis Beginn
- 5,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Cerebrovascular accident
Symptomtext
ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 21.06.2023
- Impfdatum
- 12.10.2022
- Beginn
- 16.01.2023
- Tage bis Beginn
- 96,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Anaemia of chronic disease
Atrial fibrillation
Transient ischaemic attack
Symptomtext
TRANSIENT CEREBRAL ISCHEMIA 4/9/2023 ATRIAL FIBRILLATION, UNSPECIFIED ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/12/2023 ATRIAL FIBRILLATION, UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA 4/9/2023 ANEMIA OF CHRONIC DISEASE ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/12/2023 ANEMIA OF CHRONIC DISEASE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 07.06.2023
- Impfdatum
- 22.10.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 10,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute myocardial infarction
Symptomtext
ACUTE NON ST ELEVATION MI
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 07.05.2023
- Impfdatum
- 20.10.2022
- Beginn
- 27.12.2022
- Tage bis Beginn
- 68,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood test
Computerised tomogram
Pulmonary embolism
Symptomtext
Several months after vaccination I suffered pulmonary embolism.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 5,0
- Labordaten
- 01/02/2023 - Blood tests and CT scan
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- Allergies to mold and dust.
- Andere Medikamente
- Allegra 60mg, Zyrtec 10mg, probiotics, Centrum Older Male Vitamins, Mucinex 400mg
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 13.02.2023
- Impfdatum
- 14.10.2022
- Beginn
- 30.01.2023
- Tage bis Beginn
- 108,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Patient expired
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- s/p hip replacement
- Vorgeschichte
- A-fib
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 17.01.2023
- Impfdatum
- 21.10.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 11,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blindness
Cerebral thrombosis
Cerebrovascular accident
Death
Dysarthria
Cardio-respiratory arrest
Dyspnoea
Fatigue
Headache
Gastrointestinal tube insertion
Hemiplegia
Intensive care
Laboratory test
Mechanical ventilation
Myalgia
Symptomtext
patient was having a stroke/experienced a massive blood clot in the brain/severely paralyzed from her left side/she began to slur her speech/they were about to have dinner when his wife mentioned she could not see the table; out of breath; headaches coming and going; muscle pain; fatigue every day; cardio respiratory arrest; This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (patient was having a stroke/experienced a massive blood clot in the brain/severely paralyzed from her left side/she began to slur her speech/they were about to have dinner when his wife mentioned she could not see the table), DYSPNOEA (out of breath) and CARDIO-RESPIRATORY ARREST (cardio respiratory arrest) in an 81-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (Dose 1) on 27-Feb-2021, Moderna COVID-19 Vaccine (Dose 2) on 16-May-2021 and Moderna COVID-19 Vaccine (1st booster) on 16-May-2022. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine. On 21-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 02-Nov-2022, the patient experienced CEREBROVASCULAR ACCIDENT (patient was having a stroke/experienced a massive blood clot in the brain/severely paralyzed from her left side/she began to slur her speech/they were about to have dinner when his wife mentioned she could not see the table) (seriousness criteria death, hospitalization and medically significant) and DYSPNOEA (out of breath) (seriousness criteria death and hospitalization). In November 2022, the patient experienced CARDIO-RESPIRATORY ARREST (cardio respiratory arrest) (seriousness criteria death and medically significant). On an unknown date, the patient experienced HEADACHE (headaches coming and going), MYALGIA (muscle pain) and FATIGUE (fatigue every day). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Muscle pain, at an unspecified dose and frequency. The patient died on 11-Nov-2022. The reported cause of death was cardio respiratory arrest, patient was having a stroke/experienced a massive blood clot in the brain/severely paralyzed from her left side/she began to slur her speech/they were about to have dinner when his wife mentioned she could not see the table and out of breath. An autopsy was performed, but no results were provided. At the time of death, HEADACHE (headaches coming and going), MYALGIA (muscle pain) and FATIGUE (fatigue every day) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Patient received 1st dose of Moderna vaccine on 27-Feb-2021, 2nd dose of Moderna vaccine on 16-May-2021 and 1st booster dose on 16-May-2022. After receiving the bivalent booster on 21-Oct-2022, patient experienced headaches coming and going, muscle pain during a couple of days, and fatigue every day. Patient took Tylenol. On 02-Nov-2022, caregiver explained they were about to have dinner when his wife mentioned she could not see the table, and was out of breath, she began to slur her speech, and the lady beside her who was a nurse stated his wife was having a stroke, they called an ambulance and 15 minutes later they went to the hospital. Doctors mentioned she experienced a massive blood clot in the brain and administered a pill to break it, but it did not work, they tried to catheterized her twice unsuccessfully, and patient became severely paralyzed from her left side, doctors mentioned she would not get much better after this, and caregiver took the decision to let her die. Patient died 9 days later at 10 am on 11-Nov-2022 in a hospice. On an unknown date, unspecified lab test was performed, no relevant results reported. Company Comment: This fatal spontaneous case concerns an 81-year-old female patient, with no reported medical history, who experienced the unexpected and serious (death, hospitalization and medically significant) events of CEREBROVASCULAR ACCIDENT, DYSPNOEA and CARDIO-RESPIRATORY ARREST, among other non-serious events, and die after the second booster dose of mRNA-1273.222 vaccine. She experienced headaches coming and going, muscle pain during a couple days, and fatigue every day, and she took paracetamol. Having dinner twelve days after vaccination, she mentioned she could not see and being out of breath, and she began to slur her speech. She was transferred to hospital where a massive blood clot in her brain was found. She received an unknown oral medication and two unsuccessful catheterizations treatment. She became severely paralyzed from her left side. Since she was not going to improve, her caregiver took the decision to let her die. Patient died 9 days later (21 days after vaccination). The reported cause of death was cardiorespiratory arrest, cerebrovascular accident and dyspnoea. An autopsy was performed, but no results were provided. No further clinical information was available for medical review. Patient?s age could be a risk factor for cerebrovascular accident. The benefit-risk relationship of mRNA-1273.222 is not affected by this report.; Sender's Comments: This fatal spontaneous case concerns an 81-year-old female patient, with no reported medical history, who experienced the unexpected and serious (death, hospitalization and medically significant) events of CEREBROVASCULAR ACCIDENT, DYSPNOEA and CARDIO-RESPIRATORY ARREST, among other non-serious events, and die after the second booster dose of mRNA-1273.222 vaccine. She experienced headaches coming and going, muscle pain during a couple days, and fatigue every day, and she took paracetamol. Having dinner twelve days after vaccination, she mentioned she could not see and being out of breath, and she began to slur her speech. She was transferred to hospital where a massive blood clot in her brain was found. She received an unknown oral medication and two unsuccessful catheterizations treatment. She became severely paralyzed from her left side. Since she was not going to improve, her caregiver took the decision to let her die. Patient died 9 days later (21 days after vaccination). The reported cause of death was cardiorespiratory arrest, cerebrovascular accident and dyspnoea. An autopsy was performed, but no results were provided. No further clinical information was available for medical review. Patient?s age could be a risk factor for cerebrovascular accident. The benefit-risk relationship of mRNA-1273.222 is not affected by this report.; Reported Cause(s) of Death: cardio respiratory arrest; patient was having a stroke/experienced a massive blood clot in the brain/severely paralyzed from her left side/she began to slur her speech/they were about to have dinner when his wife mentioned she could not see the table
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 17.01.2023
- Impfdatum
- 21.10.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 11,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blindness
Cerebral thrombosis
Cerebrovascular accident
Death
Dysarthria
Cardio-respiratory arrest
Dyspnoea
Fatigue
Headache
Gastrointestinal tube insertion
Hemiplegia
Intensive care
Laboratory test
Mechanical ventilation
Myalgia
Symptomtext
patient was having a stroke/experienced a massive blood clot in the brain/severely paralyzed from her left side/she began to slur her speech/they were about to have dinner when his wife mentioned she could not see the table; out of breath; headaches coming and going; muscle pain; fatigue every day; cardio respiratory arrest; This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (patient was having a stroke/experienced a massive blood clot in the brain/severely paralyzed from her left side/she began to slur her speech/they were about to have dinner when his wife mentioned she could not see the table), DYSPNOEA (out of breath) and CARDIO-RESPIRATORY ARREST (cardio respiratory arrest) in an 81-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (Dose 1) on 27-Feb-2021, Moderna COVID-19 Vaccine (Dose 2) on 16-May-2021 and Moderna COVID-19 Vaccine (1st booster) on 16-May-2022. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine. On 21-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 02-Nov-2022, the patient experienced CEREBROVASCULAR ACCIDENT (patient was having a stroke/experienced a massive blood clot in the brain/severely paralyzed from her left side/she began to slur her speech/they were about to have dinner when his wife mentioned she could not see the table) (seriousness criteria death, hospitalization and medically significant) and DYSPNOEA (out of breath) (seriousness criteria death and hospitalization). In November 2022, the patient experienced CARDIO-RESPIRATORY ARREST (cardio respiratory arrest) (seriousness criteria death and medically significant). On an unknown date, the patient experienced HEADACHE (headaches coming and going), MYALGIA (muscle pain) and FATIGUE (fatigue every day). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Muscle pain, at an unspecified dose and frequency. The patient died on 11-Nov-2022. The reported cause of death was cardio respiratory arrest, patient was having a stroke/experienced a massive blood clot in the brain/severely paralyzed from her left side/she began to slur her speech/they were about to have dinner when his wife mentioned she could not see the table and out of breath. An autopsy was performed, but no results were provided. At the time of death, HEADACHE (headaches coming and going), MYALGIA (muscle pain) and FATIGUE (fatigue every day) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Patient received 1st dose of Moderna vaccine on 27-Feb-2021, 2nd dose of Moderna vaccine on 16-May-2021 and 1st booster dose on 16-May-2022. After receiving the bivalent booster on 21-Oct-2022, patient experienced headaches coming and going, muscle pain during a couple of days, and fatigue every day. Patient took Tylenol. On 02-Nov-2022, caregiver explained they were about to have dinner when his wife mentioned she could not see the table, and was out of breath, she began to slur her speech, and the lady beside her who was a nurse stated his wife was having a stroke, they called an ambulance and 15 minutes later they went to the hospital. Doctors mentioned she experienced a massive blood clot in the brain and administered a pill to break it, but it did not work, they tried to catheterized her twice unsuccessfully, and patient became severely paralyzed from her left side, doctors mentioned she would not get much better after this, and caregiver took the decision to let her die. Patient died 9 days later at 10 am on 11-Nov-2022 in a hospice. On an unknown date, unspecified lab test was performed, no relevant results reported. Company Comment: This fatal spontaneous case concerns an 81-year-old female patient, with no reported medical history, who experienced the unexpected and serious (death, hospitalization and medically significant) events of CEREBROVASCULAR ACCIDENT, DYSPNOEA and CARDIO-RESPIRATORY ARREST, among other non-serious events, and die after the second booster dose of mRNA-1273.222 vaccine. She experienced headaches coming and going, muscle pain during a couple days, and fatigue every day, and she took paracetamol. Having dinner twelve days after vaccination, she mentioned she could not see and being out of breath, and she began to slur her speech. She was transferred to hospital where a massive blood clot in her brain was found. She received an unknown oral medication and two unsuccessful catheterizations treatment. She became severely paralyzed from her left side. Since she was not going to improve, her caregiver took the decision to let her die. Patient died 9 days later (21 days after vaccination). The reported cause of death was cardiorespiratory arrest, cerebrovascular accident and dyspnoea. An autopsy was performed, but no results were provided. No further clinical information was available for medical review. Patient?s age could be a risk factor for cerebrovascular accident. The benefit-risk relationship of mRNA-1273.222 is not affected by this report.; Sender's Comments: This fatal spontaneous case concerns an 81-year-old female patient, with no reported medical history, who experienced the unexpected and serious (death, hospitalization and medically significant) events of CEREBROVASCULAR ACCIDENT, DYSPNOEA and CARDIO-RESPIRATORY ARREST, among other non-serious events, and die after the second booster dose of mRNA-1273.222 vaccine. She experienced headaches coming and going, muscle pain during a couple days, and fatigue every day, and she took paracetamol. Having dinner twelve days after vaccination, she mentioned she could not see and being out of breath, and she began to slur her speech. She was transferred to hospital where a massive blood clot in her brain was found. She received an unknown oral medication and two unsuccessful catheterizations treatment. She became severely paralyzed from her left side. Since she was not going to improve, her caregiver took the decision to let her die. Patient died 9 days later (21 days after vaccination). The reported cause of death was cardiorespiratory arrest, cerebrovascular accident and dyspnoea. An autopsy was performed, but no results were provided. No further clinical information was available for medical review. Patient?s age could be a risk factor for cerebrovascular accident. The benefit-risk relationship of mRNA-1273.222 is not affected by this report.; Reported Cause(s) of Death: cardio respiratory arrest; patient was having a stroke/experienced a massive blood clot in the brain/severely paralyzed from her left side/she began to slur her speech/they were about to have dinner when his wife mentioned she could not see the table
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 30.12.2022
- Impfdatum
- 04.11.2022
- Beginn
- 07.12.2022
- Tage bis Beginn
- 33,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Bell's palsy
Cellulitis
Computerised tomogram head normal
Computerised tomogram neck
Intensive care
Septic shock
Symptomtext
R sided Bells palsy developed early December. He did receive with fluzone in R deltoid 11/18/22. He has now been admitted to ICU with cellulitis of the L ear, face and neck with septic shock.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Septic shock
- Hospital-Tage
- 1,0
- Labordaten
- CT head and neck negative for acute stroke.
- Aktuelle Erkrankungen
- Recent osteomyelitis of L toe.
- Vorgeschichte
- Diabetes, HTN, hyperlipidemia, obesity, OA, chronic back pain.
- Andere Medikamente
- Outpatient Medications cyanocobalamin, vitamin B-12, 100 mcg tablet Take 100 mcg by mouth 1 time per day magnesium oxide 500 mg TABS tablet Take 250 mg by mouth 1 time per day multivitamin therapeutic with minerals (THERA-M) tablet
- Allergien
- PCN, keflex, codeine, eggs, chicken derived products, hydrocodone, pineapple.
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 09.11.2022
- Impfdatum
- 03.11.2022
- Beginn
- 04.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Cardiac arrest
Chest discomfort
Dyspnoea
Mechanical ventilation
Pyrexia
Symptomtext
On 11/4/22 began to have fever chills, and some chest tightness with shortness of breath, went to ER on 11/5/22 and went into cardiac arrest was put on vent and transported to hospital. Is still in hospital as of today, 11/9/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiac arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- unable to obtain
- Andere Medikamente
- unable to get information
- Allergien
- unable to get information
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 08.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cerebral haemorrhage
Concussion
Fall
Syncope
Vaccination site pain
Symptomtext
Some bleeding into the brain; Patient has a concussion; Later that day the patient fainted, fell to the ground and hit her head; Later that day the patient fainted, fell to the ground and hit her head; Sore left injection site arm; This spontaneous case was reported by a patient and describes the occurrence of CEREBRAL HEMORRHAGE (Some bleeding into the brain), CONCUSSION (Patient has a concussion), FALL (Later that day the patient fainted, fell to the ground and hit her head) and SYNCOPE (Later that day the patient fainted, fell to the ground and hit her head) in a 75-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included High cholesterol. On 27-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Oct-2022, the patient experienced CEREBRAL HEMORRHAGE (Some bleeding into the brain) (seriousness criteria hospitalization and medically significant), CONCUSSION (Patient has a concussion) (seriousness criterion hospitalization), FALL (Later that day the patient fainted, fell to the ground and hit her head) (seriousness criterion hospitalization), SYNCOPE (Later that day the patient fainted, fell to the ground and hit her head) (seriousness criteria hospitalization and medically significant) and VACCINATION SITE PAIN (Sore left injection site arm). At the time of the report, CEREBRAL HEMORRHAGE (Some bleeding into the brain), CONCUSSION (Patient has a concussion), FALL (Later that day the patient fainted, fell to the ground and hit her head), SYNCOPE (Later that day the patient fainted, fell to the ground and hit her head) and VACCINATION SITE PAIN (Sore left injection site arm) outcome was unknown. Patient's height was 5 foot 6 inch. Concomitant medication included high cholesterol medication. The patient received the first dose of Moderna Covid-19 vaccine on 26-Feb-2021 of lot number 001A21A on the left arm. The patient received the second dose of Moderna Covid-19 vaccine on 26-Mar-2021 of lot number 008B21A on the left arm. The patient received the first booster dose of Moderna Covid-19 vaccine on 28-Oct-2021 of lot number 001A21A on the left arm. On 27-Oct-2022, the patient received first Moderna Covid-19 bivalent vaccine booster dose. Later on the day of bivalent booster dose administration, the patient fainted, fell to the ground and hit the head and the patient went to the emergency room and was admitted to the hospital. Treatment information was not provided. Company comment: This spontaneous case concerns a 75-year-old female with high blood cholesterol who experienced the unexpected, serious (hospitalization, medically significant) event of cerebral hemorrhage, the unexpected serious (hospitalization) event of concussion and fall and the expected serious (hospitalization, medically significant) event of syncope, which occurred the same day after receiving a dose of mRNA1273 bivalent BA .4/5 as fourth dose in the COVID-19 vaccine series. The events of this case may be in association with each other. Approximately a few hours post vaccination the patient fainted, fell to the ground and hit her head. This prompted her to visit the emergency room and was subsequently admitted. Further details on the clinical course, diagnostic and ancillary test done were not provided. The patient's advanced age may be considered as a risk factor for cerebral hemorrhage, fall and syncope. The benefit-risk relationship of mRNA-1273 is not affected by this report. Event seriousness assessed as per medical judgment. This case was linked to MOD-2022-666798, MOD-2022-666790 (Patient Link). Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns a 75 year old female with high blood cholesterol who experienced the unexpected, serious (hospitalization, medically significant) event of cerebral hemorrhage, the unexpected serious (hospitalization) event of concussion and fall and the expected serious (hospitalization, medically significant) event of syncope, which occurred the same day after receiving a dose of mRNA1273 bivalent BA .4/5 as fourth dose in the COVID-19 vaccine series. The events of this case may be in association with each other. Approximately a few hours post vaccination the patient fainted, fell to the ground and hit her head. This prompted her to visit the emergency room and was subsequently admitted. Further details on the clinical course, diagnostic and ancillary test done were not provided. The patient's advanced age may be considered as a risk factor for cerebral haemorrhage, fall and syncope. The benefit-risk relationship of mRNA-1273 is not affected by this report. Event seriousness assessed as per medical judgment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebral haemorrhage
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- High cholesterol
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 02.11.2022
- Impfdatum
- 24.10.2022
- Beginn
- 31.10.2022
- Tage bis Beginn
- 7,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Death
Symptomtext
Client was diagnosed with COVID-19 at facility he lived at. Death was reported on 11/1/2022 by facility Administrator
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Penicillin G Influenza Vaccines
- Vorherige Impfungen
- Reported having skin rash after past Flu Vaccine
- Staat
- -
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 11.07.2023
- Impfdatum
- 02.11.2022
- Beginn
- 17.02.2023
- Tage bis Beginn
- 107,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Deep vein thrombosis
Symptomtext
ACUTE DVT, UNSPECIFIED VEIN ACUTE DVT OF BILAT FEMORAL VEINS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 13.06.2023
- Impfdatum
- 25.10.2022
- Beginn
- 04.11.2022
- Tage bis Beginn
- 10,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Deep vein thrombosis
Symptom recurrence
Symptomtext
ACUTE DVT OF RIGHT POPLITEAL VEIN 2/17/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 11.04.2023
- Impfdatum
- 14.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Anticoagulant therapy
Arthralgia
Deep vein thrombosis
Magnetic resonance imaging spinal
Pain in extremity
Peripheral swelling
Ultrasound Doppler abnormal
X-ray abnormal
X-ray limb abnormal
X-ray limb normal
Symptomtext
Bilateral shoulder pain 10-14-22 R > L (R) hand pain and swelling - 12-30-22 HH/Physical Therapy Neck shoulder & hand xrays - 12-30-22 given prednisone & cyclobenzaprine. 1-6-23 MRI C-spine, prednisone, cyclobenzaprine 1-26-23 Ortho consult 1-26-23 DVT proximal to distal brachial vein - Eliquis
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deep vein thrombosis
- Hospital-Tage
- -
- Labordaten
- 12-30-22 Neck xray - DDD R hand xray - osteroarthritic changes (R) shoulder xray - Nl 1-26-23 (R) venous doppler - DVT brachial vein
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Arthritis, COPD HTN, Hyperlipidemia, generalized anxiety disorder, atherosclerosis coronary artery
- Andere Medikamente
- Atorvastatin and aspirin 81mg
- Allergien
- Losartan and Sulfa Drugs
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 55,0
- Geschlecht
- M
- Eingang
- 20.01.2023
- Impfdatum
- 30.11.2022
- Beginn
- 05.12.2022
- Tage bis Beginn
- 5,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bell's palsy
Facial paralysis
Hypoaesthesia
Muscle twitching
Symptomtext
On the late morning of Monday December 5th I began to have some facial dropping, lip twitching and check felt numb like it had Novocain. The next day, Dec 6th, since the paralysis was getting worse in my face I went to the hospital out patient office to get it checked and they sent me to the hospital emergency room. After speaking with the ER Doctor he said it was very likely Bell's palsy and prescribed some steroids to help with the condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- The checked my finger strength but didn't run any lab tests.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 19.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 7,0
- Dosis
- 4
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: ja
Erholt: nein
Bell's palsy
Facial paralysis
Symptomtext
Right side facial paralysis, DX in ER as Belle's Palsy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- ER visit, ran through verbal and physical test, as well as stroke protocols.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Multi vitamin, D3, Calcium, magnesium, tumeric, multi flavanoid, metformin,
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 27.10.2022
- Impfdatum
- 23.10.2022
- Beginn
- 23.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Dizziness
Nausea
Syncope
Tremor
Unresponsive to stimuli
Symptomtext
Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Nausea-Medium, Systemic: Shakiness-Medium, Additional Details: Patient came to the pharmacy and received both flu and moderna vaccines. While patient was waiting after vaccination, she became unresponsive for less than a minute upon which I intervened. Patient said she was hung over from drinking alcohol. Epipen was not administered because she regained consciousness as sson as I got to the vaccination area and she refused epipen.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 26.10.2022
- Impfdatum
- 26.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Immediate post-injection reaction
Seizure
Symptomtext
PATIENT HAD A SEIZURE APPROXIMATELY 10 MINUTES AFTER HE RECEIVED THE VACCINATION. THE SEIZURE LASTED ABOUT 45 SECONDS TO 1 MINUTES. THE PATIENT WAS ABLE TO ANSWER QUESTIONS RELATED TO TIME AND SPACE AFTER HE RECOVERED FROM THE SEIZURE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 19.10.2022
- Impfdatum
- 15.10.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Chills
Confusional state
Dizziness
Fatigue
Feeling abnormal
Flushing
Hyperhidrosis
Hypertension
Lethargy
Loss of consciousness
Nervousness
Posture abnormal
Syncope
Tremor
Unresponsive to stimuli
Symptomtext
Systemic: Chills-Severe, Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypertension-Mild, Systemic: Shakiness-Mild, Additional Details: Pt received COVID Bivalent moderna booster in left delt, Fluad in right delt. felt fine for around 2 minutes before head tilted back and pt lost consciousness, excessive sweating. pt still felt bad when he woke up. blood pressure 145/84, pulse 54. shaky, weak. water and orange juice did not resolve symptoms. wife drove pt to local urgent care. will follow up with pt tomorrow.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 18.10.2022
- Impfdatum
- 16.10.2022
- Beginn
- 16.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Dizziness
Dysstasia
Heart rate increased
Hypertension
Nausea
Syncope
Throat tightness
Symptomtext
10/16/2022 08:50 pm: Sudden throat tightness, dizziness, lightheadedness, followed by fainting briefly. Nausea, dizziness and lightheadedness lasted for a couple hours after. 10/17/2022 09:15 am: Dizziness and lightheadedness, worsening until I could not stand or sit up around 9:30 am. High heart rate and blood pressure, subsided by 10:00 am. Continued dizziness, lightheadedness, nausea, headaches, joint aches, and chills on and off throughout the rest of the day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma Vocal Cord Dysfunction High cholesterol
- Andere Medikamente
- Monteleukast Sodium Atorvastatin Loratadine Omega-3 Albuterol Sulfate HFA Inhaler
- Allergien
- None
- Vorherige Impfungen
- Age 23; Vaccination date 11/11/2021; Moderna monovalent COVID booster; 104 deg F fever, bad chills, sensitive skin, headache, na
- Staat
- AR
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 15.06.2023
- Impfdatum
- 04.11.2022
- Beginn
- 23.05.2023
- Tage bis Beginn
- 200,0
- Dosis
- 5
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Acute kidney injury
COVID-19
Dyspnoea at rest
Hyperkalaemia
Pneumonia
Symptomtext
Patient was seen at the local ER for c/o shortness of breath at rest for the past 5 days. Patient was previously seen by PCP and diagnosed wth covid and started on paxlovid. Patient was admitted with a Dx of pneumonia, acute kidney failure and hyperkalemia for further evaluation and treatment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea at rest
- Hospital-Tage
- 8,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Diabetes mellitus, hypertensive disorder, covid 19, chronic kidney disease
- Andere Medikamente
- Amlodipine 10mg po BID Gabapentin 300mg po TID Glimepiride 2mg po daily Hydralazine 50mg po TID Magnesium chloride 64mg po BID Protonix 40mg po daily Spironolactone 25mg po BID Tizanidine 4mg po every 6 hours prn
- Allergien
- Betadine
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 28.04.2023
- Impfdatum
- 27.10.2022
- Beginn
- 20.04.2023
- Tage bis Beginn
- 175,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cold sweat
Cough
Dyspnoea
Enlarged uvula
Feeling of body temperature change
Headache
Pyrexia
SARS-CoV-2 test positive
Throat tightness
Symptomtext
Two days before testing positive I woke up with a massive headache. 23APR2023 at 4AM I woke up and using the facilities I coughed I realized it was a very deep lung cough and immediately grabbed a home test and it was positive. I have had a low grade consistent fever hot and cold at the same to time clammy I had to call the EMS and then it was no t so easy. this past Wednesday I was getting ready for bed and had trouble breathing and took a breath off of my inhaler and instead of helping it made my Uvula swell and my throat closed so I called 911 and they were great EMS gave Dexamethasone and convinced me to go the ER. In the ER the Doctor was unaware of the correlation between my swollen Uvula and my inhaler and my research including CDC, Clinic, agency, hospital information that it is the alcohol in the inhaler that can cause it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 23APR2023 COVID-19 Test-Positive.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Penicillin; Codeine; Synthetics; Tramadol; Soy
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 11.04.2023
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hypoaesthesia
Magnetic resonance imaging head
Paraesthesia
Symptomtext
On October 10, 2022 I experienced numbness and tingling on the left down my face and into my legs. No medications were prescribed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- Brain MRI
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Ankylosing Spondylitis; Crohn's; Mitral valve regurgitation; Pre-diabetic; renal insufficiency; High Cholesterol; Osteopenia; Arthritis; Venus Insufficiency;
- Andere Medikamente
- Humira; Mesalamine; Famotidine; Ezetimibe; Cetirizine;
- Allergien
- Shrimp; Yellow dye; Celebrex; Capsaicin;
- Vorherige Impfungen
- Covid-19 vaccine
- Staat
- AR
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 04.04.2023
- Impfdatum
- 20.10.2022
- Beginn
- 28.12.2022
- Tage bis Beginn
- 69,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Blood test abnormal
Chest pain
Cold sweat
Coronary arterial stent insertion
Coronary artery occlusion
Dyspnoea
Echocardiogram abnormal
Electrocardiogram abnormal
Symptomtext
I was having chest pains after a gardening endeavor. I tried to take to a shower but had to cut it short but started to feel clammy, short of breath. I drove to a friend's house and asked him to drive me to the emergency room. Upon arrival to the emergency room, they ran an EKG, blood work, echocardiogram. I was given two choices to wait four days as they did not have anyone there to help with my episode to be transported to the hospital locally. Once in the hospital, they ran the same test found that I had 99% blockage that I had in 2017. The cardiologist stated the stents that were originally put in were too small. He cleaned the vessel, implanted a larger stent, let me know my other vessels were clean and I should be able to live a long healthy life. I am currently partway through cardiopulmonary rehab.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- 2,0
- Labordaten
- 28DEC2022 EKG positive for cardiac issues; 28DEC2022 Blood work positive for cardiac issues; 28DEC2022 Echocardiogram positive for cardiac issues
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- CRESTOR; baby aspirin; turmeric
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 07.02.2023
- Impfdatum
- 26.10.2022
- Beginn
- 28.01.2023
- Tage bis Beginn
- 94,0
- Dosis
- 5
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Arrhythmia
Burning sensation
COVID-19
Cough
Dizziness
Headache
Malaise
Oropharyngeal pain
Pain
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Sinusitis
Symptomtext
I came down with symptoms when I woke up. I had the classic symptoms with coughing, fever, sore throat, and body aches. I took a home test and it was positive. I went to the urgent care and I was given Paxlovid. They wanted to give me Remdesivir as an injection, but it was noted I needed to stop taking Atorvastatin for a week, so we went with the Paxlovid. The Paxlovid had taken care of all the symptoms besides dizziness, headaches, and some heart arrhythmias. Yesterday evening was day 9 or 10. I just had a complete relapse. I had the worst sinus infection with burning sensations. It's just horrible. A lot of discharge and the cough is pretty bad. That's been my experience with COVID-19 so far.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arrhythmia
- Hospital-Tage
- -
- Labordaten
- 29JAN2023 At Home COVID-19 Test - Positive; 30JAN2023 At Home COVID-19 Test - Positive; 31JAN2023 At Home COVID-19 Test - Positive; 01FEB2023 At Home COVID-19 Test - Positive; 02FEB2023 At Home COVID-19 Test - Positive; 03FEB2023 At Home COVID-19 Test - Positive; 04FEB2023 At Home COVID-19 Test - Positive; 06FEB2023 At Home COVID-19 Test - Positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Heart Disease; Ankylosing Spondylitis
- Andere Medikamente
- Zetia; Atorvastatin; Pristiq; Multivitamin; Omega 3; Vitamin B12; Kratom
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 19.01.2023
- Impfdatum
- 12.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anxiety
Dyspnoea
Hallucination, auditory
Immediate post-injection reaction
Urinary tract infection
Symptomtext
Immediately following vaccination, patient reported difficulty breathing/anxiety which subsided shortly. In weeks following vaccination, patient has been experiencing auditory hallucinations (ie. hearing voices telling her disturbing things about her family, telling her to end her life). Patient was started on quetiapine on 1/4/23, with the dose being increased on 1/12/23. She was also started on treatment for UTI on 1/17/23. Family member reports that hallucinations are continuing, but otherwise patient is lucid and at physical baseline. She has an appointment scheduled with neurology some time at the end of January 2023.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- None at this time, patient has follow-up with neurology provider scheduled for end of January 2023.
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- hypothyroidism, gerd, trouble sleeping, depression, hypertension
- Andere Medikamente
- Albuterol inhaler, amlodipine, baclofen, diclofenac topical gel, hydroxyzine, isosorbide, levothyroxine, metoprolol, mirtazapine, omeprazole, poly glycol powder, potassium, preservision, spiriva respimat, torsemide, unisom sleeptab, vitamin
- Allergien
- Azithromycin, bumetanide, nitrofurantoin, sulfa, iodine contrast, adhesive tape
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 17.01.2023
- Impfdatum
- 17.10.2022
- Beginn
- 05.12.2022
- Tage bis Beginn
- 49,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Dyspnoea
Oropharyngeal pain
SARS-CoV-2 test positive
Symptomtext
On the 5th of December I was having a sore throat something like I have never had before. I tested at home and was negative then I went to a local clinic, and I tested positive for COVID-19. The doctor told me to take emergency and a Vicks shower bomb, and this stuff didn't work. These symptoms only lasted for 24 hours, and I tested 14 days later and was negative. I still have shortness of breathe.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- COVID-19
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Calcium
- Allergien
- N/A
- Vorherige Impfungen
- flu- COVID-19 like symptoms
- Staat
- KS
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 13.01.2023
- Impfdatum
- 13.10.2022
- Beginn
- 13.12.2022
- Tage bis Beginn
- 61,0
- Dosis
- 5
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Bradycardia
COVID-19
Chills
Cough
Fatigue
Hypertension
Malaise
Nasopharyngitis
Pain
Palpitations
Pyrexia
Respiratory tract congestion
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
I started having symptoms of COVID-19 on December 13, 2022. I called my doctor and requested a COVID-19 test. I took a PCR COVID-19 test on December 14, 2022. I requested a prescription for PAXLOVID. I started PAXLOVID that evening. My symptoms initially included fever, chills, body aches, and joint pain. Those symptoms resolved by Friday, December 16, 2022. I also had head cold symptoms that included congestion, cough, and runny nose. Those continued for two weeks. I still feel fatigued. I've experienced heart palpitations, and those have continued as well. I saw a cardiologist on January 4, 2023. The cardiologist noted changes in my condition from a year ago including bradycardia and hypertension.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- 12/14/2022 PCR COVID-19 test positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Primary Hypocholesteremia; Heart Murmur; Osteopenia
- Andere Medikamente
- Alendronate; metoprolol; lovastatin; calcium and vitamin D combined; CENTRUM SILVER for women
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 10.01.2023
- Impfdatum
- 10.10.2022
- Beginn
- 10.12.2022
- Tage bis Beginn
- 61,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Back disorder
COVID-19
Condition aggravated
Myalgia
Nasal congestion
Oropharyngeal pain
Pyrexia
SARS-CoV-2 test positive
Symptomtext
I had a fever, extreme muscle aches, stuffy nose, sore throat, no chest congestion, and nasal congestion. I already have back issues and COVID made it worse. I tested positive for COVID-19. The doctor prescribed me PAXLOVID.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- COVID-19 test, 12/10/2022, positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Lower back problems; History of Heart Attack
- Andere Medikamente
- Aspirin; lisinopril; BYSTOLIC; atorvastatin; clonazepam; fish oil
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 08.01.2023
- Impfdatum
- 26.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Injected limb mobility decreased
Injection site pain
Loss of personal independence in daily activities
Pain in extremity
Symptomtext
Site: Pain at Injection Site-Severe, Systemic: Joint Pain-Medium, Additional Details: patient stated that she had pain in arm soon after shot and the following days she had reduced movement. she consulted with her md who told her to do some exercises and use topical preps for relief.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 08.01.2023
- Impfdatum
- 26.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Injected limb mobility decreased
Injection site pain
Loss of personal independence in daily activities
Pain in extremity
Symptomtext
Site: Pain at Injection Site-Severe, Systemic: Joint Pain-Medium, Additional Details: patient stated that she had pain in arm soon after shot and the following days she had reduced movement. she consulted with her md who told her to do some exercises and use topical preps for relief.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 15.12.2022
- Impfdatum
- 06.12.2022
- Beginn
- 07.12.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Dizziness
Lethargy
Pyrexia
Tremor
Symptomtext
Severe chills with violent shaking which were unresponsive to Acetaminophen or aspirin. Lasted 24 hours. Fever, Lethargy, Dizziness, which lasted 24 hours as well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Oral birth control
- Allergien
- None
- Vorherige Impfungen
- Previous Covid vaccinations
- Staat
- TN
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 02.12.2022
- Impfdatum
- 18.10.2022
- Beginn
- 19.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Mobility decreased
Symptomtext
About 12 hours after vaccine I woke up the next morning and the arm I received my injection in was so painful that I could barely move. I would say my pain that morning was an 11 on a scale to 1-10. I didn't even get out of bed that first day. Pain continued without relent and I went in to see my PCP after two weeks. PCP was unable to identify reason for extreme pain. Pain has improved slightly but still comes and goes. When I do experience the pain I would put it at a 5 on a scale of 1-10.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Physical examination
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetic; high blood pressure; high cholesterol; thyroid
- Andere Medikamente
- Warfarin; glimepiride; trazodone; ZOFRAN; simvastatin; metformin; PERCOCET; probiotic; levothyroxine; venlafaxine; nortriptyline; MG; metoprolol; pantoprazole; FLONASE; furosemide; ZYRTEC; hydrocodone
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 33,0
- Geschlecht
- M
- Eingang
- 28.11.2022
- Impfdatum
- 14.10.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood test normal
Chest X-ray normal
Chest pain
Computerised tomogram
Echocardiogram abnormal
Electrocardiogram normal
Exercise tolerance decreased
Mitral valve prolapse
Scan with contrast
Sleep disorder
Symptomtext
About 10 hours after getting vaccination woke up with chest pain that I had never experienced before. On a scale of 0-10 the intensity varied between a 2 & 4. Went to urgent care on Sunday and they performed chest x-ray, blood work, and EKG with everything returning within normal limits. They referred me to a cardiologist. Went to cardiologist on 10/24. 10/25 Echocardiogram prolapsed mitral valve which doctor said was common. 11/14 CT scan with contrast of heart, awaiting results. Chest pain was always present the first two weeks. Ever since then it has been intermittent varying between 0 and 2 in intensity. Before adverse event I rode bicycle 3-6 days a week and since 10/15 I have ridden my bike 3 times. The shot produced the most tolerable side effects outside of the chest pain. Had no fever; chills; or fatigue with this dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- Chest x-ray normal; EKG normal; blood work returned normal; Echo normal; CT w/ contrast of heart awaiting results.
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Seasonal allergies
- Andere Medikamente
- Budesonide sinus rinse; CLARITIN; vitamin D3; azelastine; melatonin
- Allergien
- Seasonal
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 27.11.2022
- Impfdatum
- 11.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 3,0
- Dosis
- 4
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Headache
Inflammation
Injected limb mobility decreased
Injection site inflammation
Injection site pain
Insomnia
Loss of personal independence in daily activities
Mobility decreased
Pain in extremity
Symptomtext
Starting several days after the vaccination (usual soreness in injection reason which lasted a few days) I developed some neck inflammation as well as more severe inflammation in right and left shoulders. This got worse and lasted for at least 6 weeks but is now significantly reduced. Symptoms were pain and difficulty using both right arm (worse) and left arm to perform physical tasks (lift objects). Similar to having arthritis which makes the shoulder and arms almost completely unusable. Also, pain in shoulder when lying on left and right sides led to difficulty sleeping. Also, mild strange headaches from time-to-time. Most symptoms have now subsided although I still have some pain in the right shoulder.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Anxiety (started abruptly in March 2018, ,now much reduced)
- Andere Medikamente
- Lexapro (10 mg/day), Ativan (0.5 mg/day), Gabapentin (300 mg/day), Vitamin D, CoQ10, magnesium, fish oil
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 26.11.2022
- Impfdatum
- 11.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bladder catheterisation
Gait inability
Urinary retention
Confusional state
Dehydration
Dysuria
Headache
Lung infiltration
Symptomtext
Still confused; Infiltrate in her lungs; Dehydration; Could not walk; Headache; Could not pee at all/could not urinate/hard time peeing/continues to have trouble urinating/Full bladder; This spontaneous case was reported by a patient and describes the occurrence of DYSURIA (Could not pee at all/could not urinate/hard time peeing/continues to have trouble urinating/Full bladder), CONFUSIONAL STATE (Still confused), LUNG INFILTRATION (Infiltrate in her lungs), DEHYDRATION (Dehydration), GAIT INABILITY (Could not walk) and HEADACHE (Headache) in a 63-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F220A) for COVID-19 vaccination. The patient was never tested positive or diagnosed with COVID-19. No other vaccines were given to the patient within 1 month prior to Moderna COVID-19 vaccine. The patient's past medical history included Stent placement (Three heart stents). Concurrent medical conditions included Allergy to antibiotic (Vancomycin), Penicillin allergy, Drug allergy (Aleve), Drug allergy (Dilantin) and Seizures. Concomitant products included LAMOTRIGINE (LAMICTAL), MIRTAZAPINE, QUETIAPINE, CLONAZEPAM (KLONOPIN), ASPIRIN [ACETYLSALICYLIC ACID], BACLOFEN, FUROSEMIDE (LASIX [FUROSEMIDE]), POTASSIUM CHLORIDE, ATORVASTATIN, PIROXICAM (PAXIL [PIROXICAM]), CARBIDOPA, LEVODOPA (CARBIDOPA/LEVODOPA), ISOSORBIDE, TRAZODONE and TOPIRAMATE for an unknown indication. On 11-Nov-2022, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 15-Nov-2022, the patient experienced CONFUSIONAL STATE (Still confused) (seriousness criterion hospitalization). In November 2022, the patient experienced DYSURIA (Could not pee at all/could not urinate/hard time peeing/continues to have trouble urinating/Full bladder) (seriousness criterion hospitalization), LUNG INFILTRATION (Infiltrate in her lungs) (seriousness criterion hospitalization), DEHYDRATION (Dehydration) (seriousness criterion hospitalization), GAIT INABILITY (Could not walk) (seriousness criterion hospitalization) and HEADACHE (Headache) (seriousness criterion hospitalization). The patient was hospitalized from 15-Nov-2022 to 20-Nov-2022 due to CONFUSIONAL STATE, DEHYDRATION, DYSURIA, GAIT INABILITY, HEADACHE and LUNG INFILTRATION. At the time of the report, DYSURIA (Could not pee at all/could not urinate/hard time peeing/continues to have trouble urinating/Full bladder) was resolving, CONFUSIONAL STATE (Still confused) had not resolved and LUNG INFILTRATION (Infiltrate in her lungs), DEHYDRATION (Dehydration), GAIT INABILITY (Could not walk) and HEADACHE (Headache) outcome was unknown. The patient received her first primary vaccine dose on 18-May-2021 with lot number 016C21A. No adverse reactions were reported. The patient received her second Moderna dose on 16-Jun-2021 with lot number 024C21A. The patient was reporting side effects after taking the Moderna booster dose. The patient could not pee at all before hospitaliztion. It was reported that the patient could pee now, but the patient was still having a hard time. The patient reported that she ended up in the hospital from 11-Nov-2022 or 15-Nov-2022 to 20-Nov-2022 with a Foley catheter. The patient reported that she was still confused and she continued to have trouble urinating. The patient's symptoms of unable to urinate and full bladder had improved. Company comment: This spontaneous case concerns a 63-year-old female patient, with no relevant medical history reported, who experienced the unexpected serious (Hospitalization) events of Dysuria, Confusional state, Lung infiltration, Dehydration, Gait inability and Headache that occurred within few days after receiving the third dose of mRNA-1273 Bivalent BA.4/BA.5 vaccine in COVID-19 vaccination series. After taking Moderna vaccine, patient was finding difficulty in passing urine, was hospitalized for 9 days with Foley's catheter. She also had headache, infiltrates in her lungs, dehydration and was not able to walk. She was able to urinate but was still having a hard time. No further information regarding investigations and additional vaccination details were provided. The outcome of the event Dysuria was recovering, Confusional state was not recovered, Lung infiltration, Dehydration, Gait inability and Headache was unknown.The benefit-risk relationship of mRNA-1273 Bivalent BA.4/BA.5 Vaccine in not affected by this report. This case was linked to MOD-2022-675634 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 21-Nov-2022: Significant Live Follow-up information included concomitant medications added, events added and narrative has been updated.; Sender's Comments: This spontaneous case concerns a 63-year-old female patient, with no relevant medical history reported, who experienced the unexpected serious (Hospitalization) events of Dysuria, Confusional state, Lung infiltration, Dehydration, Gait inability and Headache that occurred within few days after receiving the third dose of mRNA-1273 Bivalent BA.4/BA.5 vaccine in COVID-19 vaccination series. After taking Moderna vaccine, patient was finding difficulty in passing urine, was hospitalized for 9 days with Foley's catheter. She also had headache, infiltrates in her lungs, dehydration and was not able to walk. She was able to urinate but was still having a hard time. No further information regarding investigations and additional vaccination details were provided. The outcome of the event Dysuria was recovering, Confusional state was not recovered, Lung infiltration, Dehydration, Gait inability and Headache was unknown.The benefit-risk relationship of mRNA-1273 Bivalent BA.4/BA.5 Vaccine in not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dehydration
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- Allergy to antibiotic (Vancomycin); Drug allergy (Dilantin); Drug allergy (Aleve); Penicillin allergy; Seizures
- Vorgeschichte
- Medical History/Concurrent Conditions: Stent placement (Three heart stents); Comments: The patient was never tested positive or diagnosed with COVID-19. No other vaccines were given to the patient within 1 month prior to Moderna COVID-19 vaccine.
- Andere Medikamente
- LAMICTAL; MIRTAZAPINE; QUETIAPINE; KLONOPIN; ASPIRIN [ACETYLSALICYLIC ACID]; BACLOFEN; LASIX [FUROSEMIDE]; POTASSIUM CHLORIDE; ATORVASTATIN; PAXIL [PIROXICAM]; CARBIDOPA/LEVODOPA; ISOSORBIDE; TRAZODONE; TOPIRAMATE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 25.11.2022
- Impfdatum
- 18.10.2022
- Beginn
- 19.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Feeling abnormal
Headache
Malaise
Mobility decreased
Myalgia
Pyrexia
Symptomtext
The morning after my dose 5 I woke up with fever, headache, muscle aches. The two weeks I felt terrible and was in bed and down for two weeks. My fever ranged from 100.5-103.1. I was pretty sick and felt terrible the whole time. I did contact my doctor and there was nothing they could do for me so I had to just wait it out. As of today once and while I will get a high fever and will be gone in a day. I have never had this issue before.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Gastroparesis; High Blood Pressure; Migraines
- Andere Medikamente
- Omeprazole; adult aspirin; lisinopril; duloxetine HCL; metoprolol; tartrate; topiramate; promethazine; CENTRUM SILVER women's 50; loratadine
- Allergien
- Penicillin; bananas; REGLAN
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 22.11.2022
- Impfdatum
- 17.10.2022
- Beginn
- 18.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal distension
Abdominal pain
Headache
Joint swelling
Musculoskeletal chest pain
Oedema
Splenomegaly
Symptomtext
The day after receiving my bivalent, Moderna vaccine, I started to experience sharp pain under my left rib cage to the side. I checked my pulse and it was 55, steady and even. The pain did not subside. My stomach extended also. I looked online to see what the possibilities could be and I thought that it may have been from the vaccine. I went to bed that night and the next morning, the pain was gone. My doctor feels that my body over produced white blood cells and my spleen swelled, producing the pain. The other health event I experienced was that I was experiencing regular headaches. I went to see my rheumatologist and my blood pressure was 142/80. I normally run a BP of 110/70. I went on a boat trip and I noticed that my ankles were swollen. I put my thumb in my ankle and realized that I had pitted edema. I knew that something was really wrong. I went to the ship's infirmary, and they checked my BP. It was 158/80. They had me lay down for a while. The next day my systolic was 142 and 138 a couple of hours apart. When we came home, I purchased a BP cuff and have been monitoring myself daily. My systolic has come down to around 132, which is still high, but better than it was. I have sent a note to my doctor and I am waiting on a response to do a follow up to my health event.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Musculoskeletal chest pain
- Hospital-Tage
- -
- Labordaten
- BP check
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Sjogren's; osteoarthritis
- Andere Medikamente
- Rosuvastatin; estradiol
- Allergien
- Sulfa; codeine
- Vorherige Impfungen
- When I was a child, I passed out after receiving the flu vaccine. Also, it seems that if I get the flu vaccine, I experience the
- Staat
- TN
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 18.11.2022
- Impfdatum
- 09.11.2022
- Beginn
- 09.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Chills
Fatigue
Headache
Lethargy
Pain
Tremor
Symptomtext
Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Headache-Severe, Systemic: Shakiness-Severe, Systemic: Weakness-Severe
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 09.11.2022
- Impfdatum
- 26.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acupuncture
Hypoaesthesia
Injection site hypoaesthesia
Injection site pain
Injection site paraesthesia
Injection site reaction
Muscle spasms
Neuralgia
Pain in extremity
Paraesthesia
Sleep disorder
Symptomtext
He reports that he received his COVID booster (Moderna) at clinic two weeks ago today in his L arm. He tells me that he is experiencing nerve pain, numbness, and tingling in his left shoulder, arm, hand & deltoid area that began 2 hours after his booster. He reports he did not experience any pain/soreness at the time of vaccine administration. He then developed severe muscle cramping and pain in his left shoulder, arm & deltoid that keeps him awake at night. He reports taking muscle relaxants (methylcarbamol), tylenol, and ibuprofen with minimal symptom improvement in order to help him sleep and to function during the day. He's been to PT, chiropractor, massage therapist, and acupuncture without significant symptom improvement. He reports the pain level is the same, but slightly less frequent than two weeks ago.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site paraesthesia
- Hospital-Tage
- -
- Labordaten
- Client has not seen a medical provider for this adverse effect.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 09.11.2022
- Impfdatum
- 02.11.2022
- Beginn
- 05.11.2022
- Tage bis Beginn
- 3,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Injection site pain
Mobility decreased
Symptomtext
Site: Pain at Injection Site-Medium, Additional Details: pt arrived at the pharmacy 3 days after administration and complained of shoulder soreness that affected his ability to raise his arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 02.11.2022
- Impfdatum
- 24.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 3,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypertension
Symptomtext
high blood pressure
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- arthritis, hearing issues, heart
- Andere Medikamente
- toparal, statin
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 26.10.2022
- Impfdatum
- 19.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 5,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest X-ray normal
Chest pain
Dizziness
Electrocardiogram normal
Nausea
Pain in extremity
Palpitations
Symptomtext
At 2 am I was awaken by sudden chest pain, a dull ache in the center of my chest, heart palpitations, dizzy, nausea, light headedness, pain in left arm and chest pain that got worse when laying down. I went to the hospital because I thought it was a heart attack. EKG and chest x-Ray showed no obvious signs and I was discharged and told to take ibuprofen for pain and follow up with my primary care doctor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- EKG and chest x-Ray showed no obvious signs
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- -
- Andere Medikamente
- LISINOPRIL
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 24.10.2022
- Impfdatum
- 20.10.2022
- Beginn
- 20.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Hypertension
Symptomtext
Systemic: Dizziness / Lightheadness-Medium, Systemic: Hypertension-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 21.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Paraesthesia
Rash pruritic
Symptomtext
Tingling sensation moving up the arm/shoulder, itching rash on upper arm/shoulder/neck, improved with one dose 25mg diphenhydramine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- hypertension, hypercholesterolemia, glaucoma, hypothyroid
- Andere Medikamente
- unknown
- Allergien
- penicillin, sulfa antibiotics, meperidine, no prior reactions/allergies/adverse effects with any previous covid vaccines (4 prior)
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 14.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Back pain
Dyspnoea
Fatigue
Hypersensitivity
Lethargy
Paraesthesia
Tachycardia
Tremor
Symptomtext
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Tremors and back pain-Medium, Systemic: Shakiness-Medium, Systemic: Tachycardia-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: emergency and EMS were called, patient left the pharmacy with them. Initially she was fine after the vaccination, but came back a few minutes later complaining of severe back pain and difficulty breathing. She developed tremors a couple of minutes later.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 12.10.2022
- Impfdatum
- 08.10.2022
- Beginn
- 08.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Paraesthesia oral
Respiratory rate increased
Symptomtext
Tongue tingling Rapid Breathing
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia oral
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 11.10.2022
- Impfdatum
- 11.10.2022
- Beginn
- 11.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood glucose normal
Chest discomfort
Fear
Feeling abnormal
Flushing
Headache
Tremor
Vision blurred
Symptomtext
Patient request #5 Covid series, she has signed consent for shot and was aware of side effects. She had had side effects from all of her other shots. Normal side effects list on sheet. Shot was given at 15:08 and she sat with the nurse about 30 second and stated I am feeling fine, I wait in lobby 15 to 20 minutes and tell you if i feel weird. At 15:10 Patient stated, "I feel funny". Epi Pen was grabbed and O2 was taken to lobby at assist the patient if she needed them. Code was call as per Hospital policy. O2 was applied N/C at 4 Liters. Patient was holding her (L) hand over her heart, she reported she had some blurred vision, headache, flushing face, as well as shaking with her (L) arm and hand. She reported chest pressure also. She relaxed after about 10 minutes said, "I better". Blood sugar was taken it was 123 at 15:18. ER staff on site and encouraged patient to F/U with them. She refused but did report she had headache (Slight). She was really scared. she spoke. ER staff returned to ER and Staff from Occ. Health sat with Patient in Lobby area. Vital 15;15 133/101 Pulse 99 rapid O2 was remove as she denied any SOB, 98% RA. 15:25 BP 139/90 Pulse 83, 15:35 BP 135/93 Pulse 80, O2 98% RA. At 15:45 she grabbed at her heart again reported Chest pressure starting again Code was called again Bp. 134/90 Pulse 81, O2 97% RA. ER staff MD on sit again, Patient was wheeler to ER at 15,49.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- She was taken to ER..
- Aktuelle Erkrankungen
- Diabetic Factor V
- Vorgeschichte
- Unsure
- Andere Medikamente
- Unsure
- Allergien
- Latex , But she has had shots from a Multi Dose Bottle in past has done fine.,
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 07.11.2023
- Impfdatum
- 07.11.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 5
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Headache
Pain in extremity
Symptomtext
At most she experienced a headache or sore arm, but that's it.; At most she experienced a headache or sore arm, but that's it.; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (At most she experienced a headache or sore arm, but that's it.) and HEADACHE (At most she experienced a headache or sore arm, but that's it.) in a 76-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. Patient had no relevant medical history, allergy and COVID-19 diagnosis. Patient received other vaccines in the 4 weeks prior to COVID-19 vaccine. On 07-Nov-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (At most she experienced a headache or sore arm, but that's it.) and HEADACHE (At most she experienced a headache or sore arm, but that's it.). At the time of the report, PAIN IN EXTREMITY (At most she experienced a headache or sore arm, but that's it.) and HEADACHE (At most she experienced a headache or sore arm, but that's it.) outcome was unknown. No concomitant medication was reported. No treatment information was provided. This case was linked to MOD-2023-748230, MOD-2023-748238.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: Patient had no relevant medical history, allergy and COVID-19 diagnosis. Patient received other vaccines in the 4 weeks prior to COVID-19 vaccine.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 06.11.2023
- Impfdatum
- 14.11.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Headache
Vaccination site pain
Symptomtext
her vaccinated right arm hurt; slight headache; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (her vaccinated right arm hurt) and HEADACHE (slight headache) in an 8-decade-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. The patient's past medical history included Cancer in 2019, Chemotherapy in 2019 and Radiotherapy in 2019. Concurrent medical conditions included Epilepsy (since teenage years). Concomitant products included PRIMIDONE (MYSOLINE) for Epilepsy, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication. On 14-Nov-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (her vaccinated right arm hurt) and HEADACHE (slight headache). At the time of the report, VACCINATION SITE PAIN (her vaccinated right arm hurt) and HEADACHE (slight headache) outcome was unknown. It was reported that because of the cancer treatment in 2019, sometimes she tried to say something, and it doesn't always come out the way she intended. She has had Epilepsy since teenage years & takes Mysoline. She stated that the Epilepsy medication makes her whole body slow. That was why she was slow to respond. Her whole system was like that, just in general without a vaccination, that's just from every day. She stated that part didn't change after vaccination. She takes Vit D3, and the doctor had asked her to monitor her High Blood Pressure. She mentioned that they are monitoring her blood pressure and have not prescribed any medication for it. No treatment information was provided. This case was linked to MOD-2023-748129 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Epilepsy (since teenage years)
- Vorgeschichte
- Medical History/Concurrent Conditions: Cancer; Chemotherapy; Radiotherapy
- Andere Medikamente
- MYSOLINE; VITAMIN D [COLECALCIFEROL]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 25.05.2023
- Impfdatum
- 19.05.2023
- Beginn
- 19.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Pyrexia
Symptomtext
ran a slight fever; Dose given after the published expiration date on 19MAY2023. Lot number 061F22A, expiration date 16MAY2023; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (ran a slight fever) and EXPIRED PRODUCT ADMINISTERED (Dose given after the published expiration date on 19MAY2023. Lot number 061F22A, expiration date 16MAY2023) in a 30-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. The patient had no known allergies. The patient had no acute illnesses at the time of vaccination and upto one month before and no chronic or long standing health conditions. The patient had never been tested positive or been diagnosed with COVID-19. It was reported that the patient received other vaccines 4 weeks prior to Moderna Covid-19 vaccine. Previously administered products included for Product used for unknown indication: Tdap and Hepatitis B (booster). Past adverse reactions to the above products included No adverse event with Hepatitis B and Tdap. On 19-May-2023 at 2:30 PM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 19-May-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose given after the published expiration date on 19MAY2023. Lot number 061F22A, expiration date 16MAY2023). On 20-May-2023, the patient experienced PYREXIA (ran a slight fever). On 20-May-2023, PYREXIA (ran a slight fever) had resolved. At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose given after the published expiration date on 19MAY2023. Lot number 061F22A, expiration date 16MAY2023) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. On 19-May-2023 at 2:30 PM, the patient received booster dose of Moderna Covid-19 vaccine. In the left deltoid, the patient had no soreness. Concomitant medication information was not provided. It was reported that the dose was given to the patient after the published expiration date. The published expiration date of the vaccine was 16-May-2023. No adverse effects were felt by the patient except the fact that the patient felt slight fever in A.M hours of 20-May-2023. The patient felt fine later on that day. No additional doses, medications, or treatments were provided to the patient. This case was linked to MOD-2023-725968 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 24-May-2023: Follow-up received include Patient details (Ethnic, race, height, weight) added, suspect Product (Spikevax Bivalent) dose details updated, event Pyrexia added.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: The patient had no known allergies. The patient had no acute illnesses at the time of vaccination and upto one month before and no chronic or long standing health conditions. The patient had never been tested positive or been diagnosed with COVID-19. It was reported that the patient received other vaccines 4 weeks prior to Moderna Covid-19 vaccine.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 23.05.2023
- Impfdatum
- 07.11.2022
- Beginn
- 01.03.2023
- Tage bis Beginn
- 114,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bacterial test negative
Chlamydia test negative
Fungal infection
Laboratory test normal
Neisseria test negative
Sexually transmitted disease test
Vaginal discharge
Vaginal odour
Vulvovaginal pruritus
Symptomtext
I had vaginal itching and discharge that I knew to be like a yeast infection from experience. I had an expired fluconazole tablet from a previous prescription, so I took that and it seemed to go away. Maybe about a month later on March 25, I had green vaginal discharge that also looked like a yeast infection. My sister is a women's health nurse practitioner (NP) and prescribed me fluconazole. I took that and it got better. I went to GYN on March 28 to be tested for yeast, bacterial vaginosis, chlamydia and gonorrhea. NP thought it looked like bacterial vaginosis (BV) as well and prescribed metronidazole gel and more fluconazole to treat yeast infections expected with BV treatment. I used the gel for 1/5 nights before finding out that all tests were negative (I had already treated the yeast infection before testing). I stopped using the gel. I developed a vaginal odor and discharge congruent with bacterial vaginosis. I didn't have time to go to the GYN, so around mid April, I ended up treating it with the metronidazole gel that I still had. After the first night of using the metro gel, I developed a yeast infection as expected and treated it with the fluconazole. I took one more fluconazole on the fifth/last day of treatment. Everything seemed cured until I developed another yeast infection around mid May. I treated that with one more fluconazole tablet and have been cured since.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vulvovaginal pruritus
- Hospital-Tage
- -
- Labordaten
- March 28, 2023: Atopobium vaginae Low - 0 BVAB 2 Low - 0 Megasphaera 1 Low - 0 Candida albicans, NAA Negative Candida glabrata, NAA Negative Candida lusitaniae, NAA Negative Candida krusei, NAA Negative Trich vag by NAA Negative Negative Chlamydia trachomatis, NAA Negative Neisseria gonorrhoeae, NAA Negative
- Aktuelle Erkrankungen
- Acne, depression
- Vorgeschichte
- None
- Andere Medikamente
- Escitalopram Spironolactone Vitamin D Probiotics
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 23.05.2023
- Impfdatum
- 14.10.2022
- Beginn
- 21.11.2022
- Tage bis Beginn
- 38,0
- Dosis
- 5
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Dizziness
Headache
Nasopharyngitis
Pain
Pyrexia
SARS-CoV-2 test positive
Throat irritation
Symptomtext
On 11/21/20222 I had headache, scratchy throat. I tested positive on 11/22/2022 using a home COVID-19 test. After testing positive I had more symptoms such as a fever, cough, body aches and head cold. I did a telehealth on the same day with my doctor who then prescribed me with Paxlovid for 5 days. I did a home test 11/30/2022 which was negative. After 5 days on 12/04/2022 I tested positive again. I had a rebound case of COVID-19. I woke up with a scratchy throat in the morning. I was light headed for 1 week. This time I didn't take any medication I got better in a week.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- 22NOV2022 COVID-19 Test- Positive; 30NOV2022 COVID-19 Test-Negative; 04DEC2022 COVID-19 Test- Positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- High Blood Pressure
- Andere Medikamente
- Lisinopril; Potassium Capsules; Tylenol
- Allergien
- Allergies to Sulfa and Penicillin; Reactions to Sulpician; Laetrile; Losartan; Atenolol
- Vorherige Impfungen
- Initial COVID-19 Vaccine - I had a Rapid Heart Beat.
- Staat
- -
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 15.05.2023
- Impfdatum
- 11.10.2022
- Beginn
- 11.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Angioedema
Body temperature
Fatigue
Head discomfort
Lymphadenopathy
Pyrexia
Symptomtext
was pressure around my head "like a rubber band around my head."; tired; Mild fever; around the lymph nodes were a little swollen and hurt the reaction from my lymph nodes; Angioedema attack/swollen lips; This spontaneous case was reported by a patient and describes the occurrence of ANGIOEDEMA (Angioedema attack/swollen lips) in a 68-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Angioedema (prior history of Angioedema before receiving any Moderna Covid-19 vaccines). On 11-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Oct-2022, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced ANGIOEDEMA (Angioedema attack/swollen lips) (seriousness criterion medically significant). On an unknown date, the patient experienced HEAD DISCOMFORT (was pressure around my head "like a rubber band around my head."), FATIGUE (tired), PYREXIA (Mild fever) and LYMPHADENOPATHY (around the lymph nodes were a little swollen and hurt the reaction from my lymph nodes). At the time of the report, ANGIOEDEMA (Angioedema attack/swollen lips) and PYREXIA (Mild fever) had resolved and HEAD DISCOMFORT (was pressure around my head "like a rubber band around my head."), FATIGUE (tired) and LYMPHADENOPATHY (around the lymph nodes were a little swollen and hurt the reaction from my lymph nodes) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.4 100.4 degrees Fahrenheit. No concomitant medication was reported. The patient was tired but that was not as bad as usual. There was no headache. The reaction from lymph nodes and immune system was very weak. The patient told her Doctor that she was worried that she was not making antibodies after the first bivalent booster dose. Doctor said that the patient was probably making antibodies but maybe less than before. Patient saw the allergist and the allergist says that the Angioedema attack was probably an indirect reaction to the other things that are going on. No treatment information was reported. Company Comment: This is a spontaneous case concerning a 68-year-old, female patient with a relevant medical history of Angioedema who experienced the serious (due to medically significant) unexpected, event of Angioedema, the non-serious unexpected event of Head discomfort, and the listed events of Pyrexia, Fatigue and Lymphadenopathy. The event Angioedema occurred on the same day after a booster dose of mRNA-1273 vaccine, and the rest of the events occurred after a booster dose but latency cannot be provided as onset dates were not reported. It was reported that the patient received the vaccine in her left arm, and that she was tired but that was not as bad as usual; she also endorsed mild fever of 100.4 degrees Fahrenheit, pressure around her head and swollen lymph nodes. The outcome of the events Angioedema and Pyrexia was reported as recovered, and the outcome of the rest of the events was reported as unknown. The mentioned medical history of Angioedema remains as a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Reporter did not allow further contact
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Test Name: mild fever; Result Unstructured Data: 100.4 degrees Fahrenheit
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Angioedema (prior history of Angioedema before receiving any Moderna Covid-19 vaccines)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 10.05.2023
- Impfdatum
- 13.10.2022
- Beginn
- 28.12.2022
- Tage bis Beginn
- 76,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Fatigue
Loss of personal independence in daily activities
Respiratory tract congestion
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
I tested positive for COVID-19 in December 2022. I had coughing, head congestion, runny nose but no fever. The symptoms lasted about 9 days. I consulted the doctor on December 28th and was prescribed an antiviral. As of today, the only long-term symptom I have is fatigue after simple chores.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- COVID-19, positive, 122022
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Coronary Artery Disease
- Andere Medikamente
- Eliquis; Diltiazem HCL; Hydrochlorothiazide; Vitamin B12; Vitamin C; Arids2; Zinc; Aspirin; Methimazole; Centrum Silver; Vitamin D3; Fish Oil; Turmeric; Coagulant
- Allergien
- Statins; Tetracycline; Cat Dander; Shellfish; Dust; Pollens
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 04.05.2023
- Impfdatum
- 14.10.2022
- Beginn
- 27.12.2022
- Tage bis Beginn
- 74,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Exposure to SARS-CoV-2
Influenza
Malaise
Nasopharyngitis
SARS-CoV-2 test positive
Symptomtext
My twin sister tested positive, then my husband, I started showing symptoms, so I tested using a home COVID-19 test. It came back positive; I did not take anything for when I had COVID-19 as the symptoms were not bad but it did take twelve days before I tested negative. I then got influenza A, in the first part of March 2023, that lasted for a week. A month after getting over Influenza I got a cold and horrible cough. I was prescribed and inhaler with a steroid. I am currently using this medication, if the condition does not get better to come in to see him again.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- 27DEC2023 home COVID-19 test positive
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- Meloxicam; vitamin B; vitamin D; vitamin C
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 02.05.2023
- Impfdatum
- 28.10.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 4,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood test
Bronchitis
Computerised tomogram abnormal
Cough
Fibrin D dimer increased
Headache
Insomnia
Paranasal sinus discomfort
X-ray normal
Symptomtext
I had sinus pressure with a dry frequent cough and a headache. This happened in October and went away. Then it came back in March and the cough was productive and I was having trouble sleeping. I went to the emergency department. I was diagnosed with bronchitis. I tried an antibiotic and then I was treated for a week with prednisone. I was also treated with inhalers.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- Blood panel, abnormal D-Dimer, 032023; X-Ray, normal, 032023; CT Scan, incidental finding, 032023
- Aktuelle Erkrankungen
- I had an upper respiratory infection in the month of October.
- Vorgeschichte
- Hypertension; High Cholesterol
- Andere Medikamente
- Atorvastatin; Tenoxicam; Prozac; Baby Aspirin; Amlodipine; Vitamin D; Vitamin C; Multi Vitamin
- Allergien
- Demurral
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 02.05.2023
- Impfdatum
- 18.10.2022
- Beginn
- 28.04.2023
- Tage bis Beginn
- 192,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
COVID-19
Headache
Nasal congestion
Pain
Pyrexia
Respiratory tract congestion
SARS-CoV-2 test positive
Throat irritation
Symptomtext
I tested positive for COVID-19 on 4/28/23. I had congestion, irritated throat, fever, body, headache, and joint aches. I contacted my doctor and was prescribed Paxlovid and Zofran. I am still dealing with nasal congestion, but I feel much better now.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- 28APR2023 COVID-19 Test - Positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Gastro Esophageal Reflux
- Andere Medikamente
- Vitamin D3; Levothyroxine; Pepcid; Fluoxetine
- Allergien
- Contrast Dye
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 01.05.2023
- Impfdatum
- 25.10.2022
- Beginn
- 24.03.2023
- Tage bis Beginn
- 150,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Bronchitis
Cough
Fatigue
Impaired work ability
Wheezing
Symptomtext
In April, 2023, I felt like I had something going on in my chest. I began to have a dry, hacking cough. I got really tired and left work early. I went to urgent care on Tuesday, April 25, 2023. I was prescribed steroids and an inhaler. I was diagnosed with bronchitis based on a physical exam and evidence of wheezing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- KEPPRA; BIOTIN; collagen; TYLENOL; MOTRIN
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 21.04.2023
- Impfdatum
- 20.10.2022
- Beginn
- 02.03.2023
- Tage bis Beginn
- 133,0
- Dosis
- 4
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Ageusia
Anosmia
COVID-19
Chills
Cough
Fatigue
Insomnia
Pain
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
I experienced a breakthrough case of COVID-19 with tiredness, fever, chills, body aches for the first couple of days. Then I developed a cough and runny nose, loss of smell/taste and trouble sleeping.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- 04March2023 - COVID-19 Test - Positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Asthma
- Andere Medikamente
- Albuterol Inhaler
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 20.04.2023
- Impfdatum
- 12.10.2022
- Beginn
- 13.02.2023
- Tage bis Beginn
- 124,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Dizziness
Exposure to SARS-CoV-2
No adverse event
SARS-CoV-2 test positive
Symptomtext
I did not have an adverse reaction to the vaccine. I was exposed to COVID-19 while on a family trip. I tested positive for COVID-19 on 02/13/2023. I contacted my provider via a telehealth visit. I got a prescription for Paxlovid. I tolerated the medication without any complications. I was a little lightheaded but I never really felt sick. As of today, I do not have any lingering symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- 13FEB2023 COVID-19 Test - Positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 20.04.2023
- Impfdatum
- 18.10.2022
- Beginn
- 25.03.2023
- Tage bis Beginn
- 158,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Pain
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
I had a significant head stuffiness, body aches, I did a home COVID-19 test, that came back positive. I called my doctor's office to discuss my symptoms. I had a telehealth visit with a Physician Assistant and was prescribed Paxlovid. I took the five-day regimen and was feeling better by the next few days. The congestion lasted a few days after but I am feeling much better now.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- 25MAR2023 Home COVID-19 test - positive
- Aktuelle Erkrankungen
- Hip Replacement
- Vorgeschichte
- Obese
- Andere Medikamente
- Multivitamin; Fish Oil; Fiber Supplement
- Allergien
- No
- Vorherige Impfungen
- When I was a child, I had Rubella symptoms after receiving that vaccine.
- Staat
- DE
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 18.04.2023
- Impfdatum
- 13.10.2022
- Beginn
- 29.01.2023
- Tage bis Beginn
- 108,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Diarrhoea
Fatigue
Feeling abnormal
Oropharyngeal pain
Pyrexia
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
1/29/23 I was tired, sore throat, coughed some and felt really down. As it progressed, I got diarrhea and had a fever. I took an at home COVID test which was positive. I called the doctor and was prescribed PAXLOVID. I only took the PAXLOVID for one day because I felt it made my symptoms worse. After the other symptoms were gone, I still was very congested.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- 29JAN23 at home COVID test positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- CLARITIN; atorvastatin; vitamin C; multivitamin; calcium; cranberries; NEXIUM; TYLENOL PM
- Allergien
- Seasonal allergies
- Vorherige Impfungen
- -
- Staat
- DC
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 18.04.2023
- Impfdatum
- 13.10.2022
- Beginn
- 13.03.2023
- Tage bis Beginn
- 151,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anxiety
Blood glucose normal
Dizziness
Electrocardiogram normal
Heart rate increased
Laboratory test normal
Pregnancy test negative
Vertigo
Vertigo positional
Symptomtext
On March 15th, I had a complete dizziness, I was laying down, resting, the room started spinning, it lasted 1 minute, after that I was stable to walk, but if I turn over, I get a vertigo feeling, next day I went to UC and suggested for me to ER because my heart rate was elevated. I think it was anxiety, because when I got there to the ER, my hear was fine, they diagnosed me with vertigo, I felt better two weeks after. I have an appointment this Thursday with ear, throat doctor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- 16MARCH2023 - EKG - Normal; 16MARCH2023 Glucose Test - Normal;16MARCH2023 - Lab Work - Normal; 16MARCH2023 - Pregnancy Test - Negative
- Aktuelle Erkrankungen
- N?A
- Vorgeschichte
- Crohn's Disease
- Andere Medikamente
- Xeljanz; XR; Centrium Women Multivitamin; D3 Supplement
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 17.04.2023
- Impfdatum
- 10.10.2022
- Beginn
- 07.02.2023
- Tage bis Beginn
- 120,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Cough
Fatigue
Nasal congestion
Pain
Painful respiration
SARS-CoV-2 test positive
Symptomtext
I contracted COVID-19. My symptoms included pain whenever I inhaled and exhaled. I was coughing, felt tired, slightly achy, and had nasal congestion. I took a home COVID-19 test and it turned out negative. But I went to the doctor the next day on 02/8/2023 and took another test. The result was positive. I was prescribed PAXLOVID but I took some over the counter cough syrup. So eventually, the coughing went away and it took awhile for the other symptoms to go away. I pretty much recovered in that 7 day period.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 06Feb2023 home COVID-19 test, negative; 07Feb2023 COVID-19 test, positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Osteoarthritis; Peripheral neuropathy; Seasonal allergies; High blood pressure; Hyperthyroidism; High cholesterol; Borderline diabetic
- Andere Medikamente
- Atorvastatin; levothyroxine sodium; CYMBALTA; carvedilol; montelukast; hydrocodone acetaminophen; losartan potassium; pantoprazole; vitamin B12; vitamin D3; vitamin C; brown flaxseed; rosemary oil; BENEFIBER; MIRALAX
- Allergien
- ACE inhibitors
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 14.04.2023
- Impfdatum
- 13.10.2022
- Beginn
- 06.03.2023
- Tage bis Beginn
- 144,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Muscle disorder
Neck pain
Symptomtext
In early March, 2023 my neck started hurting, I thought the pain would go away but it persisted throughout the month. It just would not let up. i made an appointment with my physician to find out if it was something I needed to be concerned about. We discussed my symptoms; he performed a physical exam. Currently he has concluded it is a muscular issue, I do have a follow up exam with him id June to see if the pain has resolved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Neck pain
- Hospital-Tage
- -
- Labordaten
- No
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- Tylenol as needed; Advil as needed; Vitamin B-12; Calcium with Vitamin D; Magnesium; Vitamin D3
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 13.04.2023
- Impfdatum
- 20.10.2022
- Beginn
- 08.04.2023
- Tage bis Beginn
- 170,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Cough
Nasopharyngitis
Oropharyngeal pain
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
In the middle of the night, I felt like had been hit with a cold, my nose was running, I had a fever. I used a home COVID-19 test that came back positive, I called my doctor to let him know that I was positive and to discuss my symptoms. I was advised to go into an urgent care to have a PCR rapid test. I waited to talk to my doctor on Monday, I was prescribed PAXLOVID, I am noticing that my fever is going away but my cough is lingering, my sore throat is going away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- 8APR2023 home COVID-19 test positive
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- N/A
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 13.04.2023
- Impfdatum
- 10.10.2022
- Beginn
- 17.02.2023
- Tage bis Beginn
- 130,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anticoagulant therapy
Atrial fibrillation
Blood magnesium decreased
Blood test normal
Cardioversion
Electrocardiogram abnormal
Heart rate irregular
Oropharyngeal pain
SARS-CoV-2 test negative
White blood cell count increased
Symptomtext
2/17/2023 I woke up with the worse sore throat that I have ever had. I noticed I also had an irregular heartbeat. The sore throat seemed to resolve during the day, but the irregular heartbeat remained. I went to the Emergency Room and was diagnosed with Atrial Fibrillation. They tried to resolve it ,unsuccessfully, with medication. I was prescribed a blood thinner. I remained in Atrial Fibrillation for six weeks. March 27, 2023, I had a Cardio Version which took me out of Atrial Fibrillation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- 17FEB2023- EKG- Atrial Fibrillation; 17FEB2023- COVID Test-Negative; 17FEB23- Bloodwork-No evidence of heart attack, elevated WBC from sore throat, low magnesium
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes Type 2, Chronic Ulcerative Proctitis, Hypertension Controlled
- Andere Medikamente
- Rosuvastatin, Ramipril ,Gabapentin, Metoprolol, Metformin, Novolog, Lantus, Low Dose Aspirin, Gingko Biloba, Multi Vitamin, COQ10, Turmeric, Iron, Acetyl L-Carnitine, Resveratrol, Vitamin D3
- Allergien
- Dyes that are in iodine, Levaquin
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 10.04.2023
- Impfdatum
- 18.10.2022
- Beginn
- 27.03.2023
- Tage bis Beginn
- 160,0
- Dosis
- 5
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Cough
Diarrhoea
Fatigue
Feeling abnormal
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
My symptoms started on March 27, 2023. I felt poor. I had congestion, cough, and diarrhea. I tested myself for COVID-19 on March 28, 2023. The result was positive. I went to Urgent Care. They prescribed Paxlovid, a cough suppressant, and nasal spray. I felt horrible for two more days. I was tired. I was also coughing and had more diarrhea. By the end of the fourth day, I was feeling better. I still have a little bit of a cough and a little bit of congestion periodically.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- 03/28/2023 At Home COVID-19 - Positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Vitamin D
- Allergien
- Penicillin; Seasonal
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 10.04.2023
- Impfdatum
- 01.11.2022
- Beginn
- 03.03.2023
- Tage bis Beginn
- 122,0
- Dosis
- 5
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cough
Oropharyngeal pain
Pain
Pyrexia
Respiratory tract infection
Sinusitis
Symptomtext
Cough, sore throat, fever, body aches. Given antibiotics for 10 days to treat Sinusitis and respiratory infection Resolved after treatment
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypertension, Hypothyroidism
- Andere Medikamente
- Atenolol, Atorvastatin, Levothyroxine, Multivitamin
- Allergien
- Latex
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 07.04.2023
- Impfdatum
- 06.10.2022
- Beginn
- 18.01.2023
- Tage bis Beginn
- 104,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Fatigue
Influenza virus test negative
Malaise
Pyrexia
SARS-CoV-2 test positive
Symptomtext
Jan 18 began not feeling well and running low grade temp. Jan 19 woke up feeling worse went and tested for flu and COVID-19. Jan 20 symptoms began to resolve. Symptoms resolved quickly with fatigue lasting about a week.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Flu, negative, COVID-19 positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Blood pressure; cholesterol
- Andere Medikamente
- Simvastatin; losartan; hydrochlorothiazide; ZYRTEC; vitamin D
- Allergien
- None
- Vorherige Impfungen
- COVID-19 first two doses my arm swelled
- Staat
- WI
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 28.03.2023
- Impfdatum
- 24.10.2022
- Beginn
- 18.01.2023
- Tage bis Beginn
- 86,0
- Dosis
- 4
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
COVID-19
Chest X-ray normal
Computerised tomogram thorax normal
Cough
Diarrhoea
Malaise
Respiratory tract congestion
SARS-CoV-2 test positive
Sepsis
Urinary tract infection
Symptomtext
On 1/18/2023, patient presented to the emergency department for evaluation of being ill for the past 5 days with cough, congestion, malaise, diarrhea and generalized weakness. She was given a COVID-19 NAA test in the ED which resulted positive; Her chest x-ray showed no acute findings; she was not hypoxic. CT scan of the chest was negative for pulmonary embolism. Patient was diagnosed with COVID-19, sepsis, and urinary tract infection without hematuria. She was admitted to the hospital for further evaluation and treatment. Submitter does not have access to further medical information on this case including discharge date. If more information is needed, please contact the admitting hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- 1/18/2023 - positive COVID-19 NAA test; Chest x-ray showed no acute findings; CT scan of the chest was negative for pulmonary embolism.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Hypertension, hyperlipidemia, diabetes mellitus, obstructive sleep apnea, primary osteoarthritis of both knees, osteoporosis, chronic pain/post-laminectomy syndrome.
- Andere Medikamente
- Unknown
- Allergien
- ALLERGIES: Penicillins. Tolerates cephalosporins. Tolerated ceftriaxone, cefepime, and cefpodoxime.
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 28.02.2023
- Impfdatum
- 26.11.2022
- Beginn
- 01.01.2023
- Tage bis Beginn
- 36,0
- Dosis
- 5
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Fatigue
Headache
Oropharyngeal pain
Pain
SARS-CoV-2 test positive
Symptomtext
I had several days of headaches with a sore throat and felt a little ran down in the 4-5 days before testing positive. 1/25/2023 I woke up and felt like I was hit by a truck, I felt bad and body aches. No fever. Symptoms lasted about 2 days and then were greatly diminished, mostly just soreness. Televisit on 1/25, after testing positive on an at home COVID-19 test. Doctor prescribed PAXLOVID.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 25Jan2023 at home COVID-19 test, positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Rheumatoid Arthritis; Asthma; Osteo Arthritis; High Blood Pressure
- Andere Medikamente
- Levothyroxine; probiotic; PRILOSEC; MIRALAX; CLARITIN; hydroxychloroquine; hydrochlorothiazide; naproxen; multivitamin; omega 3 B12; ubiquinol; D3 folic acid; estradiol; MOVE FREE; montelukast; BREO-ELLIPTA; FLONASE
- Allergien
- Seasonal
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 23.02.2023
- Impfdatum
- 17.11.2022
- Beginn
- 30.01.2023
- Tage bis Beginn
- 74,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Oropharyngeal pain
Pyrexia
Respiratory tract congestion
Rhinorrhoea
SARS-CoV-2 test negative
Streptococcus test negative
Symptomtext
Monday evening, I started having nasal drainage and it started going into my throat. I woke up Tuesday morning and I was very congested, I had more nasal drainage, and my throat was very sore. I did an at home test and it was negative. I started taking MUCINEX and TYLENOL. As the day went on it got worse, so I went to urgent care. I had a fever of 101 there. They did a COVID-19 test and a Strep Test and they were negative. He gave me a steroid shot and two days' worth of prednisone. He also prescribed cefdinir.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- 30JAN2023 COVID-19 test negative; 31JAN2023 COVID-19 test negative; 31JAN2023 Strep Test negative
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Asthma; Allergies
- Andere Medikamente
- ARNUITY; NASONEX; CLARITIN; ZYRTEC; calcium; vitamin D; multivitamin
- Allergien
- Latex
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 14.02.2023
- Impfdatum
- 13.02.2023
- Beginn
- 13.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Hyperhidrosis
Pallor
Symptomtext
COVID booster was administered first in left arm, then HPV administered in right arm. Immediately after the HPV vaccine, looked pale and sweaty and said she felt like she was going to "pass out". I laid her back and put ice pack on head and gave her a cup of water. She rested for about 20 min, then was back to her usual self. Ate a popsicle, was talking and smiling and walked out of clinic independently.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- Pulse ox was 94%, HR 84.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- depression
- Andere Medikamente
- sertraline, fish oil, vit D, magnesium with pre and pro biotics
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 08.02.2023
- Impfdatum
- 15.10.2022
- Beginn
- 20.01.2023
- Tage bis Beginn
- 97,0
- Dosis
- 5
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Ageusia
Anosmia
COVID-19
Cough
Fatigue
Oropharyngeal pain
Pain
Pyrexia
SARS-CoV-2 test positive
Upper-airway cough syndrome
Symptomtext
I tested positive for COVID-19 on 1/22/2023. I had a sore throat, postnasal drip, fever, fatigue, body aches, cough, loss of taste and smell. I contacted my doctor and was prescribed LAGEVRIO and VENTOLIN. I also took over-the-counter FLONASE. I was improving at days, but I still have fatigue.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 22JAN2023 COVID-19 test positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Reactive Airway Disease
- Andere Medikamente
- Metoprolol; EYLEA; vitamin C; vitamin D; biotin; multivitamin; magnesium
- Allergien
- Amoxicillin; NSAIDS; iodine; adhesive tapes
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 03.02.2023
- Impfdatum
- 03.11.2022
- Beginn
- 19.11.2022
- Tage bis Beginn
- 16,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test abnormal
Erythema
Peripheral swelling
Pruritus
Symptomtext
On my arm I would touch my arm and it was itching and red and swelling, the more I scratched the worst it got. I seen my provider and she had me try Claritin and Alegra and did not work. Then they put me on Prednisone, and it did help with symptoms. My next appointment will be for medication Xolair injection is going to be my next treatment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- DEC2022-Blood Work-Abnormal (Not sure of actual date)
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Narcolepsy, Depression
- Andere Medikamente
- Cilas; Ritalin; Prozac; Xyzal; Vitamin B Complex
- Allergien
- Seasonal Allergies
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 25.01.2023
- Impfdatum
- 24.01.2023
- Beginn
- 24.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Symptomtext
Severe Chills at 13-15 hours post-injection x 2 (same problem on previous dose in April 2022)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 23.01.2023
- Impfdatum
- 20.10.2022
- Beginn
- 21.12.2022
- Tage bis Beginn
- 62,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Ear infection
Nasal congestion
Oropharyngeal pain
SARS-CoV-2 test positive
Symptomtext
I had no trouble after receiving the vaccine. I had a stuffy nose and a sore throat for a couple days before testing for COVID-19. I tested positive for COVID-19 on 12/21/2022. I contacted my doctor, and they didn't provide a prescription but recommended taking over the counter medication. I later developed an ear infection.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- 13OCT2022 COVID-19 test positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- High Blood Pressure
- Andere Medikamente
- Aspirin
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 18.01.2023
- Impfdatum
- 18.10.2022
- Beginn
- 09.01.2023
- Tage bis Beginn
- 83,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Fatigue
Malaise
Oropharyngeal pain
Pain
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
I had fatigue for about 24 hours after receiving the vaccine. I started not feeling well on 01/09/2023 with a sore throat, body aches, lots of serious congestion and no fever. I really thought I just had a bad cold. I went to a clinic to be tested and I tested positive for COVID-19 on 01/13/2023. They recommended guaifenesin to help with the congestion. I tolerated the medication well. I still have some congestion and I stay fatigued.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 13OCT2022 COVID-19 test positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- High Blood Pressure
- Andere Medikamente
- N/A
- Allergien
- Statins
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 18.01.2023
- Impfdatum
- 15.10.2022
- Beginn
- 04.12.2022
- Tage bis Beginn
- 50,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Fatigue
Pyrexia
Respiratory tract congestion
SARS-CoV-2 test
Vaccine breakthrough infection
Symptomtext
I experienced a breakthrough case of COVID-19 with fatigue, congestion, fever and cough.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- COVID-19
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Liver Cyst
- Andere Medikamente
- Spironolactone; Losartan; Atorvastatin
- Allergien
- Sulfa; Morphine
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 13.01.2023
- Impfdatum
- 17.10.2022
- Beginn
- 18.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Burning sensation
Dizziness
Headache
Malaise
Rash
Rash erythematous
Rash pruritic
Scar
Symptomtext
I had 100 degree temperature for two days. But a month later I started to have rashes on my upper armes n my legs. N they went away. N again about month later a few bumps came up n this time I felt dizzy for a few days. N they went away. N this month which about a month later a few bumps appeared and not feeling well. I dealt with headache with bumps. Bumps are usually itchy n burning feeling, even I don't scratch them. They are red or pink. N scars won't go away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- No. I talked to doctors about my reaction to the boosters but nobody offered me for any help or test.
- Aktuelle Erkrankungen
- No. No sickness. But I had reaction to Pfizer booster. I had rashes here n there for 10 months. I had Pfizer booster in 11/24/2021. Finally my rash stop coming up in September so I took moderna booster shot in October.
- Vorgeschichte
- I have CFS.
- Andere Medikamente
- No. No medications were taken.
- Allergien
- No.
- Vorherige Impfungen
- Pfizer booster
- Staat
- GA
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 12.01.2023
- Impfdatum
- 28.12.2022
- Beginn
- 29.12.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Lymphadenopathy
Nausea
Oedema peripheral
Pain
Pyrexia
Symptomtext
I receive vaccine and the next day I had fever body ache, slight nausea and pain at the injection site. The day after that everything was gone with exception of the pain at the injection site. Then Jan 1 around 6 I had swelling under my arms the injection pain was. I thought it was a mass with fluid 4 in long and 2 inches wide. I waited a couple of days and couldn't get in touch with him until Jan 10. By this time the swelling had gone down, and he said it was my lymph nodes they were measured at 305 centimeters. The doctor ordered blood work and a CT scan on my upper body. I am waiting on the orders to come through.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- CT scan, blood work
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- High Blood Pressure; Cholesterol
- Andere Medikamente
- Lisinopril; atorvastatin; amlodipine
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 11.01.2023
- Impfdatum
- 11.10.2022
- Beginn
- 01.01.2023
- Tage bis Beginn
- 82,0
- Dosis
- 5
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
COVID-19
Cough
Diarrhoea
Headache
Malaise
Nasal congestion
Oropharyngeal pain
Pain
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
My COVID-19 infection symptoms started on 01/01/2023 in the morning at 08:00AM. I had a headache, weakness, nasal congestions, sore throat, cough, runny nose and body aches. I also had a loose stool. I thought it was allergies so I took MUCINEX. On 01/04/2023 I took 2 COVID-19 home tests which were positive. I called and left voicemail for my doctors office. The nurse called me back on Thursday evening telling me that they prescribed me with PAXLOVID for 5 days and ANORO ELLIPTA inhaler at the pharmacy. I received my medication from the pharmacy on Friday morning and I started taking it right away. I am still taking MUCINEX every 12 hours for cough.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- 04JAN2023 COVID-19 test positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Blood Pressure; COPD; Breast Cancer; Chronic Back Pain; Arthritis
- Andere Medikamente
- Metoprolol; hydrochlorothiazide; simvastatin; alprazolam; tramadol; multivitamins; stool softener
- Allergien
- Eggs; penicillin
- Vorherige Impfungen
- Swelling and rash, flu shot
- Staat
- CT
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 11.01.2023
- Impfdatum
- 11.10.2022
- Beginn
- 23.12.2022
- Tage bis Beginn
- 73,0
- Dosis
- 5
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Feeling abnormal
Malaise
Nasopharyngitis
SARS-CoV-2 test positive
Symptomtext
Starting 12/23/2022, at night, I went to bed not feeling great. I woke up the next day I was sick with head cold symptoms and I took an at-home COVID-19 test (12/24/2022) which came back positive. The symptoms continued until they were bad head cold symptoms. I contacted the doctor that same day and they prescribed Paxlovid. I was unable to start it until 12/26/2022 due to the holidays. Starting 12/27/2022 after starting the medicine the day before, I gradually started feeling better. I did have the side effect from the Paxlovid where the taste in my mouth was awful. The acute symptoms (bad cold symptoms) lasted until about 12/31. As of today, I am still not 100% better but I am much better than I was.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- At-home COVID-19 test (12/24/2022): Positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma
- Andere Medikamente
- Vitamin D
- Allergien
- Penicillin; Latex
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 11.01.2023
- Impfdatum
- 10.10.2022
- Beginn
- 02.12.2022
- Tage bis Beginn
- 53,0
- Dosis
- 5
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Chills
Cough
Lethargy
Nasopharyngitis
Rhinorrhoea
SARS-CoV-2 test positive
Upper-airway cough syndrome
Symptomtext
I had a drippy nose with post-nasal drip, a cough related to the post-nasal drip, and body chills. I took an at-home COVID-19 test on 12/05/2022 which came back positive; I contacted my doctor's office the next morning and was told to use the patient portal to input my symptoms and was prescribed PAXLOVID for treatment. I started the prescription that evening of 12/06/2022. The cold symptoms pretty much went away while on the prescription; I did still feel a little lethargic for a couple of weeks after, but overall I was fine. I still tested periodically which was still positive but I'm pretty much fine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- COVID-19 test: 12/05/2022
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Hypothyroidism; Osteoporosis; Crest Syndrome; Osteoarthritis
- Andere Medikamente
- Levothyroxine; nifedipine; pravastatin; multivitamin; vitamin C; glucosamine
- Allergien
- BACTRIM
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 02.01.2023
- Impfdatum
- 24.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
Pain in extremity
Symptomtext
PATIENT'S SPOUSE CAME TO PHARMACY INQUIRING ABOUT LINGERING PAIN IN PATIENTS RIGHT ARM DUE TO VACCINE BEING ADMINISTERED "INTO THE BONE." PHARMACIST RECOMMENDED EXERCISING ARM, ANTI-IMFLAMMATORY MEDICATIONS, AND CONSULTING PRIMARY PROVIDER.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 6,0
- Geschlecht
- F
- Eingang
- 03.12.2022
- Impfdatum
- 01.12.2022
- Beginn
- 02.12.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Headache
Interchange of vaccine products
Lethargy
Loss of personal independence in daily activities
Pyrexia
Vomiting
Symptomtext
15.5 hours post-injection, woke up with low-grade fever and headache. 21.5 hours post-injection, sent home from school with 101 fever and severe headache. 26 hours post-injection, 102 fever, repetitive vomiting, lethargic. 38 hours post-injection, all symptoms completely resolved. The entire adverse event lasted less than 24 hours, leading us to believe this was a vaccine reaction and not an illness. Patient has a twin sister who received the same vaccination at the same time from the same lot, but exhibited only an insignificant and brief low-grade fever. Patient's previous COVID-19 immunizations were without adverse effects, BUT were Pfizer rather than Moderna.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 02.12.2022
- Impfdatum
- 20.10.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Arthritis
Splint application
Tendonitis
X-ray limb abnormal
Symptomtext
I started having gradual pain in the joint in my right thumb that became very severe. I couldn?t pick up a cup without it hurting. I went into the doctor, and they x-rayed the thumb and found arthritis that haven?t been there before. They also found tendonitis and prescribed prednisone. They recommend me to splint it, ice it, and warm compress. I still wear the splint, but it is a little better. I tried not to wear the splint one day and it got worse, so I keep it on.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- 11/22/2022, Thumb X-ray, Tendonitis and Arthritis
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Knee Arthritis
- Andere Medikamente
- Multivitamin
- Allergien
- Penicillin; Pollen
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 28.11.2022
- Impfdatum
- 22.10.2022
- Beginn
- 22.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Alopecia
Vaccination site pain
Symptomtext
This spontaneous case was reported by a patient and describes the occurrence of ALOPECIA (significant hair loss) and VACCINATION SITE PAIN (soreness in the site of injection) in a 70-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: flu shot (Flu shot 1 month before bivalent booster.) in September 2022. Past adverse reactions to the above products included No adverse event with flu shot. Concurrent medical conditions included Drug allergy (Codeine) and Drug allergy (Vicodin). No concomitant medication was reported. Reportedly, patients doctor did not recommend any treatment and told her it would be solved within a few months. Patient wanted someone to call her back to follow up on her case and tell if this would stop. Treatment details was not reported by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Drug allergy (Vicodin); Drug allergy (Codeine)
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 28.11.2022
- Impfdatum
- 14.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Insomnia
Pain in extremity
Symptomtext
I had pretty severe pain in my left arm a few hours after the vaccine. I started to take TYLENOL and it did not relieve the pain immediately. I ended up not sleeping at all. I continued taking the TYLENOL and it started to get better. My arm remained sore about a week. I have completely recovered from the pain at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Chronic Leukemia; Hypertension
- Andere Medikamente
- Losartan; rosuvastatin; ELIQUIS; metoprolol; venetoclax; multivitamin
- Allergien
- N/A
- Vorherige Impfungen
- Similar reaction to the 2nd dose but not as severe. There was a blotty red spot.
- Staat
- MD
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 25.11.2022
- Impfdatum
- 20.10.2022
- Beginn
- 19.11.2022
- Tage bis Beginn
- 30,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Headache
Lacrimation increased
Nasal pruritus
Nasopharyngitis
Respiratory tract congestion
SARS-CoV-2 test positive
Sneezing
Somnolence
Symptomtext
I experienced COVID-19 after my vaccine. It started in 11-19-2022. I thought I was having allergy problems, itchy nose, runny eyes and by Sunday I was sneezing violently and I wore a mask. My symptoms had been cold symptoms, started with heavy congestion and sneezing. by Monday I can stay it stopped. I have been dealing with a bit of congestion, slight headache, I did not have a sore throat and fever. I am also kind of sleepy at times. I did take an at home COVID-19 test on 11-19-2022 and it was positive and my husband test was negative. At this time, we are masking at home, following CDC recommendations. I tested again yesterday and I am still positive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- 19NOV2022 At Home COVID-19 Test - Positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Overweight; Airborne Allergies; Asthma
- Andere Medikamente
- Aleve; Lisinopril; Montelukast; Calcium; Vitamin D3; Vitamin B12; Multivitamin
- Allergien
- None
- Vorherige Impfungen
- COVID vaccines, sore arm for a few days
- Staat
- WI
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 23.11.2022
- Impfdatum
- 11.10.2022
- Beginn
- 15.11.2022
- Tage bis Beginn
- 35,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Cough
Diarrhoea
Dry mouth
Exposure to SARS-CoV-2
Headache
Influenza like illness
Nasopharyngitis
Oropharyngeal pain
Pain
Pyrexia
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
Exposed to COVID-19 on either Nov. 13 or 14 per notification system on Nov. 16 AM after 5-day trip for a national conference with 6,000 people. Sore throat started on Tuesday, Nov. 15 PM after flying home. Tested negative at home on Wed, Nov. 16. Went to Urgent Care on Friday, Nov. 18 for PCR test with results provided on Nov. 19th as positive for COVID. Received Rx for Paxlovid and have taken all but final two doses to date (Nov. 23, 2022). Symptoms Nov. 18-22 included fever (100.1 highest), sore throat, cough, chest congestion, body aches, headache, diarrhea (for only 1 day), dry mouth. Felt mostly like a bad cold or the flu. Started feeling better on Nov. 20 after starting Paxlovid regime. Fever only lasted 1.5 day.s No fever since Nov. 19th, PM. Still minor coughing and chest congestion. Minor headache on 11/23/22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- COVID-19 PCR test, resulted in positive indication of COVID infection.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Type II Diabetes Obstructive Sleep Apnea Lactose intolerance GERD, reflux Knee arthritis Obesity NAFLD
- Andere Medikamente
- Lisinopril, 5 mg, 1/day Magnesium tab, 250 mg, 2/day Flonase, 2x daily Lipitor, 1, 20 mg, 1/day Metformin 24 hr, 500 mg, 2x/2/daily Zoloft, 50 mg, 1.5 tabs, 1/day Protonix, 40 mg, 1/day Jardiance, 25 mg, 1/day Aspirin, 81 mg, 1/day Glucosam
- Allergien
- Atenolol Hydrochlorothiazide Prevacid Omeprazole
- Vorherige Impfungen
- Hives following Annual Flu shot(s) with preservatives
- Staat
- MT
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 22.11.2022
- Impfdatum
- 24.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Neck pain
Pain
Pain in extremity
Symptomtext
Patient has experienced very intense pain in her left arm since receiving both vaccines in the same arm. She reports it being sharp and constant, radiating up her neck and down the back of her arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Neck pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hypertension, Hypocholesteremia, Arthritis, Mood disorder, Hypothyroidism
- Andere Medikamente
- Meloxicam, Duloxetine, Amlodipine, Zolpidem, Zetia, Methocarbamol, Valium, Levothyroxine, Zoloft, Losartan
- Allergien
- Metronidazole, mirapex, prednisone, penicillins
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 22.11.2022
- Impfdatum
- 07.11.2022
- Beginn
- 17.11.2022
- Tage bis Beginn
- 10,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Chills
Cough
Dry throat
Fatigue
Oropharyngeal pain
Pyrexia
Respiratory tract congestion
SARS-CoV-2 test positive
Throat irritation
Symptomtext
10 days after receiving vaccination I began having mild congestion and dry scratchy sore throat. Sore throat worsened to a dry cough. Congestion, sore throat, and cough worsened the next day. That evening I began having fever. Fever was 101 also had fatigue and chills. During this time I had to use my rescue inhalers. Called PCP on Friday and had video visit on Saturday. Was prescribed flovent inhaler and paxlovid. Began Paxlovid that afternoon. Symptoms were the worst on Saturday and have slowly been improving. At telehealth visit on 11/19/2022 also discussed possible drug interaction between Buprenorphine and Paxlovid. It was decided that the reward outweighs the possible risks.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- COVID-19 - positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma; inflammatory bowl disease
- Andere Medikamente
- Lunesta 3mg; Buprenorphine 4mg twice daily; Zofran 8mg PRN; Albuterol 90MCG PRN; citrucel powder; Miralax; Famotidine 20mg daily
- Allergien
- Keflex; amitriptyline; nortriptyline; soy and gluten intolerance
- Vorherige Impfungen
- 2nd dose of Moderna caused 102 fever and fatigue
- Staat
- FL
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 16.11.2022
- Impfdatum
- 02.10.2022
- Beginn
- 12.11.2022
- Tage bis Beginn
- 41,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Fatigue
Oropharyngeal pain
Respiratory tract congestion
SARS-CoV-2 test positive
Throat irritation
Symptomtext
Approximately one month after getting my vaccination I developed COVID-19. On 11/12 I began having a tickle in my throat that evening. On 11/13 I woke up with a worse sore throat, fatigue, and congestion. Tested positive on an at home COVID-19 and reached out to PCP. Prescribed steroids and an antiviral. Prescriptions have helped resolve symptoms but some are still lingering.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- COVID-19 test
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High Cholesterol; osteoporosis
- Andere Medikamente
- Simvastatin; PROLIA injections every 6 months; multivitamin; calcium supplement
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 12.11.2022
- Impfdatum
- 21.10.2022
- Beginn
- 03.11.2022
- Tage bis Beginn
- 13,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypersensitivity
Pruritus
Rash
Symptomtext
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Additional Details: has not resolved. being refered to allergist
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 09.11.2022
- Impfdatum
- 05.11.2022
- Beginn
- 05.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Back pain
Dysstasia
Gait disturbance
Loss of personal independence in daily activities
Musculoskeletal stiffness
Sitting disability
Symptomtext
Approximately 2-4 hours after receiving the vaccine, I began to notice a pain in my lower back that was settling into my hips while relaxing in my recliner with my son. The pain became intense to the point where I had to get up and begin walking as I could no longer stand sitting in my chair. Continued pain on Sunday-Tuesday (November 5, 6, 7, 8). I was taking Tylenol and Motrin with no resolve to the pain Yesterday (November 8) I felt that I was at my worst with symptoms. I began to notice that if I sat too long I would become very stiff and when I would go to stand, I had to receive support to stand and move. Climbing the stairs became unbearable and even walking was difficult. Today, I am still stiff, but not to the degree where I am as immobile as I was days prior.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- Not Applicable.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Severe Seasonal allergies Cholocystectomy (IBS-D) related to meals.
- Andere Medikamente
- Vitamin E 360 mg Zyrtec 20 mg Whelchol 600 mg Women's Multivitamin GNC energy and Metabolism B-Complex vitamin
- Allergien
- N/A
- Vorherige Impfungen
- COVID 19 Vaccine (Johnson and Johnson and Moderna) 03/10/2021- Johnson and Johnson- Nausea and vomiting with fatigue for over 24
- Staat
- MD
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 07.11.2022
- Impfdatum
- 22.10.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 10,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cough
Fatigue
Headache
Nasopharyngitis
Poor quality sleep
Respiratory tract congestion
Rhinorrhoea
SARS-CoV-2 test negative
Symptomtext
I had cold symptoms on Tuesday 11/01/22 that seem to get worse at night. I have a runny nose, head pain, cough, congestion in my chest. In the mornings my chest is really congested, my sleep is really poor, no fever, I feel fatigued, no aches or pains. I tested on 11/04/22 with a home COVID-19 test that came back negative. I called the nurses hotline for my insurance on 11/05/2022, and she suggested that I treat myself for a cold. It has helped. The day all of this started I was knocked down by a young teenager before all of this had started. The scraps on my elbow have still not healed from this incident. This was very stressful as there were a lot of people trying to be helpful.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- No
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- Joint Support Formula; OPC3; Acai Energy; Multivitamin; Calcium; Activated B; Vitamin C Immune Support Formula
- Allergien
- Erythromycin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 07.11.2022
- Impfdatum
- 31.10.2022
- Beginn
- 31.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site discharge
Underdose
Symptomtext
When administering the booster for moderna some of the vaccine dripped out so the full dose was not recieved
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site discharge
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- Fluzone shot as well
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site pruritus
Injection site rash
Injection site swelling
Symptomtext
rash and swelling at injection site, itchiness for a week following vaccination
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 10,0
- Geschlecht
- M
- Eingang
- 01.11.2022
- Impfdatum
- 29.10.2022
- Beginn
- 29.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Irritability
Pain in extremity
Symptomtext
SORE ARM, AND IRRITABLE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 26.10.2022
- Impfdatum
- 17.10.2022
- Beginn
- 19.10.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Symptomtext
Stared on Oct 19 in the left forearm I got the shot in and in the morning, I noticed it was all over the truck of my body may abdomen and my chest they looked like a bunch of round dots. I started taking Clairton and Benadryl hydrocodone and other anti-itch medication.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Allergies
- Vorgeschichte
- No
- Andere Medikamente
- Bupropion; Naltrexone; Multivitamin
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 25.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 17.10.2022
- Tage bis Beginn
- 7,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Fatigue
Headache
Pyrexia
Respiratory tract congestion
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough Covid Infection. Symptoms _ Fever, Cough, Headaches, Congestion, Fatigue. Treated with Paxlovid-5 days. Symptoms gradually moderated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Test for Covid conducted at clinic 10/19/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Dilantin, Prilosec, Multivitamen, Sivastatin, B-12
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 22.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Neuralgia
Oedema
Pain
Skin swelling
Symptomtext
Most of left arm is puffy and feels edematous, pain in ulnar and radial nerves, mild localized pain, no inflammation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma Hypothyroidism (Hashimoto's) PCOS Migraines Nerve pain in arms
- Andere Medikamente
- Levothyroxine B vitamin complex Vitamin B-2 Spironolactone Cetirizine Sertraline Magnesium Budesonide/formoterol Flunisolide Nexplanon implant
- Allergien
- Acetaminophen (hives) Sumatryptan (sudden severe hypertension) Metformin (panic attacks)
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 22.10.2022
- Impfdatum
- 17.10.2022
- Beginn
- 18.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest discomfort
Discomfort
Injection site erythema
Injection site pain
Pain
Symptomtext
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 10,0
- Geschlecht
- M
- Eingang
- 20.10.2022
- Impfdatum
- 19.10.2022
- Beginn
- 19.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Nausea
Pyrexia
Vomiting
Symptomtext
PEDIATRIC PT CAME IN WITH MOM FOR MODERNA BIVALENT VACCINE. CONSENT FORM FILLED OUT CORRECTLY AND AGE WAS WRITTEN NEXT TO DATE OF BIRTH. PHARMACIST VERIFIED CONSENT FORM AND COUNSELED PATIENT AND PATIENT'S MOM CORRECTLY. PHARMACIST ADMINISTERED 0.5ML OF MODERNA BIVALENT INSTEAD OF 0.25ML FOR PATIENTS 6-11 YEARS OLD. PHARMACIST REALIZED ERROR AFTER ADMINISTRATION. PT EXPERIENCED MILD FEVER AND NAUSEA/VOMITTING THE FOLLOWING DAY.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 20.10.2022
- Impfdatum
- 17.10.2022
- Beginn
- 17.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pain in extremity
Peripheral swelling
Uterine spasm
Symptomtext
pt reported arm soreness, arm swelling, and uterine cramping (not sure if from vaccine or cervix exam)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- pt encouraged to reach out to ob
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 20.10.2022
- Impfdatum
- 16.10.2022
- Beginn
- 20.10.2022
- Tage bis Beginn
- 4,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Induration
Pain in extremity
Peripheral swelling
Skin warm
Symptomtext
swelling on left arm, sore and hard, warm to touch. swelling got bigger today 10-20-22 advised patient to contact primary care physician will follow up with patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- swelling but not as bad as today's
- Staat
- CA
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 18.10.2022
- Impfdatum
- 18.10.2022
- Beginn
- 18.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Headache
Pruritus
Symptomtext
PT REPORTED ITCHINESS AND REDNESS ON ARM. IT LASTED 15 MINUTES. PT REPORTED HEADACHE THAT LASTED 15 MINUTES. PT WAS PROVIDED ICE PACK, 1 TABLET OF BENEDRYL, AND 1 WATER BOTTLE TO DRINK. AFTER 15 MINTUES, PT REPORTED THAT EVERYTHING IS FINE AND SHE WAS READY TO LEAVE. PT WAS ADVISED TO STAY 30 MINUTES FOR OBSERVATION. PT DECLINED. PT ALSO DECLINED FURTHER FOLLOW UP.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- N/A
- Allergien
- SHRIMP
- Vorherige Impfungen
- PFIZER; DIZZINESS ON 1/14/22
- Staat
- HI
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 13.10.2022
- Impfdatum
- 09.10.2022
- Beginn
- 12.10.2022
- Tage bis Beginn
- 3,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Malaise
Nausea
Vertigo
Symptomtext
Vertigo, queasy stomach, malaise
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Rosuvastatin, 10 mg calcium, zinc, quercetin, c, d, saw palmetto, fish oil
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 11.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 11.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dizziness
Fall
Symptomtext
Patient reported being dizzy and then fell. She was taken to the ER because she fell.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- Unknown. Patient's husband reported that doctors diagnosed her fall as a result of a vaccine-related adverse event.
- Aktuelle Erkrankungen
- Urinary tract infection
- Vorgeschichte
- high cholesterol
- Andere Medikamente
- unknown
- Allergien
- Codeine, tramadol, sulfa, penicillins
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 07.12.2023
- Impfdatum
- 18.10.2022
- Beginn
- 01.06.2023
- Tage bis Beginn
- 226,0
- Dosis
- 6
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Triple negative breast cancer
Symptomtext
Triple negative breast cancer; This spontaneous case was reported by a patient family member or friend and describes the occurrence of TRIPLE NEGATIVE BREAST CANCER (Triple negative breast cancer) in a 78-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. Patient received other vaccines in the 4 weeks prior to COVID-19 vaccine. Previously administered products included for Product used for unknown indication: COVID-19 vaccine (1st dose and Lot 025J20-2A) on 30-Dec-2020; for COVID-19 prophylaxis: Moderna COVID-19 vaccine (2nd dose ,Lot 010M20A) on 28-Jan-2021, Moderna COVID-19 vaccine (3rd dose, Lot 939906) on 25-Oct-2021, Moderna COVID-19 Vaccine (4th dose and Lot 049L21A) on 06-May-2022. Past adverse reactions to the above products included No adverse event with COVID-19 vaccine, Moderna COVID-19 Vaccine, Moderna COVID-19 vaccine and Moderna COVID-19 vaccine. Concurrent medical conditions included Hypothyroidism. On 18-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 26-Jul-2023, received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 01-Jun-2023, the patient experienced TRIPLE NEGATIVE BREAST CANCER (Triple negative breast cancer) (seriousness criterion medically significant). At the time of the report, TRIPLE NEGATIVE BREAST CANCER (Triple negative breast cancer) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. It was reported that patient had high dose FLU Shot on 13-OCT-2023. Patient had finished 12 weeks chemo on 19-OCT-2023. Patient was taking Thyroid Medication. She was scheduled to have surgery next week for lumpectomy in the breast. This case was linked to US-MODERNATX, INC.-MOD-2023-751731. Company comment: This spontaneous case concerns a 78-year-old, female patient with no relevant medical history, who experienced the unexpected serious (medically significant) event of triple negative breast cancer. The event occurred approximately 8 months after the fifth dose of mRNA-1273 bivalent BA.4/BA.5. The patient received chemotherapy and was scheduled for lumpectomy. No further information about the events was provided. Considering patient's advanced age as risk factor as well as lack of biological plausibility for causality the event of breast cancer is assessed as not related. The benefit-risk relationship of mRNA-1273 bivalent BA.4/BA.5 is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-751731:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Triple negative breast cancer
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Hypothyroidism
- Vorgeschichte
- Comments: Patient received other vaccines in the 4 weeks prior to COVID-19 vaccine.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 28.11.2023
- Impfdatum
- 12.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Tinnitus
Symptomtext
Presistant, annoying tinnitus
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tinnitus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Levothyroxine, Zocor, Multi vitamin
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 10.11.2023
- Impfdatum
- 08.11.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthma
COVID-19
SARS-CoV-2 test
Symptomtext
asthma; Then she attended a wedding, and she picked up COVID. Her COVID test came positive; This spontaneous case was reported by a patient and describes the occurrence of ASTHMA (asthma) and COVID-19 (Then she attended a wedding, and she picked up COVID. Her COVID test came positive) in an 80-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. Co-suspect product included non-company product INFLUENZA VACCINE for an unknown indication. No Medical History information was reported. On 08-Nov-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient received dose of INFLUENZA VACCINE (unknown route) at an unspecified dose. On an unknown date, the patient experienced ASTHMA (asthma) and COVID-19 (Then she attended a wedding, and she picked up COVID. Her COVID test came positive). The patient was treated with CIPROFLOXACINE [CIPROFLOXACIN] at an unspecified dose and frequency. At the time of the report, ASTHMA (asthma) was resolving and COVID-19 (Then she attended a wedding, and she picked up COVID. Her COVID test came positive) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Patient had her first Moderna vaccine in Feb, then Mar and May. The new vaccine she believes is called Spikevax. She was going to take the Spikevax. She already took her flu vaccine. She did have fever, sore throat, cough, and asthma. She started taking Cipro and felt better. Then she attended a wedding, and she picked up COVID. Her COVID test came positive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asthma
- Hospital-Tage
- -
- Labordaten
- Test Name: SARS-CoV-2 test; Test Result: Positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 13.07.2023
- Impfdatum
- 21.10.2022
- Beginn
- 08.01.2023
- Tage bis Beginn
- 79,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chronic respiratory failure
Respiratory failure
Symptomtext
CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/10/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chronic respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 07.07.2023
- Impfdatum
- 12.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 6,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute coronary syndrome
Symptomtext
ACUTE CORONARY SYNDROME, UNSPECIFIED
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute coronary syndrome
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 27.06.2023
- Impfdatum
- 20.06.2023
- Beginn
- 20.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Symptomtext
No adverse event; she got all 3 shots bivalent, and she already had received the booster for 2021 and got it again yesterday.; This spontaneous case was reported by a patient and describes the occurrence of EXTRA DOSE ADMINISTERED (she got all 3 shots bivalent, and she already had received the booster for 2021 and got it again yesterday.) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: Moderna Covid-19 Vaccine (Booster) in 2021. Past adverse reactions to the above products included No adverse event with Moderna Covid-19 Vaccine. On 20-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Jun-2023, the patient experienced EXTRA DOSE ADMINISTERED (she got all 3 shots bivalent, and she already had received the booster for 2021 and got it again yesterday.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (she got all 3 shots bivalent, and she already had received the booster for 2021 and got it again yesterday.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (she got all 3 shots bivalent, and she already had received the booster for 2021 and got it again yesterday.). No concomitant information was reported. Suspect product dosage text was reported as unknown. It was reported that patient had 3 shots bivalent, and she alreadyhad received the booster for 2021 and got it again yesterday. It was reported that patient gave her son card instead of her card. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 22.06.2023
- Impfdatum
- 12.10.2022
- Beginn
- 06.05.2023
- Tage bis Beginn
- 206,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
COVID-19
SARS-CoV-2 test positive
Symptomtext
Hospitalization: 5/6/2023 - 5/8/2023 (2 days) Presentation to the ED: generalized weakness COVID + date: 5/6/2023 Treatment: supportive therapy. Discharge to: home. EW0178 8/26/2021 FK9895 4/16/2022 061F22A 10/12/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asthenia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CKDiv, dm, MM
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 07.06.2023
- Impfdatum
- 14.11.2022
- Beginn
- 23.11.2022
- Tage bis Beginn
- 9,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Hypoxia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypoxia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 24.05.2023
- Impfdatum
- 19.05.2023
- Beginn
- 19.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Dose given after the published expiration date on 19MAY2023. Lot number 061F22A, expiration date 16MAY2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose given after the published expiration date on 19MAY2023. Lot number 061F22A, expiration date 16MAY2023) and NO ADVERSE EVENT (No adverse event) in a 30-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Tdap and Hepatitis B (booster). Past adverse reactions to the above products included No adverse event with Hepatitis B and Tdap. On 19-May-2023, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-May-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose given after the published expiration date on 19MAY2023. Lot number 061F22A, expiration date 16MAY2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose given after the published expiration date on 19MAY2023. Lot number 061F22A, expiration date 16MAY2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose given after the published expiration date on 19MAY2023. Lot number 061F22A, expiration date 16MAY2023). It was reported that patient received other vaccines 4 weeks prior to Covid-19 vaccine. Concomitant product use was not provided by the reporter. It was reported that dose was given after the published expiration date on 19MAY2023. Lot number 061F22A, expiration date 16MAY2023. No reported symptoms. No additional doses, medications, or treatments. Treatment information was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 25.04.2023
- Impfdatum
- 16.10.2022
- Beginn
- 01.02.2023
- Tage bis Beginn
- 108,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cough
Nasopharyngitis
Symptomtext
I had a cold in February with coughing. The cold went away, but the coughing remained. It's a nagging cough. I still have it, but it is infrequent. I didn't have any type of lingering cough after the other vaccines so this is new for me. My husband is experiencing the same symptoms after receiving his third dose as well. There is no distinguishing time when the cough come and goes, but it lasted about 8 weeks back when it started in February. I've been taking allergy medicine, and it helps. It's a non-productive dry cough. It's similar to my experience after taking Metoprolol. I mentioned the cough to my doctor in my annual well visit.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cough
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Type 2 Diabetes; High Blood Pressure; Sinusitis
- Andere Medikamente
- Metformin; Atenolol; Amlodipine; Glipizide; Humalog; Baby Aspirin; Atorvastatin; Januvia; Losartan; Claritin; Zyrtec; Flonase
- Allergien
- Metoprolol; Benicar; Cats; Horse; Dust; Dander
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 19.04.2023
- Impfdatum
- 12.04.2023
- Beginn
- 12.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 6
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Pt. received a second bivalent booster dose before it was authorized. The dose given beyond its beyond use date.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 19.04.2023
- Impfdatum
- 01.02.2022
- Beginn
- 25.01.2023
- Tage bis Beginn
- 358,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Drug hypersensitivity
Nodule
SARS-CoV-2 test negative
Tenderness
Symptomtext
On 01/25/2023 in the late evening I went to the ER because I notice a painful node on back of my head. They thought it was in grown hair. They prescribe me with antibiotics and ibuprofen as per needed. I also noticed that I was having allergic reaction to the antibiotics and the ambulance had to come and get me to a different ER. At the new ER they prescribed me penicillin for 1 week. The bump on my head comes and goes. It is sensitive to touch. On 04/04/2023 I told my PCP and she prescribed me more penicillin but the bump is still there. I feel like once in a month it will come and go. As long as I take ibuprofen the pain is less.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Drug hypersensitivity
- Hospital-Tage
- -
- Labordaten
- 19APR2023 COVID-19 test negative
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Type 2 Diabetes
- Andere Medikamente
- Escitalopram; atorvastatin; metoprolol; amlodipine; carvedilol; cyclobenzaprine; baby aspirin; vitamin D3; vitamin B12; magnesium
- Allergien
- Kale; latex
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 12.04.2023
- Impfdatum
- -
- Beginn
- 20.02.2023
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
Vaccine administered to patient after temperature excursion; No adverse event; Temperature probes were being changed, Freezer 15 minutes - original temperature -19.8 celsius and temperature raised to -1.9 celsius and then up to -14.2 celsius; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature probes were being changed, Freezer 15 minutes - original temperature -19.8 celsius and temperature raised to -1.9 celsius and then up to -14.2 celsius), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered to patient after temperature excursion) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Feb-2023, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature probes were being changed, Freezer 15 minutes - original temperature -19.8 celsius and temperature raised to -1.9 celsius and then up to -14.2 celsius). On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered to patient after temperature excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature probes were being changed, Freezer 15 minutes - original temperature -19.8 celsius and temperature raised to -1.9 celsius and then up to -14.2 celsius), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered to patient after temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature probes were being changed, Freezer 15 minutes - original temperature -19.8 celsius and temperature raised to -1.9 celsius and then up to -14.2 celsius) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered to patient after temperature excursion). No concomitant medication was reported. Vaccine were provided from the lot number. 061F22A. No calls from patient in regards to side effects from the temperature excursion. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 10.04.2023
- Impfdatum
- 08.08.2022
- Beginn
- 27.03.2023
- Tage bis Beginn
- 231,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Coronary artery bypass
Electrocardiogram abnormal
Symptomtext
I went in for a checkup and my doctor noticed something on my EKG. I was referred to a Cardiologist and I ended up having to have triple bypass surgery. I am feeling a little better. This is still very new. I still have a couple months of recovery.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Coronary artery bypass
- Hospital-Tage
- -
- Labordaten
- DEC2022 EKG abnormal
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Diabetic
- Andere Medikamente
- Metformin; TRICOR; JARDIANCE; LIPITOR; JANUVIA
- Allergien
- BENADRYL
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 08.04.2023
- Impfdatum
- 10.11.2022
- Beginn
- 10.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient had already received bivalent booster on 09/03/2022. Received a second bivalent booster in error on 11/09/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 07.04.2023
- Impfdatum
- 03.11.2022
- Beginn
- 05.04.2023
- Tage bis Beginn
- 153,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
SARS-CoV-2 test positive
Symptomtext
hospitalized with covid; fully vaccinated with 3 boosters
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- 1,0
- Labordaten
- positive covid pcr 4/5/23
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- Hyperlipidemia, Peptic Ulcer Disease, Reflux and Other (morbid obesity; chronic abdominal/pelvic pain; fibromyalgia; IBS; migraines; PTSD; diverticulosis; hypomania; chronic GB disease)
- Andere Medikamente
- unknown
- Allergien
- Augmentin, doxycycline, morphine, statins, sulfa, verapamil
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 24.03.2023
- Impfdatum
- 01.04.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Symptomtext
caught covid 10 days after booster dose; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (caught covid 10 days after booster dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 061F22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Dose 1, Lot Number:EM9810) on 05-Feb-2021, PFIZER BIONTECH COVID-19 VACCINE (Dose 3, Lot Number: FF2588), PFIZER BIONTECH COVID-19 VACCINE (Dose 2 and Lot Number:EN6205). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE. In April 2022, the patient received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2022, the patient experienced COVID-19 (caught covid 10 days after booster dose). At the time of the report, COVID-19 (caught covid 10 days after booster dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The patient received the additional booster around 15-Apr-2022 and had COVID-19 vaccine, 10 days after the booster dose. The patient received the last booster as Moderna bivalent on 22-Oct-2022. The concomitant medication was not reported. The patient received the fourth dose of Moderna vaccine with batch number as 005M21A. The treatment medication was not reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 98,0
- Geschlecht
- F
- Eingang
- 20.03.2023
- Impfdatum
- 07.11.2022
- Beginn
- 14.03.2023
- Tage bis Beginn
- 127,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 4 vaccines Moderna 1/20/21 Lot# 032H20A; Moderna 2/17/21 Lot# 026L20A; Moderna 2/17/22 Lot# 028K21A; Moderna 11/7/22 Lot# 061F22A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 29,0
- Geschlecht
- U
- Eingang
- 06.03.2023
- Impfdatum
- 18.01.2023
- Beginn
- 18.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
No adverse event; Patient mistakenly received Moderna Covid-19 vaccine, bivalent for 1st dose of primary series.; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient mistakenly received Moderna Covid-19 vaccine, bivalent for 1st dose of primary series.) and NO ADVERSE EVENT (No adverse event) in a 29-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Jan-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Jan-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (Patient mistakenly received Moderna Covid-19 vaccine, bivalent for 1st dose of primary series.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient mistakenly received Moderna Covid-19 vaccine, bivalent for 1st dose of primary series.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient mistakenly received Moderna Covid-19 vaccine, bivalent for 1st dose of primary series.). The concomitant medication was not reported by reporter. The treatment medication was not reported by reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 05.03.2023
- Impfdatum
- 01.02.2023
- Beginn
- 20.02.2023
- Tage bis Beginn
- 19,0
- Dosis
- N/A
- Route/Site
- SYR / LG
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Symptomtext
Want to verify if correct dose for age was received
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ADD
- Andere Medikamente
- Concerta 18 mg qday methylphenidate 5 mg q afternoon Iron qod
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 23.02.2023
- Impfdatum
- 19.11.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
There was more than one excursion/ All of the doses were administered after the excursions since 20Oct2022; There was more than one excursion/ All of the doses were administered after the excursions since 20Oct2022; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (There was more than one excursion/ All of the doses were administered after the excursions since 20Oct2022), PRODUCT TEMPERATURE EXCURSION ISSUE (There was more than one excursion/ All of the doses were administered after the excursions since 20Oct2022) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. It was unknown whether patient ever been diagnosed or tested positive for COVID-19. Patient allergies information include NKA and NKDA. Concurrent medical conditions included Arthritis (No recent changes in condition status), Hypertension (No recent changes in condition status) and Bone spur (Bone Spurs, No recent changes in condition status). Concomitant products included LISINOPRIL for Hypertension. On 19-Nov-2022, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (There was more than one excursion/ All of the doses were administered after the excursions since 20Oct2022), PRODUCT TEMPERATURE EXCURSION ISSUE (There was more than one excursion/ All of the doses were administered after the excursions since 20Oct2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (There was more than one excursion/ All of the doses were administered after the excursions since 20Oct2022) had resolved and PRODUCT TEMPERATURE EXCURSION ISSUE (There was more than one excursion/ All of the doses were administered after the excursions since 20Oct2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered POOR QUALITY PRODUCT ADMINISTERED (There was more than one excursion/ All of the doses were administered after the excursions since 20Oct2022) and NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (There was more than one excursion/ All of the doses were administered after the excursions since 20Oct2022). It was reported that patient received moderna vaccine and was observed for 30 mins after injection w/ no adverse reactions. At the present time, advised patient to RTC or PCP should any reaction occur. It was unknown whether patient experienced similar event in the past and there were no any potential causes. It was reported that the There was more than one excursion on 20 Oct 2022, 21 Oct 2022, 24 Oct 2022, 25 Oct 2022, 27 Oct 2022, 28 Oct 2022, 29 Oct 2022, 30 Oct 2022, 31 Oct 2022, 1 Nov 2022, 2 Nov 2022, 3 Nov 2022, 4 Nov 2022, 5 Nov 2022, 6 Nov 2022, 7 Nov 2022, 8 Nov 2022, 9 Nov 2022, 10 Nov 2022, 11 Nov 2022, 12 Nov 2022, 13 Nov 2022, and 14 Nov 2022. All of the doses were administered after the excursions since 20 Oct 2022. Treatment drug information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 22-Feb-2023: Follow-up received included updated reporter details, patient details, medial history, vaccination details and narrative information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Arthritis (No recent changes in condition status); Bone spur (Bone Spurs, No recent changes in condition status); Hypertension (No recent changes in condition status)
- Vorgeschichte
- Comments: It was unknown whether patient ever been diagnosed or tested positive for COVID-19. Patient allergies information include NKA and NKDA.
- Andere Medikamente
- LISINOPRIL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 07.02.2023
- Impfdatum
- 17.11.2022
- Beginn
- 17.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date), PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered on 17-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis. No Medical History information was reported. On 17-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 17-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11, 2022, vaccine was administered on 17-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date), PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11, 2022, vaccine was administered on 17-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date) and PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11, 2022, vaccine was administered on 17-Nov-2022). Concomitant product use was not provided by the reporter. Vials did not undergo any temperature excursions. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-706651 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2023-706651:Master case - 1st adult patient MODERNATX, INC.-MOD-2023-706901:2nd adult MODERNATX, INC.-MOD-2023-706942:Master case - 2nd adult patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 06.02.2023
- Impfdatum
- 18.10.2022
- Beginn
- 18.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
No adverse event
Symptomtext
NO ADVERSE AFFECTS. DOSE WAS GIVEN ONE MONTH TOO EARLY
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.02.2023
- Impfdatum
- 22.12.2022
- Beginn
- 22.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered on 22-Dec-2022; No adverse event; 4 adults patients received doses after its beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date), PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered on 22-Dec-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 22-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered on 22-Dec-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date), PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered on 22-Dec-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date) and PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered on 22-Dec-2022). No concomitant medication was provided. It was unknown that the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Vial size included 2.5 mL and vials did not undergone any temperature excursions. Treatment medication was not provided by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2023-706651, US-MODERNATX, INC.-MOD-2023-706894, US-MODERNATX, INC.-MOD-2023-706901 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-706651:Master case - 1st adult patient US-MODERNATX, INC.-MOD-2023-706894:Master case - 2nd adult patient US-MODERNATX, INC.-MOD-2023-706901:Master case - 3rd adult patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.02.2023
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Vials was initially stored in the refrigerator and then thawed shipment received in liquid state on Oct 11 2022, vaccine was administered on 30-Nov-2022; No adverse event; Patient received doses after its beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received doses after its beyond use date), PRODUCT STORAGE ERROR (Vials was initially stored in the refrigerator and then thawed shipment received in liquid state on Oct 11 2022, vaccine was administered on 30-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis. No Medical History information was reported. On 30-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 30-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vials was initially stored in the refrigerator and then thawed shipment received in liquid state on Oct 11 2022, vaccine was administered on 30-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received doses after its beyond use date), PRODUCT STORAGE ERROR (Vials was initially stored in the refrigerator and then thawed shipment received in liquid state on Oct 11 2022, vaccine was administered on 30-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received doses after its beyond use date) and PRODUCT STORAGE ERROR (Vials was initially stored in the refrigerator and then thawed shipment received in liquid state on Oct 11 2022, vaccine was administered on 30-Nov-2022). This was the case for 3rd adult patient who received vaccine on 30-Nov-2022 out of 4 adult patients. Concomitant product use was not provided by the reporter. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Vials sizes were 2.5 ml and there was total 4 vials. Vials were received in liquid state on 11-Oct-2022. Dose of administration date were as follows two doses were on 17-Nov-2022, one dose was on 30-Nov-2022 and one dose was on 22-Dec-2022. Vials did not undergo any temperature excursions. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-706651, US-MODERNATX, INC.-MOD-2023-706942, US-MODERNATX, INC.-MOD-2023-706894 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-706651:Master case - 1st adult patient US-MODERNATX, INC.-MOD-2023-706942:4th adult patient US-MODERNATX, INC.-MOD-2023-706894:2nd adult
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.02.2023
- Impfdatum
- 17.11.2022
- Beginn
- 17.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered 17-Nov-2022; No adverse event; 4 adults patients received doses after its beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date), PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered 17-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. On 17-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 17-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered 17-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date), PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered 17-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date) and PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered 17-Nov-2022). Concomitant product use was not provided by the reporter. Vials did not undergone any temperature excursions. Treatment information was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 33,0
- Geschlecht
- M
- Eingang
- 02.02.2023
- Impfdatum
- 01.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Patient was given Moderna Bivalent vaccine but only received one dose of Moderna Monovalent vaccine. Patient should have been offered and given dose two of Moderna not Bivalent booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- psychiatric
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- -
- Beginn
- 31.10.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (A patient received a booster without receiving any other vaccine) and NO ADVERSE EVENT (no adverse event) in a 75-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 31-Oct-2022, the patient experienced NO ADVERSE EVENT (no adverse event). On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (A patient received a booster without receiving any other vaccine). At the time of the report, WRONG PRODUCT ADMINISTERED (A patient received a booster without receiving any other vaccine) and NO ADVERSE EVENT (no adverse event) outcome was unknown. Concomitant and treatment medications were not reported. A patient received a booster without receiving any other vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 30.01.2023
- Impfdatum
- 30.01.2023
- Beginn
- 30.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
No adverse reaction. Patient had previously received the Moderna Bivalent Booster on 9/30/2022. A second Moderna Bivalent Booster was given on 1/30/2023 at 1315. Patient was kept in clinic from 1315 to 1345. Patient felt fine. Had no issues. Patient educated on error and signs to watch for and encouraged to call with any questions or concerns.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- No testing done.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- hx of positive hepatitis C/low back pain/depression/R)hip replacement/headache/dehydration/anxiety/positional vertigo/dyslipidemia/HTN/hypertriglyceridemia/obesity/type 2 DM/osteoarthritis of L)Hip/costochondritis/osteoporosis/smoker/PTSD/chronic constipation/insomnia disorder/OCD
- Andere Medikamente
- aripiprazole 5mg/aspirin 81mg,/buspirone 7.5mg/vitamin b-12 injection every month/Prolia every 6 months/dexlansoprazole 60mg/duloxetine 60mg/eszopiclone 3mg/fenofibrate 160mg/levothyroxine 112mcg/lorazepam 0.5mg as needed/melatonin 9mg/metf
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 25.01.2023
- Impfdatum
- 31.10.2022
- Beginn
- 31.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
No adverse event
Symptomtext
PATIENT RECEIVED THE MODERNA BIVALENT VACCINE AS HIS FIRST VACCINE IN ERROR - NO 2 MONOVALENT VACCINES GIVEN PREVIOUSLY --- NO ADVERSE REACTION AT ALL!!!
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 23.01.2023
- Impfdatum
- 21.10.2022
- Beginn
- 24.12.2022
- Tage bis Beginn
- 64,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Feeling abnormal
Lung disorder
Symptomtext
I started feeling a little tickle in my lungs. Several days went by and I was not feeling good. We went out of town, and I forgot my inhaler, so, I went to urgent care to get a prescription for albuterol, and they told me that I needed prednisone too.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Feeling abnormal
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Asthma; COPD; Obesity
- Andere Medikamente
- TRELEGY; albuterol; montelukast; saline nasal spray; calcium; vitamin D; zinc; fish oil; lutein
- Allergien
- Peanuts; pork; elm trees; ragweed; mold; pollen
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 20.01.2023
- Impfdatum
- 20.10.2022
- Beginn
- 10.01.2023
- Tage bis Beginn
- 82,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Laboratory test
Symptomtext
No adverse event from vaccine, patient caught covid in January
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- lab test performed at Hospital lab
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- -
- Andere Medikamente
- gabapentin/atorvastatin/amlodipine besylate/losartan hctzb/tamsulosin/ low dose aspirin/ ferosul
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 17.01.2023
- Impfdatum
- 14.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 12,0
- Dosis
- 5
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
SARS-CoV-2 test positive
Symptomtext
I received the Moderna Bivalent COVID-19 booster on 10/14/2022. On 10/26/2022, my daughter-in-law tested positive for COVID-19. I had recently spent time with her, so I decided to test myself. I took a home antigen test and got a positive result. I tested myself during the following days, and I didn't test negative until 10/30/2022. I never really had any symptoms, but I contacted my NP, who prescribed me PAXLOVID, which I started taking on 10/26/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 10/26/2022-10/29/2022 home antigen tests positive results; 10/30/2022 home antigen test negative result.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Left Bundle Branch Block; Hypothyroidism; High Cholesterol; Hypertension.
- Andere Medikamente
- Levothyroxine; bupropion; pravastatin sodium; progesterone; atenolol; vitamin D; iron; baby aspirin.
- Allergien
- Codeine.
- Vorherige Impfungen
- After I got the second dose of the Pfizer COVID-19 vaccine, I developed body aches, which lasted for a couple of days
- Staat
- TX
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 05.01.2023
- Impfdatum
- 10.11.2022
- Beginn
- 31.12.2022
- Tage bis Beginn
- 51,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abnormal uterine bleeding
Symptomtext
Dysfunctional uterine bleeding. Work up has been ordered to r/o other causes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abnormal uterine bleeding
- Hospital-Tage
- -
- Labordaten
- Pending
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 28.12.2022
- Impfdatum
- 28.12.2022
- Beginn
- 28.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Patient received second bivalent vaccine by mistake today. I read last dose as 11/07/2021 (while it was 11/07/2022)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 22.12.2022
- Impfdatum
- 14.11.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- 17,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blood test
- Hospital-Tage
- -
- Labordaten
- Blood test
- Aktuelle Erkrankungen
- High blood pressure
- Vorgeschichte
- None
- Andere Medikamente
- NIASPAN
- Allergien
- Dust; mites
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 22.12.2022
- Impfdatum
- 16.12.2022
- Beginn
- 16.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Poor quality product administered
Symptomtext
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture), POOR QUALITY PRODUCT ADMINISTERED (The date vial was initially stored in the refrigerator: 14DEC2022. The date and time vial were first punctured: 15DEC2022, 2:00 PM) and NO ADVERSE EVENT (No adverse event) in a 41-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 16-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 2.5 milliliter. On 16-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture) and POOR QUALITY PRODUCT ADMINISTERED (The date vial was initially stored in the refrigerator: 14DEC2022. The date and time vial were first punctured: 15DEC2022, 2:00 PM). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture), POOR QUALITY PRODUCT ADMINISTERED (The date vial was initially stored in the refrigerator: 14DEC2022. The date and time vial were first punctured: 15DEC2022, 2:00 PM) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture) and POOR QUALITY PRODUCT ADMINISTERED (The date vial was initially stored in the refrigerator: 14DEC2022. The date and time vial were first punctured: 15DEC2022, 2:00 PM). No concomitant medication was provided by reporter. The date vial was initially stored in the refrigerator: 14DEC2022. The date and time vial were first punctured: 15DEC2022, 2:00 PM and time of administration of vaccine: 16DEC2022, 9:42 AM How was the vial stored post puncture. The vial did not undergo any temperature excursions. No treatment medication was provided by reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 21.12.2022
- Impfdatum
- 16.12.2022
- Beginn
- 16.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture; No adverse event; patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture), EXPIRED PRODUCT ADMINISTERED (patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture) and NO ADVERSE EVENT (No adverse event) in a 68-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 16-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 16-Dec-2022, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT STORAGE ERROR (patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture), EXPIRED PRODUCT ADMINISTERED (patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture) and EXPIRED PRODUCT ADMINISTERED (patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture). No relevant concomitant medications were reported. HCP stated that 2 patients were administered a dose of the Moderna COVID-19 bivalent vaccine after more than 12 hours of vial puncture. Date the vial was initially stored in the refrigerator was on 14 DEC 2022. Vial was first punctured on 15 DEC 2022, 2:00 PM and administered on 16 Dec 2022 at 09:42 AM. The vial haven't undergone any temperature excursions. Total amount of time the vial was exposed to room temperature range (8 degree to 25 degree Celsius = 46 degree to 77 degree Fahrenheit): Approximately 18 hours. No treatment medication reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 16.12.2022
- Impfdatum
- 16.12.2022
- Beginn
- 16.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
The Moderna Bivalent Booster given on 12/16/22 was administered 9:42AM after being punctured at 2pm on 12/15/22 and stored at ambient temperature. This exceeds the 12 hour recommended range to store this vaccine at ambient temperature. The CDC and manufacturer was contacted and information gathered from both. This vaccine is considered safe to administer for up to 24 hours after puncture though there is a minute increase in risk for microbial infection, repeat dosage is not recommended.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- Patient did not have any adverse symptoms or reaction this is an immunization error
- Aktuelle Erkrankungen
- attention deficit hyperactivity disorder binge eating disorder chronic daily headache compression of brachial plexus Crohn's disease of colon dry eyes essential hypertension exercise-induced asthma generalized anxiety disorder low back strain male hypogonadism neutrophilia obstructive sleep apnea syndrome psoriasis radiculopathy due to lumbar intervertebral disc disorder scalenus anticus syndrome severe recurrent major depression
- Vorgeschichte
- attention deficit hyperactivity disorder binge eating disorder chronic daily headache compression of brachial plexus Crohn's disease of colon dry eyes essential hypertension exercise-induced asthma generalized anxiety disorder low back strain male hypogonadism neutrophilia obstructive sleep apnea syndrome psoriasis radiculopathy due to lumbar intervertebral disc disorder scalenus anticus syndrome severe recurrent major depression
- Andere Medikamente
- acetaminophen albuterol sulfate amoxicillin atorvastatin baclofen betamethasone valerate cholecalciferol (vitamin D3) clobetasol dicyclomine docosahexaenoic acid-epa ezetimibe gabapentin ibuprofen lorazepam losartan Lubricating Plus methylp
- Allergien
- duloxetine lisinopril naproxen
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 16.12.2022
- Impfdatum
- 16.12.2022
- Beginn
- 16.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administration error
Product storage error
Symptomtext
The Moderna Bivalent Booster given on 12/16/22 was administered 9:42AM after being punctured at 2pm on 12/15/22 and stored at ambient temperature. This exceeds the 12 hour recommended range to store this vaccine at ambient temperature. The CDC and manufacturer was contacted and information gathered from both. This vaccine is considered safe to administer for up to 24 hours after puncture though there is a minute increase in risk for microbial infection, repeat dosage is not recommended.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- no adverse reaction this was an immunization error
- Aktuelle Erkrankungen
- actinic keratosis aortic root dilatation aortic valve stenosis bilateral knee pain chest pain depressive disorder epidermoid cyst of skin of postauricular region hypertensive disorder influenza-like symptoms insomnia low back pain lumbar radiculopathy mild memory disturbance sinusitis strain of neck muscle vitamin B12 deficiency (non anemic)
- Vorgeschichte
- actinic keratosis aortic root dilatation aortic valve stenosis bilateral knee pain chest pain depressive disorder epidermoid cyst of skin of postauricular region hypertensive disorder influenza-like symptoms insomnia low back pain lumbar radiculopathy mild memory disturbance sinusitis strain of neck muscle vitamin B12 deficiency (non anemic)
- Andere Medikamente
- amlodipine aspirin atorvastatin Efudex losartan ProAir HFA tamsulosin trazodone
- Allergien
- no know allergies
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 14.12.2022
- Impfdatum
- 03.11.2022
- Beginn
- 10.11.2022
- Tage bis Beginn
- 7,0
- Dosis
- 4
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood creatine phosphokinase increased
Blood creatinine increased
Blood glucose decreased
Brain natriuretic peptide increased
COVID-19
Chest X-ray normal
Confusional state
Fall
Full blood count
Haemoglobin decreased
Hypoglycaemia
International normalised ratio increased
Metabolic function test
Platelet count normal
Rhabdomyolysis
SARS-CoV-2 test positive
Symptomtext
Patient was brought to local Hospital 11/10/2021 for increased confusion and low blood sugar. EMS called. Paramedics came and administered glucose juice with improvement of his symptoms. A second episode which occurred when patient woke up with confusion prompted patient?s family to bring the patient to the ED for further evaluation. In the ED patient received D50 and D5 infusion with recurrent hypoglycemia to 57. Ultimately patient was started on D10 infusion with improvement in his symptoms. Patient endorses recent mechanical fall but did not hit his head. CK noted to be elevated to 2600 s. Rapid COVID was positive on admission. BNP 3600s. UA positive for leukocyte esterase, WBC 21-30, urine cultures pending. CBC shows no leukocytosis WBC 4.58, hemoglobin 9.6, platelets 190. INR 1.95. CMP shows no AKI creatinine 2.01, baseline 2.6. AST 88, ALT 37. CXR negative for acute cardiopulmonary abnormalities. Patient admitted for recurrent hypoglycemia likely due to sulfonylurea use, complicated UTI, mechanical fall with rhabdomyolysis and COVID-19 virus infection. Patient was recently vaccinated with 2nd booster. Bivalent Moderna on 11/3/2022 lot # 061F22A and flu vaccine 11/3/2022. Local County public Health department has no further information on the outcome of this patient. Please contact provider/facility for any further information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Alanine aminotransferase increased
- Hospital-Tage
- -
- Labordaten
- Lab work, chest X-ray
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- CAD s/p bypass, diabetes and glimepiride, chronically anticoagulated on warfarin
- Andere Medikamente
- unknown
- Allergien
- not noted if patient has any allergies.
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- -
- Geschlecht
- U
- Eingang
- 14.12.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
Some adult patients received Bivalent as first dose and some received Bivalent as 2nd primary dose; No Adverse Event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Some adult patients received Bivalent as first dose and some received Bivalent as 2nd primary dose) and NO ADVERSE EVENT (No Adverse Event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Some adult patients received Bivalent as first dose and some received Bivalent as 2nd primary dose) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, WRONG PRODUCT ADMINISTERED (Some adult patients received Bivalent as first dose and some received Bivalent as 2nd primary dose) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Some adult patients received Bivalent as first dose and some received Bivalent as 2nd primary dose). No concomitant medications were reported. Reporter stated that patient receive any other vaccines in the 4 weeks prior to COVID-19 vaccine as Unknown. It was reported Some of the patients came from another country and they do not had any way of identifying what the original series were. Date of administrations were several different days. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 12.12.2022
- Impfdatum
- 12.12.2022
- Beginn
- 12.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
Multiuse vial was in the refrigerator, dated 12/09 as being opened. Vial was used for administration 12/12 but the vial should have been discarded. There was no adverse reaction noted to the patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- AV block, 1st degree Benign hypertension with chronic kidney disease, stage II Tortuous aorta (HCC) Multi-infarct dementia with depression Hyperlipidemia obesity Vascular dementia (HCC) Hemiparesis of left nondominant side as late effect of cerebrovascular disease (HCC) OSA (obstructive sleep apnea) Plaque psoriasis Gout
- Andere Medikamente
- acetaminophen, allopurinol, aspirin, atorvastatin, cholecalciferol, lasix, hydralazine, lisinopril, melatonin, oxybutynin
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 09.12.2022
- Impfdatum
- 08.12.2022
- Beginn
- 08.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / OT
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Medication error
Symptomtext
The patient was vaccinated by MA after being signed off by the provider PA- number of doses was not mentioned by the pt in the vaccine consent form and the vaccination card was not presented to the MA prior to vaccination. After the shot , the pt gave the vaccine card to MA to record the LOT and expiry date and that is when she realized that the pt had received a Moderna bivalent shot on 9/23/2022. Both the provider and pt was informed about the medication error. The pt was asked to contact our clinic should she have any adverse reaction or does not feel comfortable, if can't reach us in the clinic then to go to ER immediately. i followed up with the pt today and doing good.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- not needed
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.12.2022
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Vial was initially stored in the refrigerator on 11-Oct-2022 and administered on 30-Nov-2022; No adverse event; Received doses after its beyond use date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 11-Oct-2022 and administered on 30-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis. No Medical History information was reported. On 30-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 30-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 11-Oct-2022 and administered on 30-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 11-Oct-2022 and administered on 30-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 11-Oct-2022 and administered on 30-Nov-2022). Concomitant medication was not reported. Reporter reported that the vial was individual vial and size was 2.5 ml. The vial was initially stored in refrigerator on 11-Oct-2022. The vial did not undergo any temperature excursion. Treatment information was not reported. This case contains information for the 7th patient out of 8 adult patients as described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-680810, US-MODERNATX, INC.-MOD-2022-680811, US-MODERNATX, INC.-MOD-2022-680808 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-680810:Samer Reporter US-MODERNATX, INC.-MOD-2022-680808:Samer Reporter US-MODERNATX, INC.-MOD-2022-680811:Samer Reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.12.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received doses after its beyond use date), PRODUCT STORAGE ERROR (Patient received doses after its beyond use date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received doses after its beyond use date), PRODUCT STORAGE ERROR (Patient received doses after its beyond use date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received doses after its beyond use date), PRODUCT STORAGE ERROR (Patient received doses after its beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.12.2022
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date; No adverse event; Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date), PRODUCT STORAGE ERROR (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis. No Medical History information was reported. On 30-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 30-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date), PRODUCT STORAGE ERROR (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date) and PRODUCT STORAGE ERROR (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date). No concomitant medications were reported. It was the individual vial with size of 2.5 mL and vial did not underwent the temperature excursion. No treatment medications were reported. This case is for the 8th patient of 8 adult patients described by the reported. This case was linked to MODERNATX, INC.-MOD-2022-680810, MODERNATX, INC.-MOD-2022-680811, MODERNATX, INC.-MOD-2022-680808 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2022-680810:Samer Reporter MODERNATX, INC.-MOD-2022-680808:Samer Reporter MODERNATX, INC.-MOD-2022-680811:Samer Reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.12.2022
- Impfdatum
- 01.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 11-Oct-2022 and vaccines were admistered on 16Nov2022, 5 patients, 30Nov2022, 3 patients (two different vials); No adverse event; Patients received bivalent dose after its beyond use date; This spontaneous case was reported by a physician assistant and describes the occurrence of PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Oct-2022 and vaccines were admistered on 16Nov2022, 5 patients, 30Nov2022, 3 patients (two different vials)), EXPIRED PRODUCT ADMINISTERED (Patients received bivalent dose after its beyond use date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. In November 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In November 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received bivalent dose after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Oct-2022 and vaccines were admistered on 16Nov2022, 5 patients, 30Nov2022, 3 patients (two different vials)) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Oct-2022 and vaccines were admistered on 16Nov2022, 5 patients, 30Nov2022, 3 patients (two different vials)), EXPIRED PRODUCT ADMINISTERED (Patients received bivalent dose after its beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Oct-2022 and vaccines were admistered on 16Nov2022, 5 patients, 30Nov2022, 3 patients (two different vials)) and EXPIRED PRODUCT ADMINISTERED (Patients received bivalent dose after its beyond use date). No concomitant medication information was provided. Dose administered after 30-day Use By Date or after manufacturer date of expiry Vial size was reported as 2.5ml The vial was initially stored in the refrigerator on 11-Oct-2022. Date(s) of administration of vaccine on 16-Nov-2022 for 5 patients and on 30-Nov-2022 for 3 patients in two different vials. The vial did not undergo any temperature excursions. No treatment medication were provided. This case contains information for the 5th adult patient out of 8 adults patients as described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-680810, US-MODERNATX, INC.-MOD-2022-680811, US-MODERNATX, INC.-MOD-2022-680808 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-680810:Samer Reporter US-MODERNATX, INC.-MOD-2022-680811:Samer Reporter US-MODERNATX, INC.-MOD-2022-680808:Samer Reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.12.2022
- Impfdatum
- 01.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 11-Oct-2022 but vaccines were admistered on 16-Nov-2022 and 30-Nov-2022; No adverse event; Patient received bivalent doses after its beyond use date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received bivalent doses after its beyond use date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Oct-2022 but vaccines were admistered on 16-Nov-2022 and 30-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis. No Medical History information was reported. In November 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In November 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received bivalent doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Oct-2022 but vaccines were admistered on 16-Nov-2022 and 30-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received bivalent doses after its beyond use date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Oct-2022 but vaccines were admistered on 16-Nov-2022 and 30-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received bivalent doses after its beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Oct-2022 but vaccines were admistered on 16-Nov-2022 and 30-Nov-2022). No concomitant medication information was provided. Dose administered after 30-day Use By Date or after manufacturer date of expiry Vial size was reported as 2.5ml The vial was initially stored in the refrigerator on 11-Oct-2022 Date(s) of administration of vaccine on 16-Nov-2022 for 5 patients and on 30-Nov-2022 for 3 patients in two different vials. The vial did not undergo any temperature excursions. No treatment medication were provided. This case contains information for the 4th out of 8 patients. This case was linked to US-MODERNATX, INC.-MOD-2022-680810, US-MODERNATX, INC.-MOD-2022-680811, US-MODERNATX, INC.-MOD-2022-680808 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-680810:Samer Reporter US-MODERNATX, INC.-MOD-2022-680811:Samer Reporter US-MODERNATX, INC.-MOD-2022-680808:Samer Reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.12.2022
- Impfdatum
- 01.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients; No adverse event; Received doses after its beyond use date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date), PRODUCT STORAGE ERROR (Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis. No Medical History information was reported. In November 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In November 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date), PRODUCT STORAGE ERROR (Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date) and PRODUCT STORAGE ERROR (Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients). No concomitant product use was reported. Via size individual vial 2.5 ml. On 11-Oct-2022, vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. 8 Patients received bivalent doses after beyond use date on 16-Nov-2022, 5 patients and on 30-Nov-2022, 3 patients. No treatment information was provided. This case contains information for the 3rd patient out of 8 patients as described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-680810, US-MODERNATX, INC.-MOD-2022-680808, US-MODERNATX, INC.-MOD-2022-680812, US-MODERNATX, INC.-MOD-2022-680813, US-MODERNATX, INC.-MOD-2022-680814, US-MODERNATX, INC.-MOD-2022-680815, US-MODERNATX, INC.-MOD-2022-680816 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-680810:Samer Reporter US-MODERNATX, INC.-MOD-2022-680808:Samer Reporter US-MODERNATX, INC.-MOD-2022-680812:Samer Reporter US-MODERNATX, INC.-MOD-2022-680813:Samer Reporter US-MODERNATX, INC.-MOD-2022-680814:Samer Reporter US-MODERNATX, INC.-MOD-2022-680815:Samer Reporter US-MODERNATX, INC.-MOD-2022-680816:Samer Reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.12.2022
- Impfdatum
- 01.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients; No adverse event; Received doses after its beyond use date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date), PRODUCT STORAGE ERROR (Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis. No Medical History information was reported. In November 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In November 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date), PRODUCT STORAGE ERROR (Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date) and PRODUCT STORAGE ERROR (Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients). No concomitant product use was reported. Via size individual vial 2.5 ml. On 11-Oct-2022, vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. 8 Patients received bivalent doses after its beyond use date on 16-Nov-2022, 5 patients and on 30-Nov-2022, 3 patients. No treatment information was provided. This case contains information for the 2nd patient out of 8 patients as described by the reporter. This case was linked to MODERNATX, INC.-MOD-2022-680808, MODERNATX, INC.-MOD-2022-680811, MODERNATX, INC.-MOD-2022-680812, MODERNATX, INC.-MOD-2022-680813, MODERNATX, INC.-MOD-2022-680814, MODERNATX, INC.-MOD-2022-680815, MODERNATX, INC.-MOD-2022-680816 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2022-680808:Samer Reporter MODERNATX, INC.-MOD-2022-680811:Samer Reporter MODERNATX, INC.-MOD-2022-680812:Samer Reporter MODERNATX, INC.-MOD-2022-680813:Samer Reporter MODERNATX, INC.-MOD-2022-680814:Samer Reporter MODERNATX, INC.-MOD-2022-680815:Samer Reporter MODERNATX, INC.-MOD-2022-680816:Samer Reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.12.2022
- Impfdatum
- 01.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients; No adverse event; Received doses after its beyond use date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date), PRODUCT STORAGE ERROR (Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis. No Medical History information was reported. In November 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In November 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date), PRODUCT STORAGE ERROR (Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Received doses after its beyond use date) and PRODUCT STORAGE ERROR (Date that the vial was initially stored in the fridge 11Oct2022, Date of administration 16Nov2022, 5 patients, 30Nov2022, 3 patients). No concomitant product use was reported. Via size individual vial 2.5 ml. On 11-Oct-2022, vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. 8 Patients received bivalent doses after its beyond use date on 16-Nov-2022, 5 patients and on 30-Nov-2022, 3 patients. No treatment information was provided. This case contains information for the 1st patient out of 8 patients as described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-680810, US-MODERNATX, INC.-MOD-2022-680811, US-MODERNATX, INC.-MOD-2022-680812, US-MODERNATX, INC.-MOD-2022-680813, US-MODERNATX, INC.-MOD-2022-680814, US-MODERNATX, INC.-MOD-2022-680815, US-MODERNATX, INC.-MOD-2022-680816 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-680810:Samer Reporter US-MODERNATX, INC.-MOD-2022-680811:Samer Reporter US-MODERNATX, INC.-MOD-2022-680812:Samer Reporter US-MODERNATX, INC.-MOD-2022-680813:Samer Reporter US-MODERNATX, INC.-MOD-2022-680814:Samer Reporter US-MODERNATX, INC.-MOD-2022-680815:Samer Reporter US-MODERNATX, INC.-MOD-2022-680816:Samer Reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 30.11.2022
- Impfdatum
- 01.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syringe issue
Underdose
Symptomtext
When the Immunizing Technician administered the Moderna vaccine the needle and syringe must not have been on tight enough and some of the vaccine leaked out of the syringe and did not go into the patient's arm. The technician said that only a very small amount leaked out of the arm, that the majority of the vaccine went into the patient's deltoid as intended. Per the Clinical Considerations the patient should have the dose repeated immediately. When I told the patient the clinical recommendation she declined to get another vaccine since she saw and agreed that she received a majority/most of the vaccine and did not want to take the risk of getting more than the recommended dose of the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syringe issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 30.11.2022
- Impfdatum
- 07.10.2022
- Beginn
- 09.10.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Induration
Lip swelling
Sensory disturbance
Symptomtext
SWOLLEN LIPS, different areas of lips at different times of occurrences. Lips will stay swollen for2-3 days at different degrees,reoccurrence 4-5 days from from last occurrence.Lips feel thick , firm to touch. I?ve taken an antihistamine , which decreases the swelling somewhat, but comes back.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Induration
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- IRBESARTIN 150 mg. ROSUVASTATIN 10 mg Calcium/Vitamin D Vitamins C,B12,Potassium, Royal jelly extract, A,
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 29.11.2022
- Impfdatum
- 21.11.2022
- Beginn
- 21.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
Patient received initial Moderna primary series on 9/26/22 and 10/24/22. Patient then on 11/21/22 requested for and received a Moderna bivalent booster 1 month earlier than advised. The interval between the primary series and booster was inadvertently too short/close.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 23.11.2022
- Impfdatum
- 01.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Circumstance or information capable of leading to medication error
Incorrect product formulation administered
Symptomtext
Patient received booster dose without receiving initial primary series. Patient did not disclose that they had not received the primary series, but had requested the bivalent booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Circumstance or information capable of leading to medication error
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 26,0
- Geschlecht
- M
- Eingang
- 23.11.2022
- Impfdatum
- 01.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Patient received booster dose without receiving initial primary series. Patient did not disclose that they had not received the primary series, but had requested the bivalent booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 21.11.2022
- Impfdatum
- 14.10.2022
- Beginn
- 21.11.2022
- Tage bis Beginn
- 38,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
The wrong dose for the first Moderna Bivalent COVID booster was given at 0.25mL dose (Lot: AS7146B) on 10/14/2022. The other 0.25mL was administered today on 11/21/2022 (Lot: 061F22A)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 21.11.2022
- Impfdatum
- 26.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
Symptomtext
Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 21.11.2022
- Impfdatum
- 14.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
No adverse event
Symptomtext
Patient was given Bivalent booster instead of 2nd Monovalent dose of the primary series. No adverse reaction at that time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- dyslipidemia, stage 3 chronic kidney disease, prediabetes, osteopenia, solitary kidney
- Andere Medikamente
- Lidocaine-Hydrocortisone ace 3-2.5% suppository
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 88,0
- Geschlecht
- M
- Eingang
- 16.11.2022
- Impfdatum
- 16.11.2022
- Beginn
- 16.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Cold sweat
Heart rate irregular
Pallor
Unresponsive to stimuli
Symptomtext
After patient received vaccine dose, they sat in a chair in the 15 minute observation area. Patients spouse reported that they were not responding to verbal responses. Patient did not offer any verbal complaints. Skin was cool and clammy/pale. Pulse was irregular, pulse ox 95%. Called 9-1-1. Paramedics arrived and transported patient to local hospital. Patient was conscious and aware.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cold sweat
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 14.11.2022
- Impfdatum
- 12.11.2022
- Beginn
- 12.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Incorrect product formulation administered
Symptomtext
Wrong dose given, needed to finish primary series. Bivalent given by mistake.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 11.11.2022
- Impfdatum
- 28.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
No Adverse Event; patient was supposed to get themonovalent vaccine, but they received the bivalent booster as their first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (patient was supposed to get themonovalent vaccine, but they received the bivalent booster as their first dose) and NO ADVERSE EVENT (No Adverse Event) in a 59-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Oct-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 28-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (patient was supposed to get themonovalent vaccine, but they received the bivalent booster as their first dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, WRONG PRODUCT ADMINISTERED (patient was supposed to get themonovalent vaccine, but they received the bivalent booster as their first dose) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (patient was supposed to get themonovalent vaccine, but they received the bivalent booster as their first dose). No concomitant medications were reported. Patient was supposed to get monovalent vaccine but received bivalent vaccine as the First dose. It was reported that patient had no known allergies or past medical conditions at the time of vaccination. Patient didn't receive other vaccine 1 month prior to Moderna COVID-19 vaccine. Patient was not taking other medications and patient's HCP was not aware of this incident. Patient not had symptoms associated with COVID-19. Not had a COVID-19 test. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 09.11.2022
- Impfdatum
- 09.11.2022
- Beginn
- 09.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
No adverse reaction. Covid vaccine given 16 hours after vial first punctured.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 09.11.2022
- Impfdatum
- 28.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Gave Moderna Bivalent Booster for their 1st shot 50mcg/0.5ml dose. They should have received the regular monovalent dose as their first shot.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none known to us
- Vorgeschichte
- none known to us
- Andere Medikamente
- omeprazole 20mg capsule cyclobenzaprine 10mg tablet advair 45-21 inhaler fluticasone 50mcg spray
- Allergien
- none known to us
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 07.11.2022
- Impfdatum
- 01.11.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Unevaluable event
Urine analysis normal
Symptomtext
11/2/2022 bp 154-89, 89% O2 sat (96% after 2L), pulse 140 bpm, temp 100.9-101.3, respiratory rate 24 11/3/2022 bp 90/39, pulse 80, respiratory rate 20, O2 95% on room air, temp 97.3
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- Urine sent out, negative UA
- Aktuelle Erkrankungen
- Mastectomy on right side on 10/27/2022 (malignant neoplasm of unspecified site of right female breast) Chronic viral hepatitis C, unspecified dementia without behavior
- Vorgeschichte
- Hx of diabetes, no s/s hypo/hyperglycemia receives tradjenta 5 mg daily.
- Andere Medikamente
- -
- Allergien
- Amlodipine Besylate, Clindamycin HCI, Levoflaxacin, Keflex, ACE Inhibitors, Penicillins, Sulfa, Antibiotics
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 07.11.2022
- Impfdatum
- 03.11.2022
- Beginn
- 03.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient received expired Bivalent Booster greater than 12 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Bivalent Booster >12 hours post puncture) and NO ADVERSE EVENT (No adverse event) in a 68-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 vaccination. No Medical History information was reported. On 03-Nov-2022 at 8:57 AM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Nov-2022, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Bivalent Booster >12 hours post puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired Bivalent Booster >12 hours post puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired Bivalent Booster >12 hours post puncture). No concomitant medication was reported. Date and time vial was first punctured on 02-NOV-2022 at 4:58 PM. The vial did not undergo any temperature excursions. No treatment information was reported. This case was linked to US-MODERNATX, INC.-MOD-2022-668692 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-668692:Patient 1
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 07.11.2022
- Impfdatum
- 03.11.2022
- Beginn
- 03.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient received expired Bivalent Booster >12 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Bivalent Booster >12 hours post puncture) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 vaccination. No Medical History information was reported. On 03-Nov-2022 at 8:57 AM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Nov-2022 at 8:57 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Bivalent Booster >12 hours post puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired Bivalent Booster >12 hours post puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired Bivalent Booster >12 hours post puncture). No concomitant medication was reported. Patient received first Primary monovalent dose on unknown date,2nd Primary monovalent dose on unknown date, First Monovalent Booster dose on unknown date and unknown Lot number and expiry date. vial size was 2.5ml Date the vial was initially stored in the refrigerator was 05OCT2022. Date and time vial was first punctured on 02-NOV-2022 at 4:58 PM. The vial did not undergo any temperature excursions. the vial was stored at room temperature in an amber pill vial after post puncture. Total amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F) was reported 15 hours. No treatment information was reported. This case was linked to MODERNATX, INC.-MOD-2022-668752 (E2B Linked Report). Sender's Comments: MODERNATX, INC.-MOD-2022-668752: Patient 1
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 07.11.2022
- Impfdatum
- 03.11.2022
- Beginn
- 03.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Mycobacterium tuberculosis complex test
No adverse event
Wrong product administered
Symptomtext
No Adverse Event; bivalent first dose; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (bivalent first dose) and NO ADVERSE EVENT (No Adverse Event) in a 40-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. The patient had not received any of the doses of COVID-19 vaccine. Previously administered products included for Product used for unknown indication: Flu shot on 01-Nov-2022. Past adverse reactions to the above products included No adverse event with Flu shot. On 03-Nov-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 03-Nov-2022, the patient experienced WRONG PRODUCT ADMINISTERED (bivalent first dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, WRONG PRODUCT ADMINISTERED (bivalent first dose) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Nov-2022, Mycobacterium tuberculosis complex test: On 03-Nov-2022, no symptoms reported.. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (bivalent first dose). The concomitant and treatment medication was not reported. No additional doses, medications or treatments.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mycobacterium tuberculosis complex test
- Hospital-Tage
- -
- Labordaten
- Test Date: 20221101; Test Name: Skin TB test; Result Unstructured Data: On 03-Nov-2022, no symptoms reported.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: The patient had not received any of the doses of COVID-19 vaccine.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 05.11.2022
- Impfdatum
- 19.10.2022
- Beginn
- 05.11.2022
- Tage bis Beginn
- 17,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Postmenopausal haemorrhage
Symptomtext
Menstrual bleeding even though I am a post-menopausal woman. Same thing happened after first booster last year and after initial Covid vaccine series even though I didn't report it
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Postmenopausal haemorrhage
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- Same thing after first Moderna Covid 19 booster, age 57, 12/23/21
- Staat
- CA
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 04.11.2022
- Impfdatum
- 24.10.2022
- Beginn
- 25.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Swollen tongue
Tongue discomfort
Symptomtext
Patient stated that on 10/25/2022 at 1:30am he noticed that half of his tongue was swollen. It was on the same side as injection site. He stated that it was uncomfortable and he was concerned so he took 2 benadryl tablets. The swelling subsided completely by 9am on the same day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Swollen tongue
- Hospital-Tage
- -
- Labordaten
- none reported
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- high blood pressure high cholesterol others not known
- Andere Medikamente
- carvedilol famotidine trelegy lisinopril juluca duloxetine rosuvastatin
- Allergien
- sulfa
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 04.11.2022
- Impfdatum
- 03.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Medication error
Wrong product administered
Symptomtext
Medication error. Moderna Bivalent was given as the 1st dose in the series. Nurse administering the injection thought the patient was requesting a booster. She did not verify previous doses. Patient is not exhibiting any signs or symptoms at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 04.11.2022
- Impfdatum
- 02.11.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Joint swelling
Symptomtext
Swelling to knees and ankles- joints
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Joint swelling
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 29.10.2022
- Tage bis Beginn
- 2,0
- Dosis
- 5
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Herpes zoster
Symptomtext
Shingles rash on torso.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Herpes zoster
- Hospital-Tage
- -
- Labordaten
- Dr was able to identify rash by sight
- Aktuelle Erkrankungen
- Lyme
- Vorgeschichte
- Non symptomatic heart weakness
- Andere Medikamente
- Doxycycline , Lipitor, aspirin, Metoprolol
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 02.11.2022
- Impfdatum
- 02.11.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Patient was scheduled to receive 1st dose of moderna, was mistakenly given moderna Bivalent. Pharmacist recommended patient receives 1st dose within one weeks time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; Lower than authorized dose of Moderna bivalent vaccine administered to patients; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Lower than authorized dose of Moderna bivalent vaccine administered to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Lower than authorized dose of Moderna bivalent vaccine administered to patients). No concomitant medications were provided. It was reported that 18 elderly patients received 0.25 mL dose instead of 0.5 mL dose. The patients have not reported any adverse reactions at that time. No treatment medication was provided. This case contains information for the 4th of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666280, US-MODERNATX, INC.-MOD-2022-666278, US-MODERNATX, INC.-MOD-2022-666286, US-MODERNATX, INC.-MOD-2022-666290, US-MODERNATX, INC.-MOD-2022-666063, US-MODERNATX, INC.-MOD-2022-666251, US-MODERNATX, INC.-MOD-2022-666248, US-MODERNATX, INC.-MOD-2022-666249, US-MODERNATX, INC.-MOD-2022-666250, US-MODERNATX, INC.-MOD-2022-666252, US-MODERNATX, INC.-MOD-2022-666255, US-MODERNATX, INC.-MOD-2022-666279, US-MODERNATX, INC.-MOD-2022-666281, US-MODERNATX, INC.-MOD-2022-666282, US-MODERNATX, INC.-MOD-2022-666283 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666251:Same reporter US-MODERNATX, INC.-MOD-2022-666280:Same reporter US-MODERNATX, INC.-MOD-2022-666284:Same reporter US-MODERNATX, INC.-MOD-2022-666286:Same reporter US-MODERNATX, INC.-MOD-2022-666278:Same reporter US-MODERNATX, INC.-MOD-2022-666063:Same reporter US-MODERNATX, INC.-MOD-2022-666290:Same reporter US-MODERNATX, INC.-MOD-2022-666277:Same reporter US-MODERNATX, INC.-MOD-2022-666248:Same reporter US-MODERNATX, INC.-MOD-2022-666249:Same reporter US-MODERNATX, INC.-MOD-2022-666250:Same reporter US-MODERNATX, INC.-MOD-2022-666252:Same reporter US-MODERNATX, INC.-MOD-2022-666255:Same reporter US-MODERNATX, INC.-MOD-2022-666279:Same reporter US-MODERNATX, INC.-MOD-2022-666281:Same reporter US-MODERNATX, INC.-MOD-2022-666282:Same reporter US-MODERNATX, INC.-MOD-2022-666283:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; lower than authorized dose of Moderna bivalent vaccine administered to patients; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients). Concomitant product use was not provided by the reporter. Patient received 0.25 mL dose instead of 0.5 mL dose. The patient had not reported any adverse reactions at this time. Treatment information was not provided. This case contains information for the 11th of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666280, US-MODERNATX, INC.-MOD-2022-666286, US-MODERNATX, INC.-MOD-2022-666063, US-MODERNATX, INC.-MOD-2022-666248, US-MODERNATX, INC.-MOD-2022-666249, US-MODERNATX, INC.-MOD-2022-666250, US-MODERNATX, INC.-MOD-2022-666295, US-MODERNATX, INC.-MOD-2022-666278, US-MODERNATX, INC.-MOD-2022-666252, US-MODERNATX, INC.-MOD-2022-666255 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666284:Patient 9 US-MODERNATX, INC.-MOD-2022-666280:Patient 16 US-MODERNATX, INC.-MOD-2022-666277:Patient 11 US-MODERNATX, INC.-MOD-2022-666286:Patient 10 US-MODERNATX, INC.-MOD-2022-666063:Patient 1 US-MODERNATX, INC.-MOD-2022-666248:Patient 2 US-MODERNATX, INC.-MOD-2022-666249:Patient 3 US-MODERNATX, INC.-MOD-2022-666250:Patient 4 US-MODERNATX, INC.-MOD-2022-666295:Patient 12 US-MODERNATX, INC.-MOD-2022-666278:Patient 14 US-MODERNATX, INC.-MOD-2022-666252:Patient 6 US-MODERNATX, INC.-MOD-2022-666255:Patient 13
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; Patient received 0.25 mL dose instead of 0.5 mL dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received 0.25 mL dose instead of 0.5 mL dose) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient received 0.25 mL dose instead of 0.5 mL dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient received 0.25 mL dose instead of 0.5 mL dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient received 0.25 mL dose instead of 0.5 mL dose). Concomitant product use was not provided by the reporter. Lower than authorized dose of Moderna bivalent vaccine administered to patient. The patient received 0.25 mL dose instead of 0.5 mL dose. The patient have not reported any adverse reactions at this time. Treatment information was not provided. This case contains information for the 10th of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666280, US-MODERNATX, INC.-MOD-2022-666278, US-MODERNATX, INC.-MOD-2022-666063, US-MODERNATX, INC.-MOD-2022-666248, US-MODERNATX, INC.-MOD-2022-666249, US-MODERNATX, INC.-MOD-2022-666250, US-MODERNATX, INC.-MOD-2022-666295, US-MODERNATX, INC.-MOD-2022-666290, US-MODERNATX, INC.-MOD-2022-666282, US-MODERNATX, INC.-MOD-2022-666281 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666284:Patient 9 US-MODERNATX, INC.-MOD-2022-666277:Patient 7 US-MODERNATX, INC.-MOD-2022-666278:Patient 14 US-MODERNATX, INC.-MOD-2022-666280:Patient 16 US-MODERNATX, INC.-MOD-2022-666063:Patient 1 US-MODERNATX, INC.-MOD-2022-666248:Patient 2 US-MODERNATX, INC.-MOD-2022-666249:Patient 3 US-MODERNATX, INC.-MOD-2022-666250:Patient 4 US-MODERNATX, INC.-MOD-2022-666295:Patient 12 US-MODERNATX, INC.-MOD-2022-666290:Patient 11 US-MODERNATX, INC.-MOD-2022-666282:Patient 18 US-MODERNATX, INC.-MOD-2022-666281:Patient 17
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; Administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine/ received 0.25 mL dose instead of 0.5 mL dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine/ received 0.25 mL dose instead of 0.5 mL dose) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine/ received 0.25 mL dose instead of 0.5 mL dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine/ received 0.25 mL dose instead of 0.5 mL dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine/ received 0.25 mL dose instead of 0.5 mL dose). No concomitant medications were provided. The patient were administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine. They received 0.25 mL dose instead of 0.5 mL dose. The patients have not reported any adverse reactions. No treatment medications were reported. This case contains information for the 6th of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666280, US-MODERNATX, INC.-MOD-2022-666278, US-MODERNATX, INC.-MOD-2022-666290, US-MODERNATX, INC.-MOD-2022-666063, US-MODERNATX, INC.-MOD-2022-666251, US-MODERNATX, INC.-MOD-2022-666295, US-MODERNATX, INC.-MOD-2022-666248, US-MODERNATX, INC.-MOD-2022-666249, US-MODERNATX, INC.-MOD-2022-666250, US-MODERNATX, INC.-MOD-2022-666252, US-MODERNATX, INC.-MOD-2022-666255, US-MODERNATX, INC.-MOD-2022-666279, US-MODERNATX, INC.-MOD-2022-666281, US-MODERNATX, INC.-MOD-2022-666282, US-MODERNATX, INC.-MOD-2022-666283, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666286, US-MODERNATX, INC.-MOD-2022-666252 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666280:Same reporter US-MODERNATX, INC.-MOD-2022-666277:Same reporter US-MODERNATX, INC.-MOD-2022-666284:Same reporter US-MODERNATX, INC.-MOD-2022-666290:Same reporter US-MODERNATX, INC.-MOD-2022-666278:Same reporter US-MODERNATX, INC.-MOD-2022-666295:Same reporter US-MODERNATX, INC.-MOD-2022-666251:Same reporter US-MODERNATX, INC.-MOD-2022-666063:Same reporter US-MODERNATX, INC.-MOD-2022-666248:Same reporter US-MODERNATX, INC.-MOD-2022-666249:Same reporter US-MODERNATX, INC.-MOD-2022-666250:Same reporter US-MODERNATX, INC.-MOD-2022-666252:Same reporter US-MODERNATX, INC.-MOD-2022-666255:Same reporter US-MODERNATX, INC.-MOD-2022-666279:Same reporter US-MODERNATX, INC.-MOD-2022-666281:Same reporter US-MODERNATX, INC.-MOD-2022-666282:Same reporter US-MODERNATX, INC.-MOD-2022-666283:Same reporter US-MODERNATX, INC.-MOD-2022-666284:Same reporter US-MODERNATX, INC.-MOD-2022-666286:Same reporter US-MODERNATX, INC.-MOD-2022-666252:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; lower than authorized dose of Moderna bivalent vaccine administered to patients; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients). No concomitant medications were provided. It was reported that 18 elderly patients received 0.25 mL dose instead of 0.5 mL dose. The patients had not reported any adverse reactions at that time. No treatment medication was provided. This case contains information for the 5th of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666280, US-MODERNATX, INC.-MOD-2022-666278, US-MODERNATX, INC.-MOD-2022-666063, US-MODERNATX, INC.-MOD-2022-666249, US-MODERNATX, INC.-MOD-2022-666248, US-MODERNATX, INC.-MOD-2022-666250, US-MODERNATX, INC.-MOD-2022-666252, US-MODERNATX, INC.-MOD-2022-666255, US-MODERNATX, INC.-MOD-2022-666279, US-MODERNATX, INC.-MOD-2022-666281, US-MODERNATX, INC.-MOD-2022-666282, US-MODERNATX, INC.-MOD-2022-666283, US-MODERNATX, INC.-MOD-2022-666286, US-MODERNATX, INC.-MOD-2022-666290, US-MODERNATX, INC.-MOD-2022-666295 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666277: US-MODERNATX, INC.-MOD-2022-666280: US-MODERNATX, INC.-MOD-2022-666063: US-MODERNATX, INC.-MOD-2022-666284: US-MODERNATX, INC.-MOD-2022-666278: US-MODERNATX, INC.-MOD-2022-666249: US-MODERNATX, INC.-MOD-2022-666248: US-MODERNATX, INC.-MOD-2022-666250: US-MODERNATX, INC.-MOD-2022-666252: US-MODERNATX, INC.-MOD-2022-666255: US-MODERNATX, INC.-MOD-2022-666279: US-MODERNATX, INC.-MOD-2022-666281: US-MODERNATX, INC.-MOD-2022-666282: US-MODERNATX, INC.-MOD-2022-666283: US-MODERNATX, INC.-MOD-2022-666286: US-MODERNATX, INC.-MOD-2022-666290: US-MODERNATX, INC.-MOD-2022-666295:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; lower than authorized dose of Moderna bivalent vaccine administered to patients; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients). No concomitant medications were provided. It was reported that 18 elderly patients received 0.25 mL dose instead of 0.5 mL dose. The patients have not reported any adverse reactions at that time. No treatment medication was provided. This case contains information for the 4th of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666280, US-MODERNATX, INC.-MOD-2022-666278, US-MODERNATX, INC.-MOD-2022-666286, US-MODERNATX, INC.-MOD-2022-666290, US-MODERNATX, INC.-MOD-2022-666063 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666277: US-MODERNATX, INC.-MOD-2022-666278: US-MODERNATX, INC.-MOD-2022-666286: US-MODERNATX, INC.-MOD-2022-666284: US-MODERNATX, INC.-MOD-2022-666290: US-MODERNATX, INC.-MOD-2022-666280: US-MODERNATX, INC.-MOD-2022-666063:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; Patient received 0.25 mL dose instead of 0.5 mL dose/lower than authorized dose of Moderna bivalent vaccine administered to patients; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received 0.25 mL dose instead of 0.5 mL dose/lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient received 0.25 mL dose instead of 0.5 mL dose/lower than authorized dose of Moderna bivalent vaccine administered to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient received 0.25 mL dose instead of 0.5 mL dose/lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient received 0.25 mL dose instead of 0.5 mL dose/lower than authorized dose of Moderna bivalent vaccine administered to patients). No concomitant medications were provided. It was reported that 18 elderly patients received 0.25 mL dose instead of 0.5 mL dose The patients had not reported any adverse reactions at that time. No treatment medication was provided. This case contains information for the 3rd of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666280, US-MODERNATX, INC.-MOD-2022-666278, US-MODERNATX, INC.-MOD-2022-666286, US-MODERNATX, INC.-MOD-2022-666290, US-MODERNATX, INC.-MOD-2022-666063, US-MODERNATX, INC.-MOD-2022-666251, US-MODERNATX, INC.-MOD-2022-666295, US-MODERNATX, INC.-MOD-2022-666252, US-MODERNATX, INC.-MOD-2022-666248, US-MODERNATX, INC.-MOD-2022-666250, US-MODERNATX, INC.-MOD-2022-666255, US-MODERNATX, INC.-MOD-2022-666279, US-MODERNATX, INC.-MOD-2022-666283, US-MODERNATX, INC.-MOD-2022-666282 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666277:Patient 7 US-MODERNATX, INC.-MOD-2022-666278:Patient 14 US-MODERNATX, INC.-MOD-2022-666286:Patient 10 US-MODERNATX, INC.-MOD-2022-666284:Patient 9 US-MODERNATX, INC.-MOD-2022-666290:Patient 11 US-MODERNATX, INC.-MOD-2022-666280:Patient 16 US-MODERNATX, INC.-MOD-2022-666063:Patient 1 US-MODERNATX, INC.-MOD-2022-666252:Patient 6 US-MODERNATX, INC.-MOD-2022-666251:Patient 5 US-MODERNATX, INC.-MOD-2022-666295:Patient 12 US-MODERNATX, INC.-MOD-2022-666248:Patient 2 US-MODERNATX, INC.-MOD-2022-666250:Patient 4 US-MODERNATX, INC.-MOD-2022-666255:Patient 13 US-MODERNATX, INC.-MOD-2022-666279:Patient 15 US-MODERNATX, INC.-MOD-2022-666283:Patient 8 US-MODERNATX, INC.-MOD-2022-666282:Patient 18
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; lower than authorized dose of Moderna bivalent vaccine administered to patient.; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patient.) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patient.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patient.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patient.). No concomitant medications were provided. It was reported that 18 elderly patients received 0.25 mL dose instead of 0.5 mL dose The patients have not reported any adverse reactions at this time. No treatment medication was provided. This case contains information for the 2nd of 18 elderly patients described by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; lower than authorized dose of Moderna bivalent vaccine administered to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patient) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patient). No concomitant medications were provided. It was reported that 18 elderly patients received 0.25 mL dose instead of 0.5 mL dose The patients had not reported any adverse reactions at that time. No treatment medication was provided. This case contains information for the 1st of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666280, US-MODERNATX, INC.-MOD-2022-666278, US-MODERNATX, INC.-MOD-2022-666286, US-MODERNATX, INC.-MOD-2022-666290, US-MODERNATX, INC.-MOD-2022-666249, US-MODERNATX, INC.-MOD-2022-666250, US-MODERNATX, INC.-MOD-2022-666251, US-MODERNATX, INC.-MOD-2022-666252, US-MODERNATX, INC.-MOD-2022-666283, US-MODERNATX, INC.-MOD-2022-666295, US-MODERNATX, INC.-MOD-2022-666279, US-MODERNATX, INC.-MOD-2022-666282, US-MODERNATX, INC.-MOD-2022-666248, US-MODERNATX, INC.-MOD-2022-666255, US-MODERNATX, INC.-MOD-2022-666281 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666277:Patient 7 US-MODERNATX, INC.-MOD-2022-666278:Patient 14 US-MODERNATX, INC.-MOD-2022-666290:Patient 11 US-MODERNATX, INC.-MOD-2022-666286:Patient 10 US-MODERNATX, INC.-MOD-2022-666280:Patient 16 US-MODERNATX, INC.-MOD-2022-666284:Patient 9 US-MODERNATX, INC.-MOD-2022-666249:Patient 3 US-MODERNATX, INC.-MOD-2022-666250:Patient 4 US-MODERNATX, INC.-MOD-2022-666251:Patient 5 US-MODERNATX, INC.-MOD-2022-666252:Patient 6 US-MODERNATX, INC.-MOD-2022-666283:Patient 8 US-MODERNATX, INC.-MOD-2022-666295:Patient 12 US-MODERNATX, INC.-MOD-2022-666279:Patient 15 US-MODERNATX, INC.-MOD-2022-666282:Patient 18 US-MODERNATX, INC.-MOD-2022-666248:patient 2 US-MODERNATX, INC.-MOD-2022-666255:Patient 13 US-MODERNATX, INC.-MOD-2022-666281:Patient 17
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 01.11.2022
- Impfdatum
- 01.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Underdose
Symptomtext
The patient was given the Bivalent booster without receiving the primary doses.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Mixed Hyperlipidemia, Anxiety, emphysema, alcohol dependence
- Andere Medikamente
- Fluticasone-Umeclidin-Vilant 200-62.5-25 MCG/ACT aerosol powder, breath activated
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 01.11.2022
- Impfdatum
- 31.10.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
A Fluzone HD vaccine was administered to a 61 year old woman. Fluzone HD is approved for ages 65 and up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Underdose
Symptomtext
No adverse event; Patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced UNDERDOSE (Patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (Patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine). No concomitant medications were provided. It was reported that 18 elderly patients received 0.25 mL dose instead of 0.5 mL dose The patients have not reported any adverse reactions at this time. No treatment medication was provided. This case contains information for the 9th of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666063, US-MODERNATX, INC.-MOD-2022-666248, US-MODERNATX, INC.-MOD-2022-666249, US-MODERNATX, INC.-MOD-2022-666250, US-MODERNATX, INC.-MOD-2022-666251, US-MODERNATX, INC.-MOD-2022-666252, US-MODERNATX, INC.-MOD-2022-666278, US-MODERNATX, INC.-MOD-2022-666279, US-MODERNATX, INC.-MOD-2022-666281, US-MODERNATX, INC.-MOD-2022-666282, US-MODERNATX, INC.-MOD-2022-666283, US-MODERNATX, INC.-MOD-2022-666286, US-MODERNATX, INC.-MOD-2022-666290, US-MODERNATX, INC.-MOD-2022-666295 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666277:Patient 7 US-MODERNATX, INC.-MOD-2022-666063: US-MODERNATX, INC.-MOD-2022-666248: US-MODERNATX, INC.-MOD-2022-666249: US-MODERNATX, INC.-MOD-2022-666250: US-MODERNATX, INC.-MOD-2022-666251: US-MODERNATX, INC.-MOD-2022-666252: US-MODERNATX, INC.-MOD-2022-666278: US-MODERNATX, INC.-MOD-2022-666279: US-MODERNATX, INC.-MOD-2022-666281: US-MODERNATX, INC.-MOD-2022-666282: US-MODERNATX, INC.-MOD-2022-666283: US-MODERNATX, INC.-MOD-2022-666286: US-MODERNATX, INC.-MOD-2022-666290: US-MODERNATX, INC.-MOD-2022-666295:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; Patient received 0.25 mL dose instead of 0.5 mL dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received 0.25 mL dose instead of 0.5 mL dose) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient received 0.25 mL dose instead of 0.5 mL dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient received 0.25 mL dose instead of 0.5 mL dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient received 0.25 mL dose instead of 0.5 mL dose). No concomitant drug was reported. No treatment drug was reported. This case contains information for the 18th patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666280 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666277:Same reporter US-MODERNATX, INC.-MOD-2022-666280:Same reporter US-MODERNATX, INC.-MOD-2022-666284:Same reporter US-MODERNATX, INC.-MOD-2022-666278:Patient 18
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Underdose
Symptomtext
No adverse event; Patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced UNDERDOSE (Patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (Patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine). No concomitant drug was reported. The patient received 0.25 mL dose instead of 0.5 mL dose (Lot: 061F22A, Expiration date: 16MAY2023) of the Moderna COVID-19 bivalent vaccine The patient had not reported any adverse reactions at that time. No treatment drug was reported. This case contains information for the 16th of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666063, US-MODERNATX, INC.-MOD-2022-666248, US-MODERNATX, INC.-MOD-2022-666249, US-MODERNATX, INC.-MOD-2022-666250, US-MODERNATX, INC.-MOD-2022-666251, US-MODERNATX, INC.-MOD-2022-666252, US-MODERNATX, INC.-MOD-2022-666255, US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666278, US-MODERNATX, INC.-MOD-2022-666279, US-MODERNATX, INC.-MOD-2022-666281, US-MODERNATX, INC.-MOD-2022-666282, US-MODERNATX, INC.-MOD-2022-666283, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666286, US-MODERNATX, INC.-MOD-2022-666290, US-MODERNATX, INC.-MOD-2022-666295, US-MODERNATX, INC.-MOD-2022-666277 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666063: US-MODERNATX, INC.-MOD-2022-666248: US-MODERNATX, INC.-MOD-2022-666249: US-MODERNATX, INC.-MOD-2022-666250: US-MODERNATX, INC.-MOD-2022-666251: US-MODERNATX, INC.-MOD-2022-666252: US-MODERNATX, INC.-MOD-2022-666255: US-MODERNATX, INC.-MOD-2022-666277: US-MODERNATX, INC.-MOD-2022-666278: US-MODERNATX, INC.-MOD-2022-666279: US-MODERNATX, INC.-MOD-2022-666281: US-MODERNATX, INC.-MOD-2022-666282: US-MODERNATX, INC.-MOD-2022-666283: US-MODERNATX, INC.-MOD-2022-666284: US-MODERNATX, INC.-MOD-2022-666286: US-MODERNATX, INC.-MOD-2022-666290: US-MODERNATX, INC.-MOD-2022-666295: US-MODERNATX, INC.-MOD-2022-666277:Patient 16
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; lower than authorized dose of Moderna bivalent vaccine administered to patients; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients). Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666280, US-MODERNATX, INC.-MOD-2022-666063, US-MODERNATX, INC.-MOD-2022-666248, US-MODERNATX, INC.-MOD-2022-666249, US-MODERNATX, INC.-MOD-2022-666250, US-MODERNATX, INC.-MOD-2022-666251, US-MODERNATX, INC.-MOD-2022-666252, US-MODERNATX, INC.-MOD-2022-666255, US-MODERNATX, INC.-MOD-2022-666279, US-MODERNATX, INC.-MOD-2022-666295, US-MODERNATX, INC.-MOD-2022-666286, US-MODERNATX, INC.-MOD-2022-666283, US-MODERNATX, INC.-MOD-2022-666282, US-MODERNATX, INC.-MOD-2022-666281 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666277:Patient 7 US-MODERNATX, INC.-MOD-2022-666280:Patient 16 US-MODERNATX, INC.-MOD-2022-666284:patient 9 US-MODERNATX, INC.-MOD-2022-666063:Patient 1 US-MODERNATX, INC.-MOD-2022-666248:Patient 2 US-MODERNATX, INC.-MOD-2022-666249:Patient 3 US-MODERNATX, INC.-MOD-2022-666250:Patient 4 US-MODERNATX, INC.-MOD-2022-666251:Patient 5 US-MODERNATX, INC.-MOD-2022-666252:Patient 6 US-MODERNATX, INC.-MOD-2022-666255:Patinet 7 US-MODERNATX, INC.-MOD-2022-666279:Patient 15 US-MODERNATX, INC.-MOD-2022-666295:Patient 12 US-MODERNATX, INC.-MOD-2022-666286:Patient 10 US-MODERNATX, INC.-MOD-2022-666283:Patient 8 US-MODERNATX, INC.-MOD-2022-666282:Patient 18 US-MODERNATX, INC.-MOD-2022-666281:patient 17
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; Lower than authorized dose of Moderna bivalent vaccine administered to patients; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Lower than authorized dose of Moderna bivalent vaccine administered to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Lower than authorized dose of Moderna bivalent vaccine administered to patients). No concomitant medications were provided. It was reported that 18 elderly patients received 0.25 mL dose instead of 0.5 mL dose The patients have not reported any adverse reactions at this time. No treatment medication was provided. This case contains information for the 7th of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666063, US-MODERNATX, INC.-MOD-2022-666248, US-MODERNATX, INC.-MOD-2022-666249, US-MODERNATX, INC.-MOD-2022-666250, US-MODERNATX, INC.-MOD-2022-666251, US-MODERNATX, INC.-MOD-2022-666252, US-MODERNATX, INC.-MOD-2022-666283, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666286, US-MODERNATX, INC.-MOD-2022-666290, US-MODERNATX, INC.-MOD-2022-666295, US-MODERNATX, INC.-MOD-2022-666278, US-MODERNATX, INC.-MOD-2022-666279, US-MODERNATX, INC.-MOD-2022-666282, US-MODERNATX, INC.-MOD-2022-666280 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666063:Patient 1 US-MODERNATX, INC.-MOD-2022-666248:Patient 2 US-MODERNATX, INC.-MOD-2022-666249:Patient 3 US-MODERNATX, INC.-MOD-2022-666250:Patient 4 US-MODERNATX, INC.-MOD-2022-666251:Patient 5 US-MODERNATX, INC.-MOD-2022-666252:Patient 6 US-MODERNATX, INC.-MOD-2022-666283:Patient 8 US-MODERNATX, INC.-MOD-2022-666284:Patient 9 US-MODERNATX, INC.-MOD-2022-666286:Patient 10 US-MODERNATX, INC.-MOD-2022-666290:Patient 11 US-MODERNATX, INC.-MOD-2022-666295:Patient 12 US-MODERNATX, INC.-MOD-2022-666278:Patient 14 US-MODERNATX, INC.-MOD-2022-666279:Patient 15 US-MODERNATX, INC.-MOD-2022-666282:Patient 18 US-MODERNATX, INC.-MOD-2022-666280:Patient 16
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Underdose
Symptomtext
No adverse event; patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced UNDERDOSE (patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine). No concomitant drug was reported. The patient received 0.25 mL dose instead of 0.5 mL dose (Lot #: 061F22A, Expiration date: 16MAY2023) of the Moderna COVID-19 bivalent vaccine The patient had not reported any adverse reactions at that time. No treatment drug was reported. This case contains information for the 8th of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666280 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666277: US-MODERNATX, INC.-MOD-2022-666284: US-MODERNATX, INC.-MOD-2022-666280:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Underdose
Symptomtext
No adverse event; patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced UNDERDOSE (patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (patient was administered a lower than authorized dose of the Moderna COVID-19 bivalent vaccine). No concomitant drug was reported. The patient received 0.25 mL dose instead of 0.5 mL dose (Lot #: 061F22A, Expiration date: 16MAY2023) of the Moderna COVID-19 bivalent vaccine The patient had not reported any adverse reactions at that time. No treatment drug was reported. This case contains information for the 17th of 18 elderly patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-666284 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666284:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Underdose
Symptomtext
No adverse event; lower than authorized dose of Moderna bivalent vaccine administered to patients; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients). No concomitant medication details was reported. The patient had not reported any adverse reactions at that time. This case is reported for 15th patient out of 18 patients. No treatment medication details was reported. This case was linked to US-MODERNATX, INC.-MOD-2022-666277, US-MODERNATX, INC.-MOD-2022-666284, US-MODERNATX, INC.-MOD-2022-666280 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666277:Patient 15 US-MODERNATX, INC.-MOD-2022-666284: US-MODERNATX, INC.-MOD-2022-666280:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 01.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
No adverse event
Symptomtext
No adverse event; lower than authorized dose of Moderna bivalent vaccine administered to patients; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent vaccine administered to patients). The concomitant and treatment medication was not reported. This case is reported for 13th patient out of 18 patients.; Sender's Comments: US-MODERNATX, INC.-MOD-2022-666280:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 01.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
No adverse event; First primary dose received as Bivalent booster; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (First primary dose received as Bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 54-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 vaccination. No Medical History information was reported. On 27-Oct-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (First primary dose received as Bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (First primary dose received as Bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (First primary dose received as Bivalent booster). Concomitant drugs were not reported. It was reported that patient received bivalent booster and after administering reporter realized that patient never had a primary dose. Treatment medications were not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 31.10.2022
- Impfdatum
- 28.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Circumstance or information capable of leading to medication error
Incorrect dose administered
Incorrect product formulation administered
Product administered to patient of inappropriate age
Symptomtext
Patient presented with his grandmother for dose 2 of moderna primary series. The incorrect registration form was provided to guardian for completion. This registration form was labeled with Moderna bivalent booster, 12+, 0.5mL sticker, according to age of indication. A Moderna bivalent booster, 12+, 0.5mL vaccine and the coinciding vaccine card sticker was provided to the administrator. Age and DOB were clearly labeled on the form. This provider called patient's mother and discussed error and answered questions as best as possible, We will also be contacting the state on-call line for further instruction following submission of this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Circumstance or information capable of leading to medication error
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 28.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 14,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
Wrong dose was given on 10/14/2022 at 0.25mL (As146B). Other 0.25mL was given on 10/28/2022 (061F22A)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 28.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 14,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
The wrong dose for Moderna COVID Bivalent vaccine was given on 10/14/2022 at 0.25mL (As146B). Another 0.25mL dose was given on 10/28/2022 (061F22A).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 28.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 14,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Underdose
Symptomtext
Wrong dose for Moderna COVID Bivalent was given on 10/14/2022 (As146B) at 0.25mL dose instead of the 0.5mL. The other 0.25mL (061F22A) was given on 10/28/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 8,0
- Geschlecht
- M
- Eingang
- 28.10.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Children received their first dose of the primary series with the Moderna bivalent vaccine booster instead of monovalent; Children received their first dose of the primary series with the Moderna bivalent vaccine booster instead of monovalent; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Children received their first dose of the primary series with the Moderna bivalent vaccine booster instead of monovalent), WRONG PRODUCT ADMINISTERED (Children received their first dose of the primary series with the Moderna bivalent vaccine booster instead of monovalent) and NO ADVERSE EVENT (No adverse event) in an 8-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Children received their first dose of the primary series with the Moderna bivalent vaccine booster instead of monovalent), WRONG PRODUCT ADMINISTERED (Children received their first dose of the primary series with the Moderna bivalent vaccine booster instead of monovalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Children received their first dose of the primary series with the Moderna bivalent vaccine booster instead of monovalent), WRONG PRODUCT ADMINISTERED (Children received their first dose of the primary series with the Moderna bivalent vaccine booster instead of monovalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Children received their first dose of the primary series with the Moderna bivalent vaccine booster instead of monovalent) and WRONG PRODUCT ADMINISTERED (Children received their first dose of the primary series with the Moderna bivalent vaccine booster instead of monovalent). This case for 2nd patient of 3 patients. No concomitant medications were provided. The Pharmacist administered Moderna vaccine to a family and 3 of the children received their first dose of the primary series with the Moderna bivalent vaccine booster. No other adverse events reported. No treatment medication was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-664257, US-MODERNATX, INC.-MOD-2022-664266 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-664257: US-MODERNATX, INC.-MOD-2022-664266:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 28.10.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
No adverse event
Symptomtext
Children received first dose of the primary series with the Moderna bivalent vaccine booster; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (Children received first dose of the primary series with the Moderna bivalent vaccine booster) and NO ADVERSE EVENT (No adverse event) in a 6-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Children received first dose of the primary series with the Moderna bivalent vaccine booster) and NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (Children received first dose of the primary series with the Moderna bivalent vaccine booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (Children received first dose of the primary series with the Moderna bivalent vaccine booster). No concomitant medications were reported. No treatment details were reported. It was reported that total 3 Children's with age 6, 8 and 10 were involved who received Moderna bivalent booster dose instead of Primary series. This case was linked to MOD-2022-664264, MOD-2022-664266 (E2B Linked Report).; Sender's Comments: MOD-2022-664264:Patient 2 of 3 MOD-2022-664266:Patient 3 of 3
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 10,0
- Geschlecht
- F
- Eingang
- 28.10.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
children received their first dose of the primary series with the Moderna bivalent vaccine booster; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (children received their first dose of the primary series with the Moderna bivalent vaccine booster) and NO ADVERSE EVENT (No adverse event) in a 10-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (children received their first dose of the primary series with the Moderna bivalent vaccine booster) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (children received their first dose of the primary series with the Moderna bivalent vaccine booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (children received their first dose of the primary series with the Moderna bivalent vaccine booster). No concomitant medication were reported. The Pharmacist administered Moderna vaccine to a family and 3 of the children received their first dose of the primary series with the Moderna bivalent vaccine booster. No treatment information was provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 27.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 13,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
Wrong dose of Moderna COVID Bivalent vaccine was given on 10/14/2022 at 0.25mL instead of the 0.5mL (As146B). Another 0.25mL was given today 10/27/2022 (061F22A)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 27.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 12,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
The Wrong dose for the Moderna COVID Bivalent booster was given on 10/14/2022 at 0.25mL (As7146B) instead of the 0.5mL dose. Another 0.25mL (061F22A) dose was given on 10/26/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 26.10.2022
- Impfdatum
- 26.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
Patient received Bivalent booster on 10/11/2022 , 0.5 mL left deltoid IM Moderna Bivalent, lot #060F22A Was then given additional Bivalent booster 10/26/2022, 0.5 mL right deltoid IM Moderna Bivalent, lot #061F22A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 26.10.2022
- Impfdatum
- 20.10.2022
- Beginn
- 17.03.2021
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Incorrect dose administered
No adverse event
Symptomtext
No adverse event; accidentally gave a booster dose before the patient completed the primary series; greater than 36 days since first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (accidentally gave a booster dose before the patient completed the primary series), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 36 days since first dose) and NO ADVERSE EVENT (No adverse event) in a 63-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 vaccination. No Medical History information was reported. On 20-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 36 days since first dose). On 20-Oct-2022, the patient experienced INCORRECT DOSE ADMINISTERED (accidentally gave a booster dose before the patient completed the primary series). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (accidentally gave a booster dose before the patient completed the primary series), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 36 days since first dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INCORRECT DOSE ADMINISTERED (accidentally gave a booster dose before the patient completed the primary series) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 36 days since first dose). No Concomitant medications were provided. It was reported that pharmacist was calling because they accidentally gave a booster dose before the patient completed the primary series. The patient received first dose of Moderna on 17 Mar 2021. No treatment medications were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- 7,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
The wrong dose for the first Moderna Bivalent COVID vaccine was administered (As7146B) on 10/14/2022 at 0.25mL instead of 0.5m. Gave the other 0.25mL dose with the new Lot number (016F22A) on 10/24/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 25.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
The wrong dose for the first Moderna Bivalent COVID vaccine was administered (As7146B) on 10/14/2022 at 0.25mL instead of 0.5m. Gave the other 0.25mL dose with the new Lot number (016F22A) on 10/24/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 25.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 25.10.2022
- Tage bis Beginn
- 11,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
The wrong dose for the first Moderna Bivalent COVID vaccine was administered (As7146B) on 10/14/2022 at 0.25mL instead of 0.5m. Gave the other 0.25mL dose with the new Lot number (016F22A) on 10/24/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
The wrong dose for the first Moderna Bivalent COVID vaccine was administered (As7146B) on 10/14/2022 at 0.25mL instead of 0.5m. Gave the other 0.25mL dose with the new Lot number (016F22A) on 10/24/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 25.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
The wrong dose for the first Moderna Bivalent COVID vaccine was administered (As7146B) on 10/14/2022 at 0.25mL instead of 0.5m. Gave the other 0.25mL dose with the new Lot number (016F22A) on 10/24/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
The wrong dose for the first Moderna Bivalent COVID vaccine was administered (As7146B) on 10/14/2022 at 0.25mL instead of 0.5m. Gave the other 0.25mL dose with the new Lot number (016F22A) on 10/24/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 10,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 24.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
Patient receivent bivalent as a first shot. (Has not completed primary series yet)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 8,0
- Geschlecht
- M
- Eingang
- 25.10.2022
- Impfdatum
- 25.10.2022
- Beginn
- 25.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Patient was administered pediatric dose of bivalent booster with no history of primary series
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 25.10.2022
- Impfdatum
- 24.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
Symptomtext
Received bivalent moderna as first dose
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 24.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
The wrong dose for the first Moderna Bilavent COVID booster was administered on10/14/2022 at 0.25mL instead of the correct 0.5mL. Gave the other 0.25mL dose with the new lot number on 10/24/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 24.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
The wrong dose for the first Moderna Bilavent COVID booster was administered on10/14/2022 at 0.25mL instead of the correct 0.5mL. Gave the other 0.25mL dose with the new lot number on 10/24/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 24.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
The wrong dose for the first Moderna Bilavent COVID booster was administered on10/14/2022 at 0.25mL instead of the correct 0.5mL. Gave the other 0.25mL dose with the new lot number on 10/24/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 24.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
The wrong dose for the first Moderna Bilavent COVID booster was administered on10/14/2022 at 0.25mL instead of the correct 0.5mL. Gave the other 0.25mL dose with the new lot number on 10/24/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 24.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
The wrong dose for the first Moderna Bilavent COVID booster was administered on10/14/2022 at 0.25mL instead of the correct 0.5mL. Gave the other 0.25mL dose with the new lot number on 10/24/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 24.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
The wrong dose for the first Moderna Bilavent COVID booster was administered on10/14/2022 at 0.25mL instead of the correct 0.5mL. Gave the other 0.25mL dose with the new lot number on 10/24/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 23.10.2022
- Impfdatum
- 23.10.2022
- Beginn
- 23.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Circumstance or information capable of leading to medication error
Product administered to patient of inappropriate age
Symptomtext
Pt is 65 years old. Technician entered fluzone HD but wrote "fluBlok HD" on the form. The handheld device would not come up so the only double check was the QCPF.. It was folded in half lengthwise and only "flublok" was visible. I did not do the subtraction but looked like she was near 65. I told pt I was giving her flublok quad as I was administering it. I told her it was for pts under 65 yo and she said "I am 65 years old". We discussed the minimal difference in response that was likely with the lower dose at her current age. Pt did not seem concerned when she left.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Circumstance or information capable of leading to medication error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- none disclosed
- Vorgeschichte
- none disclosed
- Andere Medikamente
- none disclosed by pt
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 21.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Patient was administered Moderna Bivalent booster dose as a primary administration. He had not received any primary doses prior to this vaccination. Patient waited 15 minutes after administration without any adverse reaction. We contacted patient an hour later and still denied any adverse reaction. Instructed patient to call clinic with any question or concerns.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Heart murmur elevated systolic blood pressure Asthma
- Andere Medikamente
- Buspar 15mg Muprinocin zoloft
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 20.10.2022
- Impfdatum
- 20.10.2022
- Beginn
- 20.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Incomplete course of vaccination
Incorrect product formulation administered
Wrong product administered
Symptomtext
PATIENT RECEIVED THE MODERNDA BIVALENT BOOSTER, BUT HAD NOT COMPLETED THE PRIMARY SERIES. HE RECEIVED THE 1ST DOSE OF THE PRIMARYS SERIES IN MARCH OF 2021, BUT NEVERED RETURNED TO GET THE 2ND DOSE. THE ERROR WAS MADE IN GIVING THE BIVALENT DOSE BEFORE THE 2ND PRIMARY DOSE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- HIGH BLOOD PRESSURE & CHOLESTEROL, DIABETES, THYROID
- Andere Medikamente
- BUPROPION, METFORMIN, LEVOTHYROXINE, HYDRO/APAP, ATORVASTATIN, LISINOPRIL, OMEPRAZOLE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 8,0
- Geschlecht
- F
- Eingang
- 19.10.2022
- Impfdatum
- 19.10.2022
- Beginn
- 19.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
child was given 0.5ml of adult moderna bivalent
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 19.10.2022
- Impfdatum
- 15.10.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
Symptomtext
Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 19.10.2022
- Impfdatum
- 15.10.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
Symptomtext
Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 19.10.2022
- Impfdatum
- 15.10.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 19.10.2022
- Impfdatum
- 15.10.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 19.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
Error: Wrong Vaccine/Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 14.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure via skin contact
Syringe issue
Underdose
Symptomtext
The patient felt drip and wetness while being vaccinated. Some of the vaccine leaked from the syringe almost at the end of the vaccination. Patient and pharamcist decided that patient might have not received the full dose. After discussing with the patient, another pharmacist repeated the 0.25 ml of dose with the patient's full permission to ensure the patient got the full dose of vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure via skin contact
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Allergic to chlorhexidine
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 14.10.2022
- Impfdatum
- 13.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
My nurse gave the Bivalent Booster believing the patient had the primary series already but this ended up to not be the case. No side effects reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Panic Disorder
- Andere Medikamente
- Lutera (OCP)
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 12.10.2022
- Impfdatum
- 11.10.2022
- Beginn
- 11.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Tinnitus
Symptomtext
Minor tinnitus in left ear. I received both vaccines at the same time, one in each shoulder. I am not sure which vaccine went into which shoulder and I think there is no way to tell if one vaccine or the other (or their interaction) caused the tinnitus.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tinnitus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- None
- Allergien
- -
- Vorherige Impfungen
- -